{
  "meta": {
    "title": "83_Pathology_Ini-Cet_2021",
    "url": "https://brainandscalpel.vercel.app/83-pathology-ini-cet-2021-5d00d566.html",
    "scrapedAt": "2025-11-30T12:58:28.979Z"
  },
  "questions": [
    {
      "text": "What is the cell of origin of Chronic Lymphocytic Leukaemia/Small Lymphocytic Lymphoma?",
      "choices": [
        {
          "id": 1,
          "text": "Mature B cells"
        },
        {
          "id": 2,
          "text": "Mature T cells"
        },
        {
          "id": 3,
          "text": "Progenitor T cells"
        },
        {
          "id": 4,
          "text": "Naive B cells"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>The cell of origin of Chronic Lymphocytic Leukaemia (CLL)/ Small Lymphocytic Lymphoma (SLL) is either<strong> naive B cells or post-germinal centre memory B cell.</strong> </p>\n<p>The CLL and SLL differ only in the degree of peripheral blood lymphocytes. CLL is the <strong>most common leukemia</strong> of adults in the western world. The median age of diagnosis is <strong>60 years</strong>. The most common genetic anomalies seen are <strong>deletions of 13q14.3, 11q, and 17p </strong>and<strong> trisomy 12q. </strong>Loss of tumor suppressor genes in chromosome 13 results in overexpression of the anti-apoptotic protein <strong>BCL2</strong>.</p>\n<p>The growth of CLL/SLL cells is confined to the <strong>proliferation centers </strong>(pathognomonic for CLL/SLL), where the tumor cells receive critical factors from the surrounding environments, such as <strong>NF-κB</strong> for cell survival, <strong>MYC</strong> for cell growth, <strong>Bruton Tyrosine Kinase </strong>(BTK) signaling pathway, etc.,</p>\n<p>The tumor cells express <strong>CD19, CD20, CD23, and CD5. </strong><strong>Smudge cells</strong> are also characteristic of CLL. <strong>Clinical features</strong> include easy fatiguability, weight loss, anorexia, generalized lymphadenopathy, hepatomegaly, hemolytic anemia, etc. CLL/SLL has a tendency to transform to a more aggressive diffuse large B-cell lymphoma (<strong>DLBCL</strong>)  - this is called <strong>Richter syndrome.</strong></p>\n<p>Factors with a bad prognosis include:</p>\n<ol>\n<li><strong>Presence of deletions of 11q and  17p.</strong></li>\n<li><strong>Lack of somatic hypermutation.</strong></li>\n<li><strong>Expression of ZAP-70, a protein that augments signals produced by the Ig receptor.</strong></li>\n<li><strong>Presence of NOTCH1 mutations</strong></li>\n</ol>\n<p><strong>BTK inhibitors</strong> and <strong>BCL2 inhibitors</strong> produce sustained therapeutic responses in a higher fractions of people with CLL/SLL.</p><hr><h3>Related Pearl: Lymphoid Neoplasms with their Cell of Origin</h3><img src=\"https://cdn1.dailyrounds.org/uploads/02222251e8bf4380b0c5210a9e3be106x939x699.PNG\" alt=\"Pearl Image\"><div class=\"page\" title=\"Page 597\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>CLP, Common lymphoid precursor; BLB, pre-B lymphoblast; DN, CD4/CD8 double-negative pro-T cell; DP, CD4/CD8 double-positive pre-T cell; GC, germinal-center B cell; MC, mantle B cell; MZ, marginal zone B cell; NBC, naive B cell; PTC, peripheral T cell.</p>\n</div>\n</div>\n</div><hr><h3>Related Pearl: WHO classification of Lymphoid Neoplasms</h3><table>\n<tbody>\n<tr>\n<td><strong>I. Precursor B-Cell Neoplasms</strong></td>\n</tr>\n<tr>\n<td>\n<p>B-cell acute lymphoblastic leukemia/lymphoma</p>\n<p>(B-ALL)</p>\n</td>\n</tr>\n<tr>\n<td><strong>II. Peripheral B-Cell Neoplasms</strong></td>\n</tr>\n<tr>\n<td>Chronic lymphocytic leukemia/small lymphocytic lymphoma<br />B-cell prolymphocytic leukemia<br />Lymphoplasmacytic lymphoma<br />Splenic and nodal marginal zone lymphomas<br />Extranodal marginal zone lymphoma<br />Mantle cell lymphoma<br />Follicular lymphoma<br />Marginal zone lymphoma<br />Hairy cell leukemia<br />Plasmacytoma/plasma cell myeloma<br />Diffuse large B-cell lymphoma<br />Burkitt lymphoma</td>\n</tr>\n<tr>\n<td><strong>III. Precursor T-Cell Neoplasms</strong></td>\n</tr>\n<tr>\n<td>\n<p>T-cell acute lymphoblastic leukemia/lymphoma</p>\n<p>(T-ALL)</p>\n</td>\n</tr>\n<tr>\n<td><strong>IV. Peripheral T-Cell and NK-Cell Neoplasms</strong></td>\n</tr>\n<tr>\n<td>T-cell prolymphocytic leukemia<br />Large granular lymphocytic leukemia<br />Mycosis fungoides/S&eacute;zary syndrome<br />Peripheral T-cell lymphoma, unspecified<br />Anaplastic large-cell lymphoma<br />Angioimmunoblastic T-cell lymphoma<br />Enteropathy-associated T-cell lymphoma<br />Panniculitis-like T-cell lymphoma<br />Hepatosplenic &gamma;&delta;T-cell lymphoma<br />Adult T-cell leukemia/lymphoma<br />Extranodal NK/T-cell lymphoma<br />NK-cell leukemia</td>\n</tr>\n<tr>\n<td><strong>V. Hodgkin Lymphoma</strong></td>\n</tr>\n<tr>\n<td>Nodular sclerosis<br />Mixed cellularity<br />Lymphocyte-rich<br />Lymphocyte depletion<br />Lymphocyte predominance</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><hr><h3>Related Pearl: Panel of monoclonal antibodies for classification of leukemias</h3><table>\n<tbody>\n<tr>\n<td>\n<p>Haematopoetic</p>\n<p>precursors&nbsp;</p>\n</td>\n<td>CD34,Tdt, HLA-DR&nbsp;</td>\n</tr>\n<tr>\n<td>Myeloid&nbsp;</td>\n<td>CD13, CD33, CD15, MPO, CD117&nbsp;</td>\n</tr>\n<tr>\n<td>B cell&nbsp;</td>\n<td>CD19, CD20, CD22,&nbsp;CD79 a&nbsp;</td>\n</tr>\n<tr>\n<td>T cell&nbsp;</td>\n<td>CD2, CD3, CD5, CD7&nbsp;</td>\n</tr>\n<tr>\n<td>Monocytic&nbsp;</td>\n<td>CD11b, CD14&nbsp;</td>\n</tr>\n<tr>\n<td>Megakaryoblastic&nbsp;</td>\n<td>CD41, CD42, CD61&nbsp;</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF0732",
      "difficulty": "medium"
    },
    {
      "text": "Human Papilloma Virus inactivates RB gene by which of the following proteins?",
      "choices": [
        {
          "id": 1,
          "text": "E6"
        },
        {
          "id": 2,
          "text": "E7"
        },
        {
          "id": 3,
          "text": "L1"
        },
        {
          "id": 4,
          "text": "L2"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><strong>E7 protein</strong> of Human Papilloma Virus (HPV) binds to the hypophosphorylated RB protein and displaces the <strong>E2F transcription factors</strong>, thereby promoting G1/S transition.</p>\n<p>RB gene is a key <strong>negative regulator </strong>of the cell cycle at the <strong>G1/S transition</strong>. RB gene exists in an active hypophosphorylated state in resting cells and in an inactive hyperphosphorylated state in cells undergoing G1/S transition.</p>\n<p>E7 protein from the <strong>high-risk</strong> types of HPV (such as HPV 16) binds to the hypophosphorylated RB through the same pocket that RB uses to bind and sequester the E2F transcription factors, thereby displacing the E2F which leads to the progression of the cell cycle and thus the proliferation of tumor cells. E7 proteins also <strong>inactivate</strong> the <strong>CDK inhibitors p21</strong> and <strong>p27</strong>. E7 proteins from high-risk HPVs (types 16,18 and 31) also bind and presumably <strong>activates cyclins &nbsp;A and E.</strong></p>\n<p><strong>Oncogenic activities of protein E6:</strong></p>\n<p>The E6 protein binds to and helps in the degradation of p53 and stimulates the expression of telomerase reverse transcriptase (<strong>TERT</strong>), which is the catalytic subunit of telomerase, thereby helping in the <strong>longevity</strong> of the cells.&nbsp;E6 from high-risk HPV types has a <strong>higher affinity</strong> for p53 than E6 from low-risk types.&nbsp;</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/a86d09d75c0b4dc28b0a9eb2e77b55d7x600x649.JPEG\" alt=\"Explanation Image\"><hr><h3>Related Pearl: Location of Important Genes on Chromosome</h3><table class=\"t1\">\n<tbody>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<p class=\"p1\"><strong>Gene</strong></p>\n</td>\n<td class=\"td1\" valign=\"top\">\n<p class=\"p1\"><strong>Chromosome</strong></p>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<p class=\"p1\"><em>P73</em></p>\n</td>\n<td class=\"td1\" valign=\"top\">\n<p class=\"p1\">1p</p>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<p class=\"p1\">Folate transporter</p>\n</td>\n<td class=\"td1\" valign=\"top\">\n<p class=\"p1\">21q</p>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<p class=\"p1\">Neuroblastoma</p>\n</td>\n<td class=\"td1\" valign=\"top\">\n<p class=\"p1\">1p</p>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<p class=\"p1\">Rhodopsin</p>\n</td>\n<td class=\"td1\" valign=\"top\">\n<p class=\"p1\">3</p>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<p class=\"p1\"><em>VHL</em></p>\n</td>\n<td class=\"td1\" valign=\"top\">\n<p class=\"p1\">3p</p>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<p class=\"p1\"><em>ADPKD-2</em></p>\n</td>\n<td class=\"td1\" valign=\"top\">\n<p class=\"p1\">4q</p>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<p class=\"p1\"><em>APC</em></p>\n</td>\n<td class=\"td1\" valign=\"top\">\n<p class=\"p1\">5q</p>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<p class=\"p1\"><em>MHC</em></p>\n</td>\n<td class=\"td1\" valign=\"top\">\n<p class=\"p1\">6p</p>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<p class=\"p1\"><em>ARPKD</em></p>\n</td>\n<td class=\"td1\" valign=\"top\">\n<p class=\"p1\">6</p>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<p class=\"p1\">Cystic fibrosis</p>\n</td>\n<td class=\"td1\" valign=\"top\">\n<p class=\"p1\">7q</p>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<p class=\"p1\"><em>MET</em></p>\n</td>\n<td class=\"td1\" valign=\"top\">\n<p class=\"p1\">7</p>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<p class=\"p1\"><em>RET</em></p>\n</td>\n<td class=\"td1\" valign=\"top\">\n<p class=\"p1\">10</p>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<p class=\"p1\"><em>WT-1</em></p>\n</td>\n<td class=\"td1\" valign=\"top\">\n<p class=\"p1\">11p</p>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<p class=\"p1\"><em>vWF</em></p>\n</td>\n<td class=\"td1\" valign=\"top\">\n<p class=\"p1\">12</p>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<p class=\"p1\">Retinoblastoma</p>\n</td>\n<td class=\"td1\" valign=\"top\">\n<p class=\"p1\">13q</p>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<p class=\"p1\"><em>BRCA_1</em></p>\n</td>\n<td class=\"td1\" valign=\"top\">\n<p class=\"p1\">17q</p>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<p class=\"p1\">Fibrillin -1</p>\n</td>\n<td class=\"td1\" valign=\"top\">\n<p class=\"p1\">15</p>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<p class=\"p1\">Fibrillin-2</p>\n</td>\n<td class=\"td1\" valign=\"top\">\n<p class=\"p1\">5</p>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<p class=\"p1\"><em>BRCA-2</em></p>\n</td>\n<td class=\"td1\" valign=\"top\">\n<p class=\"p1\">13q</p>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<p class=\"p1\"><em>NF-1</em></p>\n</td>\n<td class=\"td1\" valign=\"top\">\n<p class=\"p1\">17q</p>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<p class=\"p1\"><em>P53</em></p>\n</td>\n<td class=\"td1\" valign=\"top\">\n<p class=\"p1\">17</p>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<p class=\"p1\">Dystrophin</p>\n</td>\n<td class=\"td1\" valign=\"top\">\n<p class=\"p1\">Xp21.2</p>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<p class=\"p1\"><em>NF-2</em></p>\n</td>\n<td class=\"td1\" valign=\"top\">\n<p class=\"p1\">22q</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF0739",
      "difficulty": "medium"
    },
    {
      "text": "In cystic fibrosis, which of the following structure is affected in pancreas?",
      "choices": [
        {
          "id": 1,
          "text": "A"
        },
        {
          "id": 2,
          "text": "B"
        },
        {
          "id": 3,
          "text": "C"
        },
        {
          "id": 4,
          "text": "D"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The part labeled ‘B’ in the image is the <strong>exocrine</strong> <strong>pancreas</strong> which is affected in cystic fibrosis.</p>\n<p> Features of cystic fibrosis in the pancreas:</p>\n<ul>\n<li>Accumulation of <strong>mucus</strong> in the ducts leads to <strong>dilation of exocrine</strong> glands.</li>\n<li>Complete blockage of ducts with mucus leads to <strong>atrophy</strong> of the exocrine pancreas and progressive fibrosis</li>\n<li>Due to atrophy, there will be loss of exocrine secretions, which in turn leads to impaired absorption of fat and fat-soluble vitamins</li>\n<li>Associated loss of vitamin A leads to squamous metaplasia of the pancreatic duct lining epithelium</li>\n</ul><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/05ffd5d4951043478a5ae6b1d903930bx1280x1405.JPEG\" alt=\"Explanation Image\"><p>Other options:</p>\n<p>A- Endocrine pancreas</p>\n<p>C- Pancreatic ducts</p>\n<p>D- Blood vessels</p>\n<p> </p>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/73cc80aa29c4419380f1d5b9bd9a72fd.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF0906",
      "difficulty": "medium"
    },
    {
      "text": "Mediators involved in the early phase of type 1 hypersensitivity are?<div class='question-desc-html'><ol>\n<li>Mast cell</li>\n<li>Histamine</li>\n<li>Neutrophils</li>\n<li>Prostaglandins</li>\n<li>Leukotrienes</li>\n</ol></div>",
      "choices": [
        {
          "id": 1,
          "text": "1, 5"
        },
        {
          "id": 2,
          "text": "1, 2, 3, 4,"
        },
        {
          "id": 3,
          "text": "1, 2, 4, 5"
        },
        {
          "id": 4,
          "text": "2, 3, 4"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>The <strong>mediators</strong> involved in the <strong>early phase of type 1 hypersensitivity</strong> are,&nbsp;</p>\n<ul>\n<li>Mast cells,&nbsp;</li>\n<li>Histamine,</li>\n<li>Prostaglandins (D2) and&nbsp;</li>\n<li>Leukotrienes (C4 and D4).</li>\n</ul>\n<p>Early phase of type 1 hypersensitivity:</p>\n<p>The mediators produced by the <strong>mast cells</strong> are responsible for most of the immediate hypersensitivity reactions. <strong>Histamine </strong>and <strong>leukotrienes</strong> are <strong>released rapidly</strong> from the sensitized mast cells and<strong> trigger intense immediate reactions</strong> characterized by edema, mucus secretion and smooth muscle spasm.</p>\n<p><strong>Other mediators</strong> involved in the early phase are,&nbsp;</p>\n<ul>\n<li>Enzymes: neutral proteases (chymase, tryptase) and acid hydrolases</li>\n<li>Proteoglycans: heparin and chondroitin sulfate</li>\n<li>Lipid mediators: Platelet-activating factor (PAF)</li>\n</ul>\n<p>Late-phase of type 1 hypersensitivity:</p>\n<p>The <strong>late phase</strong> reaction is characterized by the <strong>recruitment of leukocytes</strong>, that <strong>amplify</strong> and <strong>sustain the inflammatory response</strong> without exposure to the triggering antigen.</p>\n<p><strong>Mediators</strong> involved in the&nbsp;<strong>late phase</strong> of type 1 hypersensitivity reaction are:</p>\n<ul>\n<li>Cytokines: TNF, IL-1, IL-4, IL-5, and chemokines (eotaxin)</li>\n<li>Leukocytes (eosinophils)</li>\n<li>Major Basic Protein (MBP)</li>\n<li>Eosinophil cationic protein</li>\n</ul><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/a1f061e9c572411eb6c43341cba6289cx1280x2558.JPEG\" alt=\"Explanation Image\"><hr><h3>Related Pearl: Mechanisms of Hypersensitivity Reactions</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Type</strong></p>\n</td>\n<td>\n<p><strong>Immune Mechanisms</strong></p>\n</td>\n<td>\n<p><strong>Histopathological lesions</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Immediate </strong><br /><strong>&nbsp;hypersensitivity<br />(type I)<br /></strong></p>\n<ul>\n<li>Anaphylaxis</li>\n<li>Allergies</li>\n<li>Bronchial asthma</li>\n<li>Atopic dermatitis</li>\n</ul>\n</td>\n<td>\n<p>Production of IgE antibody &rarr;immediate release of vasoactive amines from mast cells</p>\n</td>\n<td>\n<p>Vascular dilatation, edema, smooth muscle contraction, mucus production, tissue injury, inflammation</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Antibody-mediated hypersensitivity<br />(type II)<br /></strong></p>\n<ul>\n<li>Autoimmune hemolytic anemia</li>\n<li>Goodpasture syndrome</li>\n</ul>\n</td>\n<td>\n<p>Production of IgG, IgM &rarr; binds to antigen on target cell or tissue &rarr; phagocytosis or lysis of target cell by activated complement or Fc receptors; recruitment of leukocytes</p>\n</td>\n<td>\n<p>Phagocytosis and lysis of cells; inflammation;</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Immune complex-mediated hypersensitivity<br /> (type III)<br /></strong></p>\n<ul>\n<li>SLE</li>\n<li>Serum sickness</li>\n<li>Arthus reaction</li>\n</ul>\n</td>\n<td>\n<p>Deposition of antigen-antibody complexes &rarr; complement activation &rarr;recruitment of leukocytes by complement products and Fc receptors &rarr; release of enzymes and other toxic molecules</p>\n</td>\n<td>\n<p>Inflammation, necrotizing vasculitis (fibrinoid necrosis)</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Cell-mediated hypersensitivity<br />(type IV)</strong></p>\n<ul>\n<li>Contact dermatitis</li>\n<li>Multiple sclerosis</li>\n<li>Type 1 diabetes</li>\n<li>Tuberculosis</li>\n</ul>\n</td>\n<td>\n<p>Activated T lymphocytes &rarr;</p>\n<p>1. Release of cytokines, inflammation, and macrophage activation</p>\n<p>2. T-cell-mediated cytotoxicity</p>\n</td>\n<td>\n<p>Perivascular cellular infiltrates; edema; granuloma formation; cell destruction</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/f55cab6c8fd44a7abfe8a663dde3980ex1280x2567.JPEG\" alt=\"Pearl Image\"><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/b2a98b94d6a9479b8e6e885ee59366cex1280x2089.JPEG\" alt=\"Pearl Image\"><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/d92e092ef5874477a6da091ca3b1234ax1280x1360.JPEG\" alt=\"Pearl Image\"><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/56fc1dfb49434818b5057534a97d6621x1280x4218.JPEG\" alt=\"Pearl Image\"><hr><h3>Related Pearl: Types of Hypersensitivity</h3><table>\n<tbody>\n<tr>\n<td><strong>Type of reaction</strong></td>\n<td><strong>Clinical Syndrome</strong></td>\n<td><strong>Time for manifestation</strong></td>\n<td><strong>Mediators</strong></td>\n</tr>\n<tr>\n<td><strong>Type I</strong>: <br />IgE type</td>\n<td>\n<p>1. Anaphylaxis</p>\n<p>2. Atopy</p>\n</td>\n<td>Minutes</td>\n<td>IgE: histamine and other pharmacological agents</td>\n</tr>\n<tr>\n<td><strong>Type II</strong>: <br />Cytolytic, cytotoxic</td>\n<td>\n<p>Antibody-mediated damage: e.g. thrombocytopenia, agranulocytosis, hemolytic anemia</p>\n</td>\n<td>Hours to days</td>\n<td>IgG, IgM</td>\n</tr>\n<tr>\n<td><strong>Type III</strong>:<br /> Immune complex</td>\n<td>\n<p>1.Arthus-reaction</p>\n<p>2.Serum-sickness</p>\n</td>\n<td>Hours to days</td>\n<td>IgG, IgM, leucocytes</td>\n</tr>\n<tr>\n<td><strong>Type IV</strong>: <br />Delayed hypersensitivity</td>\n<td>\n<p>1. Tuberculin</p>\n<p>2. Contact dermatitis</p>\n</td>\n<td>Hours to days</td>\n<td>T cells, lymphokines, macrophages.</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF0773",
      "difficulty": "medium"
    },
    {
      "text": "Given below is an image of activation of the coagulation cascade, following closed endothelial injury. Identify the factor ‘L’ which combines with tissue factor to activate factor IX.",
      "choices": [
        {
          "id": 1,
          "text": "Factor XII"
        },
        {
          "id": 2,
          "text": "Factor VII"
        },
        {
          "id": 3,
          "text": "Factor VIII"
        },
        {
          "id": 4,
          "text": "vWF"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The factor marked as ‘L’ is <strong>factor VII</strong>, which combines with <strong>tissue factor</strong> that is produced following a close endothelial injury to activate factor IX. </p>\n<p>As the image represents the <strong><em>in vivo</em></strong> coagulation cascade, the <strong>tissue factor</strong> is the major initiator of coagulation. It is believed that <em><strong>in vivo</strong>, </em><strong>factor VIIa/tissue factor complex</strong> is the most important activator of <strong>factor IX</strong> and that <strong>factor IXa/factor VIIIa complex</strong> is the most important activator of <strong>factor X.</strong> </p>\n<p>Tissue factor is expressed on the surfaces of the subendothelial cellular components of the vessel wall, such as smooth muscle cells and fibroblasts. This tissue factor is exposed to blood when there is a vascular damage. This activates the <strong><em>in vivo</em> extrinsic pathway</strong> of coagulation cascade, which is as follows:</p>\n<ul>\n<li>Tissue factor binds with serine protease factor <strong>VIIa</strong></li>\n<li>This complex then activates factor <strong>IX</strong> to factor <strong>IXa</strong></li>\n<li>Factor <strong>IXa</strong> then activates factor <strong>X</strong> to factor <strong>Xa</strong></li>\n<li>Factor <strong>Xa</strong> can be formed through the actions of <strong>either</strong> the tissue factor-factor <strong>VIIa</strong> complex <strong>or</strong> factor <strong>IXa</strong> (with factor VIIIa as cofactor)</li>\n<li>Factor <strong>Xa</strong> then converts <strong>prothrombin to thrombin</strong>, which is the pivotal protease of the coagulation cascade.</li>\n<li>The cofactor essential for this conversion is factor <strong>Va.</strong></li>\n<li>The <strong>thrombin</strong> then formed <strong>converts</strong> the soluble plasma <strong>fibrinogen</strong> to an insoluble <strong>fibrin</strong> matrix.</li>\n<li>Thrombin also activates factor <strong>XIII,</strong> which is the fibrin stabilizing factor, to factor <strong>XIIIa.</strong> This factor XIIIa forms covalent cross-links and thereby stabilizes the fibrin clot.</li>\n</ul>\n<p>The below image shows the <strong><em>in vivo </em>coagulation cascade.</strong></p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/e166fa76bdd646689e605a2eaae2ed57x1280x1711.JPEG\" alt=\"Explanation Image\"><hr><h3>Related Pearl: Coagulation Pathways and its Abnormalities</h3><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/0fedd76b578148fc8ed55da37e66574cx1280x1995.JPEG\" alt=\"Pearl Image\"><table>\n<tbody>\n<tr>\n<td><strong>Test results</strong></td>\n<td><strong>Inherited causes</strong></td>\n<td><strong>Acquired causes</strong></td>\n</tr>\n<tr>\n<td>\n<p><strong>Prolonged PT </strong></p>\n<p>Evaluates extrinsic pathway factors</p>\n<p>Normal PT: 11-13 seconds</p>\n</td>\n<td>Factor VII deficiency </td>\n<td>\n<p>Mild vitamin K deficiency</p>\n<p>Liver disease</p>\n<p>Warfarin</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Prolonged aPTT </strong></p>\n<p>Evaluates intrinsic pathway factors</p>\n<p>Normal aPTT: 25-35 seconds</p>\n</td>\n<td>\n<p>Factors VIII, IX, XI deficiency</p>\n<p>Factor XII, prekallikrein, or HMW kininogen deficiency</p>\n<p>von Willebrand disease</p>\n</td>\n<td>Heparin, lupus anticoagulant, acquired von Willebrand disease</td>\n</tr>\n<tr>\n<td>\n<p>Prolonged PT + prolonged aPTT</p>\n<p>Evaluates common pathway factors</p>\n</td>\n<td>\n<p>Prothrombin (II), fibrinogen (I), factors V and factor X deficiencies</p>\n</td>\n<td>\n<p>Disseminated intravascular coagulation (DIC)</p>\n<p>Severe liver disease</p>\n<p>Severe vitamin K deficiency</p>\n<p>Direct thrombin inhibitor-argatroban, dabigatran</p>\n<p>Direct factor Xa inhibitor-rivaroxaban, apixaban, edoxaban</p>\n<p>Fondaparinux</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p> </p><hr><h3>Related Pearl: Characteristics of Inherited Coagulation Disorders</h3><table>\n<thead>\n<tr>\n<td rowspan=\"2\">\n<p><strong>Clotting Factor Deficiency</strong></p>\n</td>\n<td rowspan=\"2\">\n<p><strong>Inheritance</strong></p>\n</td>\n<td colspan=\"3\">\n<p><strong>Laboratory Abnormality&nbsp;</strong></p>\n</td>\n<td rowspan=\"2\">\n<p><strong>Treatment</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>aPTT</strong></p>\n</td>\n<td>\n<p><strong>PT</strong></p>\n</td>\n<td>\n<p><strong>TT</strong></p>\n</td>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>\n<p>Fibrinogen</p>\n</td>\n<td>\n<p>AR</p>\n</td>\n<td>\n<p>+</p>\n</td>\n<td>\n<p>+</p>\n</td>\n<td>\n<p>+</p>\n</td>\n<td>\n<p>Cryoprecipitate</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Prothrombin</p>\n</td>\n<td>\n<p>AR</p>\n</td>\n<td>\n<p>+</p>\n</td>\n<td>\n<p>+</p>\n</td>\n<td>\n<p>&ndash;</p>\n</td>\n<td>\n<p>FFP/PCC</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Factor V</p>\n</td>\n<td>\n<p>AR</p>\n</td>\n<td>\n<p>+/&ndash;</p>\n</td>\n<td>\n<p>+/&ndash;</p>\n</td>\n<td>\n<p>&ndash;</p>\n</td>\n<td>\n<p>FFP</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Factor VII</p>\n</td>\n<td>\n<p>AR</p>\n</td>\n<td>\n<p>&ndash;</p>\n</td>\n<td>\n<p>+</p>\n</td>\n<td>\n<p>&ndash;</p>\n</td>\n<td>\n<p>FFP/PCC</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Factor VIII</p>\n</td>\n<td>\n<p>X-linked</p>\n</td>\n<td>\n<p>+</p>\n</td>\n<td>\n<p>&ndash;</p>\n</td>\n<td>\n<p>&ndash;</p>\n</td>\n<td>\n<p>FVIII concentrates</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Factor IX</p>\n</td>\n<td>\n<p>X-linked</p>\n</td>\n<td>\n<p>+</p>\n</td>\n<td>\n<p>&ndash;</p>\n</td>\n<td>\n<p>&ndash;</p>\n</td>\n<td>\n<p>FIX concentrates</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Factor X</p>\n</td>\n<td>\n<p>AR</p>\n</td>\n<td>\n<p>+/&ndash;</p>\n</td>\n<td>\n<p>+/&ndash;</p>\n</td>\n<td>\n<p>&ndash;</p>\n</td>\n<td>\n<p>FFP/PCC</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Factor XI</p>\n</td>\n<td>\n<p>AR</p>\n</td>\n<td>\n<p>+</p>\n</td>\n<td>\n<p>&ndash;</p>\n</td>\n<td>\n<p>&ndash;</p>\n</td>\n<td>\n<p>FFP</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Factor XII</p>\n</td>\n<td>\n<p>AR</p>\n</td>\n<td>\n<p>+</p>\n</td>\n<td>\n<p>&ndash;</p>\n</td>\n<td>\n<p>&ndash;</p>\n</td>\n<td>\n<p><strong>No </strong>risk of bleeding; treatment not indicated</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>*FFP: Fresh frozen plasma</p>\n<p>PCC: Prothrombin complex concentrate</p>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/7af2c8b518554536a3ebb3c9d7e6c441.PNG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF0668",
      "difficulty": "medium"
    },
    {
      "text": "The vacutainer tube shown in the given image contains:",
      "choices": [
        {
          "id": 1,
          "text": "Na-EDTA"
        },
        {
          "id": 2,
          "text": "Trisodium citrate"
        },
        {
          "id": 3,
          "text": "NAF-heparin"
        },
        {
          "id": 4,
          "text": "Clot activator"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>The plastic tube shown in the given image has<strong>&nbsp;</strong>a<strong> red stopper,&nbsp;</strong>hence&nbsp;it&nbsp;contains <strong>clot activator.</strong></p>\n<p><strong>Red stopper plastic tubes</strong> contain silica as a clot activator.&nbsp;They are used for serum chemistry tests, serology&nbsp;tests, and in blood banks, where both serum and red&nbsp;blood cells may be used.</p>\n<p>The tubes are inverted five times to initiate&nbsp;the clotting process.</p>\n<p>Note:&nbsp;<strong>Red stopper glass tubes</strong> are often referred to as clot or&nbsp;<strong>plain tubes</strong> because they contain no anticoagulants or&nbsp;additives.</p><p>Some important plastic tubes and their additives:</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Cap colour</strong></td>\n<td><strong>Additive present</strong></td>\n</tr>\n<tr>\n<td>Light blue top</td>\n<td>Sodium citrate</td>\n</tr>\n<tr>\n<td>Dark green top</td>\n<td>Heparin</td>\n</tr>\n<tr>\n<td>Purple top</td>\n<td>EDTA</td>\n</tr>\n<tr>\n<td>Pale yellow top</td>\n<td>Acid citrate dextrose</td>\n</tr>\n<tr>\n<td>Light grey top</td>\n<td>Sodium fluoride and potassium oxalate</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/c1b7aafe86d343afb74cd33d0c3f010c.PNG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD4296",
      "difficulty": "easy"
    },
    {
      "text": "Arrange the following cellular events of inflammation in the correct sequence:<div class='question-desc-html'><ol>\n<li>Rolling</li>\n<li>Cytokine-mediated integrin activation</li>\n<li>Adhesion</li>\n<li>Migration</li>\n</ol></div>",
      "choices": [
        {
          "id": 1,
          "text": "1, 2, 3, 4"
        },
        {
          "id": 2,
          "text": "2, 1, 4, 3"
        },
        {
          "id": 3,
          "text": "4, 1, 2, 3"
        },
        {
          "id": 4,
          "text": "3, 4, 1, 2"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The correct sequence of cellular events that occurs during inflammation is as follows: <strong>Rolling, Cytokine-mediated integrin activation, Adhesion, Migration</strong>.</p>\n<p>The recruitment of leucocytes to the site of inflammation is a multi-step process that is mediated by adhesion molecules and cytokines called chemokines. This process can be divided into sequential phases:</p>\n<ol>\n<li>In the lumen: margination, <strong>rolling</strong> and <strong>adhesion</strong> to the endothelium occurs.</li>\n<li><strong>Migration</strong> of the leucocytes across the endothelium and vessel wall</li>\n<li><strong>Migration</strong> in the tissues towards a chemotactic stimulus.</li>\n</ol>\n<p>The process of leucocyte recruitment is as follows:</p>\n<ul>\n<li>Margination: Because of the dilation of the inflamed postcapillary venues, there is stasis of blood flow, and hence, more leucocytes assume a peripheral position along the endothelial surface; this process of leucocyte redistribution is called margination.</li>\n<li><strong>Rolling</strong>: The slowed down leucocytes then sense the signals from the endothelium and start rolling on the vessel wall.</li>\n<li><strong>Cytokine-mediated integrin activation</strong>: The attachment of leucocytes to the endothelial cells requires adhesion molecules that are activated by cytokines. The major families of proteins involved in adhesion and migration are <strong>selectins</strong> and <strong>integrins</strong> and their ligands.</li>\n<li><strong>Adhesions</strong>: The weak rolling interactions slow down the leucocytes and allow them to bind more firmly to the endothelium. <strong>Chemokines</strong> that were produced at the site of injury bind to the endothelial cell proteoglycans. These chemokines then bind to the rolling leucocytes and activate them. This, in turn, converts the ligands for β1 and β2 integrins, <strong>VLA-4,</strong> and <strong>LFA-1 </strong>present on the leucocytes to a <strong>high-affinity state</strong>.</li>\n<li>This combination of cytokine-induced expression of integrin ligands on the endothelium and increased integrin affinity on the leucocytes leads to firm <strong>adhesion</strong> of leucocytes to the endothelium at the site of inflammation.</li>\n<li>Leucocyte<strong> migration</strong>: This is the movement of leucocytes through the intact endothelium, called transmigration or diapedesis. This occurs in postcapillary venules. This migration occurs through the inter-endothelial gap towards the chemical concentration gradient created by the chemokines at the site of injury. This occurs with the help of adhesion molecules present in the intercellular junctions such as <strong>platelet endothelial cell adhesion molecule</strong> (<strong>PECAM-1</strong>) or <strong>CD31</strong>. </li>\n</ul><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/13f6cf1070f84ca2831df8bddc1eb8ecx1280x1743.JPEG\" alt=\"Explanation Image\"><hr><h3>Related Pearl: Principal Mediators of Inflammation and Their Source</h3><table>\n<tbody>\n<tr>\n<td><strong>Mediator</strong></td>\n<td><strong>Source</strong></td>\n</tr>\n<tr>\n<td>Histamine</td>\n<td>Mast&ensp;cells,&ensp;basophils,&ensp;platelets</td>\n</tr>\n<tr>\n<td>Prostaglandins</td>\n<td>Mast&ensp;cells,&ensp;leukocytes</td>\n</tr>\n<tr>\n<td>Leukotrienes</td>\n<td>Mast&ensp;cells,&ensp;leukocytes</td>\n</tr>\n<tr>\n<td>Cytokines&ensp;(TNF,&ensp;IL-1,&ensp;IL-6)</td>\n<td>Macrophages,&ensp;endothelial&ensp;cells, mast&ensp;cells</td>\n</tr>\n<tr>\n<td>Chemokines</td>\n<td>Leukocytes,&ensp;activated&ensp;macrophages</td>\n</tr>\n<tr>\n<td>Platelet-activating&ensp;factor</td>\n<td>Leukocytes,&ensp;mast&ensp;cells</td>\n</tr>\n<tr>\n<td>Complement</td>\n<td>Plasma&ensp;(produced&ensp;in&ensp;liver)</td>\n</tr>\n<tr>\n<td>Kinins</td>\n<td>Plasma&ensp;(produced&ensp;in&ensp;liver)</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><hr><h3>Related Pearl: Various actions of Principal Mediators of Inflammation</h3><table>\n<tbody>\n<tr>\n<td>Histamine</td>\n<td>Vasodilation, increased vascular permeability, endothelial activation</td>\n</tr>\n<tr>\n<td>Prostaglandins</td>\n<td>Vasodilation, pain, fever</td>\n</tr>\n<tr>\n<td>Leukotrienes</td>\n<td>Increased vascular permeability, chemotaxis, leukocyte adhesion, and activation</td>\n</tr>\n<tr>\n<td>Cytokines (TNF, IL-1, IL-6)</td>\n<td>\n<p>Local: endothelial activation (expression of adhesion molecules).</p>\n<p>Systemic: fever, metabolic abnormalities, hypotension (shock)</p>\n</td>\n</tr>\n<tr>\n<td>Chemokines</td>\n<td>Chemotaxis, leukocyte activation</td>\n</tr>\n<tr>\n<td>Platelet-activating factor</td>\n<td>Vasoconstriction, Vasodilation (at low concentration), increased vascular permeability, leukocyte adhesion, chemotaxis, degranulation, oxidative burst</td>\n</tr>\n<tr>\n<td>Complement</td>\n<td>Leukocyte chemotaxis and activation, direct target killing (membrane attack complex), vasodilation (mast cell stimulation)</td>\n</tr>\n<tr>\n<td>Kinins</td>\n<td>Increased vascular permeability, smooth muscle contraction, vasodilation, pain</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>Note: Thromboxane A2 (TXA2) is a prostaglandin, which is a potent <strong>vasoconstrictor</strong></p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF0755",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following is used in the treatment of sideroblastic anemia?",
      "choices": [
        {
          "id": 1,
          "text": "Vitamin B12"
        },
        {
          "id": 2,
          "text": "Vitamin B6"
        },
        {
          "id": 3,
          "text": "Vitamin B1"
        },
        {
          "id": 4,
          "text": "Iron"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><strong>Vitamin B6 </strong>(Pyridoxine) is used in the treatment of <strong>sideroblastic anaemia</strong>.</p>\n<p><strong>Pyridoxine 200mg per day for 2-3 months</strong> is administered routinely to all cases of sideroblastic anaemia. This cofactor is essential for ALA-synthase activity, and mutations in the pyridoxine binding site of the enzyme have been found in several responsive patients. Blood transfusion and other supportive therapy are also indicated. In cases of secondary sideroblastic anaemia, the primary focus is the <strong>removal of the offending agent</strong>. But <strong>no definitive treatment</strong> is available for hereditary and idiopathic types of sideroblastic anaemia.</p>\n<p>Sideroblasts are <strong>nucleated red cells </strong>(normoblasts) containing siderotic granules which stain positively with <strong>Prussian blue stain</strong>. Based on aetiology, sideroblastic anaemia are classified into <strong>hereditary</strong> and <strong>acquired</strong> types.</p>\n<p>Hereditary sideroblastic anaemia is an <strong>X-linked</strong> disorder caused due to a defect in the activity of <strong>aminolevulinic acid (ALA) synthetase</strong> required for heme synthesis. Affected females act as carriers while males have moderate to marked anaemia and manifest in <strong>childhood</strong> or during <strong>early adulthood</strong></p>\n<p>Acquired sideroblastic anaemia:</p>\n<p>I) <strong>Primary acquired:</strong></p>\n<ul>\n<li>Also called <strong>idiopathic</strong> or <strong>refractory</strong> acquired sideroblastic anaemia</li>\n<li>Occurs in <strong>middle-aged</strong> and <strong>older individuals</strong> of both sexes</li>\n<li>Due to the reduced activity of the <strong>enzyme ALA synthetase</strong>, there is disturbed growth and maturation of the erythroid precursors at the level of hematopoietic stem cell</li>\n<li><strong>Moderate to severe anaemia</strong>, which appears insidiously</li>\n<li><strong>Neutropenia</strong> and <strong>thrombocytopenia</strong> may also be seen</li>\n<li>Regarded as a <strong>myelodysplastic disorder </strong>in the FAB classification and thus considered <strong>preleukaemic</strong></li>\n</ul>\n<p>II) <strong>Secondary acquired:</strong></p>\n<p>May appear secondary to </p>\n<ul>\n<li><strong>Drugs, chemicals and toxins</strong>: Isoniazid, Cycloserine, Chloramphenicol, Cyclophosphamide, Alcohol, Lead, etc.,</li>\n<li><strong>Haematological disorders:</strong> myelofibrosis, polycythemia vera, acute leukaemia, myeloma, lymphoma and hemolytic anaemia.</li>\n<li><strong>Miscellaneous</strong>: Carcinoma, myxoedema, rheumatoid arthritis and SLE.</li>\n</ul>\n<p><strong>Laboratory findings:</strong></p>\n<ul>\n<li>Peripheral smear: <strong>Hypochromic</strong>, <strong>microcytic</strong> (sometimes normocytic) anaemia</li>\n<li>Absolute values: <strong>MCV, MCH </strong>and<strong> MCHC are reduced</strong> except in acquired type, where MCV is raised.</li>\n<li>Bone marrow: <strong>Erythroid hyperplasia</strong> with macronormoblastic erythropoiesis. Marrow iron stores are raised. Pathognomonic <strong>ring sideroblasts</strong> are present.</li>\n<li>Serum ferritin: <strong>Raised</strong></li>\n<li>Serum iron: <strong>Raised</strong></li>\n<li>TIBC: <strong>Normal</strong></li>\n<li>Haemoglobin electrophoresis: <strong>Normal</strong></li>\n</ul><hr><h3>Related Pearl: Features of Peripheral Blood Smear in Different Anemias</h3><p><strong>Type of anemia </strong></p>\n<p><strong>Microcytic anemia</strong></p>\n<table>\n<tbody>\n<tr>\n<td>\n<p><strong>Diagnosis</strong></p>\n</td>\n<td>\n<p><strong>Peripheral blood smear</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Thalassemia trait</p>\n</td>\n<td>\n<p>Basophilic stippling, target cells&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Iron-deficiency</p>\n</td>\n<td>\n<p>Elliptocytes, target cells</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Sideroblastic anemia</p>\n</td>\n<td>\n<p>Pappenheimer bodies, RBC dimorphism, ringed sideroblasts (Perl&rsquo;s stain)&nbsp;</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p><strong>Macrocytic anemia</strong></p>\n<table>\n<tbody>\n<tr>\n<td>\n<p><strong>Diagnosis</strong></p>\n</td>\n<td>\n<p><strong>Peripheral blood smear</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Myelodysplastic syndrome</p>\n</td>\n<td>\n<p>Hypogranular or hypolobulated neutrophils, blast cells, giant or hypogranular platelets, Pappenheimer bodies</p>\n<p>Minor population of hypochromic / microcytic cells (dimorphic), poikilocytosis&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Megaloblastic anemia</p>\n</td>\n<td>\n<p>Hypersegmented neutrophils (&gt;5 lobes), ovalocytes</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Hemolysis</p>\n</td>\n<td>\n<p>Polychromasia (purple reticulocyte) +/- spherocytes&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Chronic liver disease</p>\n</td>\n<td>\n<p>Target cells&nbsp;</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p><strong>Normocytic anemia</strong></p>\n<table>\n<tbody>\n<tr>\n<td>\n<p><strong>Diagnosis</strong></p>\n</td>\n<td>\n<p><strong>Peripheral blood smear</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Haemolytic anemia&nbsp;</p>\n</td>\n<td>\n<p>Anisocytosis, poikilocytosis, polychromasia, nucleated red cells&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Hereditary spherocytosis</p>\n</td>\n<td>\n<p>RBC lack central zone of pallor, reticulocytosis</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Glucose-6-Phosphate-Dehydrogenase (G6PD) deficiency&nbsp;</p>\n</td>\n<td>\n<p>Heinz bodies (revealed by special staining),&lsquo;Bite&rsquo; cells</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF0715",
      "difficulty": "easy"
    },
    {
      "text": "A 5-year-old child who presented with proptosis of one of the eyes was found to have a desmin positive tumour. What is the probable diagnosis?",
      "choices": [
        {
          "id": 1,
          "text": "Ewing’s sarcoma"
        },
        {
          "id": 2,
          "text": "Embryonal rhabdomyosarcoma"
        },
        {
          "id": 3,
          "text": "Leukemia"
        },
        {
          "id": 4,
          "text": "Retinoblastoma"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The clinical picture of a 5-year-old child with proptosis and a desmin positive tumor suggests a diagnosis of <strong>embryonal rhabdomyosarcoma.</strong></p>\n<p>Rhabdomyosarcoma is a malignant mesenchymal tumor with skeletal muscle differentiation. There are four subtypes:<strong> alveolar, embryonal, pleomorphic, </strong>and<strong> spindle cell/sclerosing.&nbsp;</strong>Rhabdomyosarcoma is the most common soft tissue sarcoma of childhood and adolescence and is usually of the alveolar and the embryonal variety. <strong>Pleomorphic</strong> rhabdomyosarcoma is seen predominantly in <strong>adults.&nbsp;</strong>Spindle cell/sclerosing type affects all ages. The pediatric forms often arise in the sinuses, head and neck, and genitourinary tract.</p>\n<p><strong>Embryonal rhabdomyosarcoma </strong>has&nbsp;sheets of both primitive round and spindled cells in a myxoid stroma. <strong>Rhabdomyoblasts</strong> with visible cross-striations may be present.&nbsp;<strong>Sarcoma botryoids </strong>is a&nbsp;variant of embryonal rhabdomyosarcoma in the walls of hollow, mucosal-lined structures, such as the nasopharynx, common bile duct, bladder, and vagina with cambium layer.&nbsp;<strong>Alveolar rhabdomyosarcoma </strong>has a&nbsp;network of fibrous septae that divide the cells into clusters or aggregates, creating a crude resemblance to pulmonary alveoli.</p>\n<p>Clinically, the tumor is usually <strong>aggressive, </strong>with<strong> unilateral proptosis </strong>when the orbit is involved. Swelling and redness of the overlying skin, diplopia may be present. Immunohistochemistry is positive for <strong>desmin</strong>, myoglobin, myogenin, MyoD1, and vimentin</p>\n<p>Treatment involves&nbsp;<strong>surgical resection</strong> and <strong>chemotherapy</strong>, with or without radiotherapy. The best prognosis is for the botryoid variant while the pleomorphic has variant has the worst prognosis.</p><p>Other options:</p>\n<p>A) Ewing's sarcoma: CD99 positive</p>\n<p>C) Leukaemia: CD45 positive</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF0770",
      "difficulty": "easy"
    },
    {
      "text": "A 17-year-old boy presented with intussusception and was taken up for surgery. He was found to have multiple polyps. The resected section was sent for histopathology and the whole mount image of the specimen is given below. Identify the lesion.",
      "choices": [
        {
          "id": 1,
          "text": "Tubulovillous adenoma"
        },
        {
          "id": 2,
          "text": "Hamartomatous polyp"
        },
        {
          "id": 3,
          "text": "Adenocarcinoma"
        },
        {
          "id": 4,
          "text": "Hyperplastic polyp"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The given clinical feature of intussusception and multiple polyps and the histologic picture showing an&nbsp;<strong>arborizing pattern</strong> of connective tissue, smooth muscle, lamina propria, and glands are suggestive of&nbsp;<strong class=\"ng-binding\">Peutz&ndash;Jeghers Syndrome,&nbsp;</strong><span class=\"ng-binding\">which</span><strong class=\"ng-binding\">&nbsp;</strong><span class=\"ng-binding\">is a type of <strong>hamartomatous polyp</strong> of the small intestine.</span></p>\n<p>It is an autosomal dominant condition characterized by <strong>hamartomatous polyps of the intestinal tract</strong> and melanosis of the mouth and the lips.&nbsp;</p>\n<p>Clinical features:</p>\n<ul>\n<li><strong>Hamartomatous polyps</strong>&nbsp;of the intestinal tract</li>\n<li><strong>Hyperpigmentation</strong>&nbsp;of the buccal mucosa, lips, perianal skin, and digits</li>\n<li>Increased (2% to 10%) risk for&nbsp;<strong>cancer of the intestinal tract</strong>, with cancers reported throughout the intestinal tract,&nbsp;<strong>from the stomach to the rectum</strong>.</li>\n<li>Increased risk for&nbsp;<strong>extraintestinal malig&shy;nant neoplasms</strong>, including cancer of the breast, ovary, cervix, fallopian tubes, thyroid, lung, gallbladder, bile ducts, pancreas, and testicles.</li>\n</ul>\n<p>Management:</p>\n<ul>\n<li><strong>Surgery</strong> is indicated in cases where there are <strong>bleeding</strong>, <strong>obstruction</strong>, <strong>intussusception</strong>, or <strong>adenomatous changes</strong> of the polyp.</li>\n<li>If surgery is done for these indications attempts should be made to remove as much as polyps as possible.&nbsp;</li>\n<li><strong>Regular screening</strong> with endoscopic studies should be done due to the increased risk of malignancies.</li>\n<li>Screening of other malignancies like breast and cervix are also important.</li>\n</ul><p>Other options:</p>\n<p>A) Tubulovillous adenoma:</p>\n<p>These are a mixture of tubular and villous adenoma and consist of small, <strong>pedunculated</strong> <strong>polyps</strong> composed of rounded or tubular glands and larger, sessile polyps which are covered by slender villi. These adenomas are characterized microscopically by the <strong>presence of epithelial dysplasia</strong>. The hallmarks of epithelial dysplasia are <strong>nuclear hyperchromasia</strong>, <strong>elongation</strong> and <strong>stratification</strong>.</p>\n<p>&nbsp;</p>\n<p>&nbsp;</p>\n<p>&nbsp;</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/a84b97547987411784cfa2d9950c0db9x1280x768.JPEG\" alt=\"Explanation Image\"><p>C) Adenocarcinoma:</p>\n<p>Presents with occult bleeding, changes in bowel habits, or cramping and left lower quadrant discomfort. Morphologically, they present as polypoid, exophytic masses or annular lesions that produce &lsquo;<strong>napkin-ring&rsquo;</strong> construction and luminal narrowing. Microscopically, these tumours consist of tall columnar cells with <strong>elongated</strong>, <strong>hyperchromatic nuclei</strong> and <strong>necrotic</strong> <strong>debris</strong> in the gland lumen.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/5a31fe35c587424d8b91f6fd8b8abca9x396x298.JPEG\" alt=\"Explanation Image\"><p>D) Hyperplastic polyp:</p>\n<p>Hyperplastic polyps, most commonly found in the <strong>left colon</strong> are smooth, <strong>nodular protrusions </strong>of the mucosa, often on the crests of mucosal folds. Histologically, they are composed of mature <strong>goblet</strong> and <strong>absorptive cells </strong>with a serrated surface architecture.</p>\n<p>&nbsp;</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/cdc99e69be4d4668b07b53ce71189898x720x540.JPEG\" alt=\"Explanation Image\"><hr><h3>Related Pearl: Peutz–Jeghers Syndrome</h3><ul>\n<li>Autosomal-dominant disease</li>\n<li>Germline defects in the <strong>tumor suppressor </strong>serine-threonine kinase 11 (<strong><em>STK11</em></strong>) gene on<strong> chromosome 19.</strong></li>\n</ul>\n<p><strong>Features</strong>:</p>\n<ul>\n<li><strong>Hyperpigmentation</strong> of the buccal mucosa, lips, and digits</li>\n<li><strong>Hamartomatous polyps</strong> of the intestinal tract</li>\n<li>Increased (2% to 10%) risk for <strong>cancer</strong> of the<strong> intestinal tract</strong>&nbsp;(stomach - rectum).</li>\n<li>Increased risk for <strong>extraintestinal malig&shy;nant neoplasms</strong>, including cancer of the breast, ovary, cervix, fallopian tubes, thyroid, lung, gallbladder, bile ducts, pancreas, and testicles.</li>\n</ul>\n<p><strong>Screening</strong>:&nbsp;Baseline colonoscopy and upper endoscopy at age 20 years, followed by annual flexible sigmoidoscopy thereafter.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/eff8622ebbed495bb2c50bb2544cdb48x450x600.JPEG\" alt=\"Pearl Image\"><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/1160ec99452648149a62ef6cadaef74ex418x532.JPEG\" alt=\"Pearl Image\"><p>&nbsp;</p>\n<p><strong>Histologic image</strong> showing the characteristic arborizing network of connective tissue, smooth muscle, lamina propria, and glands lined by normal-appearing intestinal epithelium:</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/e7f25b73d84249949d85119e7bd2cc28x1280x1863.JPEG\" alt=\"Pearl Image\">",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/2cd5496738d7420a974e89714e893f33.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF0785",
      "difficulty": "easy"
    },
    {
      "text": "Which of the following is true?<div class='question-desc-html'><ol>\n<li>BRCA1 is an oncogene.</li>\n<li>HER2neu is amplified only in a fraction of breast cancer.</li>\n<li>EGFR(+) is seen in non-small cell lung cancer.</li>\n<li>N-MYC is a tumour suppressor gene.</li>\n</ol></div>",
      "choices": [
        {
          "id": 1,
          "text": "1, 2"
        },
        {
          "id": 2,
          "text": "1, 3"
        },
        {
          "id": 3,
          "text": "2, 3"
        },
        {
          "id": 4,
          "text": "All of the above"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>Of the given statements, 2 and 3 are true. BRCA1 is a tumor suppressor gene and MYC is a proto-oncogene.</p>\n<p><strong>BRCA1&nbsp;</strong>is a tumor suppressor gene located on chromosome <strong>17q21</strong> and its function is to repair the double-stranded breaks in DNA. It is associated with familial breast and ovarian carcinoma. BRCA1-associated breast cancers are commonly poorly differentiated.</p>\n<p>All breast cancers are separated into 3 major groups based on the expression of two proteins, ER and HER2 (also known as <strong>ERBB2</strong>). HER2 cancers are defined as cancers overexpressing HER2 and can be either ER-positive or ER-negative. Thus HER2neu is expressed only in a fraction of people with breast cancer.</p>\n<p>EGF-receptor family has two proto-oncogenes: ERBB1 that codes for EGFR and ERBB2 that codes for HER. Mutation in EGFR results in adenocarcinoma of the lung, which is one of the main subtypes of non-small cell lung carcinoma.</p>\n<p>MYC is a proto-oncogene, that is expressed in all eukaryotic cells and belongs to the immediate-early response genes, which are rapidly induced by RAS/MAPK signaling following growth factor stimulation of quiescent cells. Normally, MYC protein concentration are tightly controlled at the level of transcription, translation and protein stability. The mechanisms by which MYC promotes neoplastic cell growth may be follows:</p>\n<ul>\n<li>MYC activates the expression of many genes like D cyclins, that are involved in cell cycle progression</li>\n<li>MYC regulates the expression of telomerase</li>\n<li>MYC is one of the transcriptional factors that can act together to reprogram somatic cells into pluripotent stem cells</li>\n</ul>\n<p>MYC gene is deregulated in a number of cancers such as Burkitt lymphoma, breast, colon, lung and other cancers. The functionally identical NMYC and LMYC genes are also amplified in neuroblastomas and small cell cancers of the lung, respectively.</p><hr><h3>Related Pearl: Tumor suppressor genes</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>&nbsp;Gene</strong></p>\n</td>\n<td>\n<p><strong>Mechanism</strong></p>\n</td>\n<td>\n<p><strong>Chromosome</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>TGF- Beta Receptor</p>\n<p>E-cadherin</p>\n</td>\n<td>\n<p>Growth inhibition&nbsp;</p>\n<p>Cell adhesion</p>\n</td>\n<td>\n<p>Chromosome 19</p>\n<p>Chromosome 16</p>\n</td>\n</tr>\n<tr>\n<td>NF1</td>\n<td>Inhibition of RAS signal transduction and of p21 cell cycle inhibitor</td>\n<td>Chromosome 17</td>\n</tr>\n<tr>\n<td>NF2</td>\n<td>Cytoskeletal instability</td>\n<td>Chromosome 22</td>\n</tr>\n<tr>\n<td>\n<p>APC/Beta-catenin</p>\n</td>\n<td>Inhibition of signal transduction</td>\n<td>Chromosome 5</td>\n</tr>\n<tr>\n<td>PTEN</td>\n<td>Pi3 kinase signal transduction</td>\n<td>Chromosome 10</td>\n</tr>\n<tr>\n<td>SMAD2 and SMAD4</td>\n<td>TGF- beta signal transduction</td>\n<td>Chromosome 18</td>\n</tr>\n<tr>\n<td>RB1</td>\n<td>Regulation of cell cycle</td>\n<td>Chromosome 13</td>\n</tr>\n<tr>\n<td>p53</td>\n<td>Cell cycle arrest and apoptosis in response to DNA damage</td>\n<td>Chromosome 17</td>\n</tr>\n<tr>\n<td>\n<p>WT1</p>\n<p>P16/INk4a</p>\n</td>\n<td>\n<p>Nuclear transcription</p>\n<p>Regulation of cell cycle by inhibition of cyclin dependent kinases</p>\n</td>\n<td>\n<p>Chromosome 11</p>\n<p>Chromosome 9</p>\n</td>\n</tr>\n<tr>\n<td>BRCA1 and BRCA2</td>\n<td>DNA repair</td>\n<td>Chromosome 17 and 13</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><hr><h3>Related Pearl: Growth Factor Receptors and Associated Tumors</h3><p><strong>Growth factor receptors and Associated Tumors</strong></p>\n<table>\n<tbody>\n<tr>\n<td>\n<p>Category</p>\n</td>\n<td>\n<p><em>Proto-Oncogene</em></p>\n</td>\n<td>\n<p>Mode of activation</p>\n</td>\n<td>\n<p>Associated tumor</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>EGF-receptor family</p>\n</td>\n<td>\n<p><em>ERBB1 (EGFR)</em></p>\n<p><em>ERBB2 (HER)</em></p>\n</td>\n<td>\n<p>Mutation</p>\n<p>Amplification</p>\n</td>\n<td>\n<p>Adenocarcinoma of lung</p>\n<p>Breast carcinoma</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>FMS- like tyrosine kinase 3</p>\n</td>\n<td>\n<p><em>FLT3</em></p>\n</td>\n<td>\n<p>Point mutation</p>\n</td>\n<td>\n<p>Leukemia</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Receptor for neurotrophic factors</p>\n</td>\n<td>\n<p><em>RET</em></p>\n</td>\n<td>\n<p>Point mutation</p>\n</td>\n<td>\n<p>Multiple endocrine neoplasia 2A and B, familial medullary thyroid carcinoma</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>PDGF receptor</p>\n</td>\n<td>\n<p><em>PDGFRB</em></p>\n</td>\n<td>\n<p>Overexpression, translocation</p>\n</td>\n<td>\n<p>Gliomas, leukemias</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Receptor for KIT ligand</p>\n</td>\n<td>\n<p><em>KIT</em></p>\n</td>\n<td>\n<p>Point mutation</p>\n</td>\n<td>\n<p>Gastrointestinal stromal tumors, seminomas, leukemias</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>ALK receptors</p>\n</td>\n<td>\n<p><em>ALK</em></p>\n</td>\n<td>\n<p>Translocation, fusion gene formation</p>\n<p>Point mutation</p>\n</td>\n<td>\n<p>Adenocarcinoma of lung, certain lymphomas</p>\n<p>Neuroblastoma</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><hr><h3>Related Pearl: Cancers associated with important oncogenes</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Oncogenes</strong></p>\n</td>\n<td><strong>Associated cancers</strong></td>\n</tr>\n<tr>\n<td>\n<p><em>c-MYC</em></p>\n</td>\n<td>\n<p>Burkitt&rsquo;s lymphoma</p>\n<p>Adenocarcinomas of the breast, lung, and colon</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><em>N-MYC</em></p>\n</td>\n<td>\n<p>Neuroblastoma</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><em>L-MYC</em></p>\n</td>\n<td>\n<p>Small-cell carcinoma of the lung</p>\n</td>\n</tr>\n<tr>\n<td><em>K-RAS</em></td>\n<td>Colon, lung, and pancreatic tumors</td>\n</tr>\n<tr>\n<td><em>N-RAS</em></td>\n<td>\n<p>Melanoma</p>\n<p>AML</p>\n</td>\n</tr>\n<tr>\n<td><em>H-RAS</em></td>\n<td>Bladder and kidney tumors</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF0789",
      "difficulty": "hard"
    },
    {
      "text": "Identify the given condition.",
      "choices": [
        {
          "id": 1,
          "text": "Pemphigus vulgaris"
        },
        {
          "id": 2,
          "text": "Leprosy"
        },
        {
          "id": 3,
          "text": "Mycosis fungoides"
        },
        {
          "id": 4,
          "text": "Visceral leishmaniasis"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The given histologic picture shows a <strong>suprabasal blister</strong> suggesting the diagnosis of <strong>pemphigus vulgaris. </strong></p>\n<p>It is caused due to the production of antibodies mainly against <strong>desmoglein 3.</strong> Rarely antibodies against desmoglein 1 can also be found. The antibodies are commonly <strong>IgG antibodies.</strong></p>\n<p>Desmoglein 3 is mainly present in the <strong>basal and suprabasal layers</strong> of the skin and mucosa. The patients, therefore, present with flaccid bullae over the skin and mucosal ulcerations. Oral mucosa is commonly affected. Other areas where ulceration can be seen are conjunctiva, nasopharynx, larynx, etc. Cutaneous lesions are more common over the scalp, face, neck, upper chest, and back.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/ea55e6373d764d269353c4a3eb06d31ax510x502.GIF\" alt=\"Explanation Image\"><p>Direct immunofluorescence will show the deposition of antibodies around the keratinocytes in the epidermis. It is treated with steroids, azathioprine, mycophenolate mofetil, rituximab, etc.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/2dea83b13d534a539f8fd2364f482fbax1280x1302.JPEG\" alt=\"Explanation Image\"><p>Other options:</p>\n<p>B) Leprosy: <strong>Tuberculoid leprosy </strong>shows <strong>granulomatous</strong> lesions, without much bacilli. Hence called <strong>paucibacillary</strong> leprosy. <strong>Lepromatous</strong> lesions contain large aggregates of lipid-laden macrophages (<strong>lepra cells</strong>), often filled with masses (<strong>globi</strong>) of acid-fast bacilli. Because of the presence of abundant bacteria, it is also called as <strong>multibacillary</strong>.</p>\n<p>Given below are the images that depict lepromatous lesion showing <strong>foamy macrophages</strong> with globi of pink/red acid-fast bacilli and tuberculoid leprosy showing <strong>granulomatous</strong> lesions, respectively.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/b66d5b7096844d97a24e74e51464066ex957x691.JPEG\" alt=\"Explanation Image\"><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/560ff93930284415965ee0d634fb870bx1024x768.JPEG\" alt=\"Explanation Image\"><p>C) Mycosis fungoides: Mycosis fungoides is a cutaneous T-cell lymphoma, characterized by polymorphic patches and plaques with fine scaling usually present on the limbs, breast, and buttocks. The lesions may be pruritic or even asymptomatic.  Histological hallmarks include: 1. <strong>Sézary-Lutzner cells</strong> - cells with cerebriform nuclei (infolded/ hyper-convoluted nuclear membrane), 2. <strong>Pautrier's microabscesses</strong> - tumor cells invade the epidermis as single cells and small clusters, forming a collection of atypical lymphocytes in the epidermis and 3. Epidermotropism - pronounced invasion of the tumor cells into the epidermis.</p>\n<p>Given below is the image of Sezary-Lutzner cells.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/108f5317125e48418758a93ecff94c73x360x363.JPEG\" alt=\"Explanation Image\"><p>Given below is the arrow pointing at Paurtier's microabcess.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/386c3b4d3b8b47308a27dcb058c9d308x720x708.JPEG\" alt=\"Explanation Image\"><p>D) Visceral leishmaniasis: In visceral leishmaniasis, parasites invade and activate the <strong>macrophages</strong> throughout the mononuclear phagocyte system. Hence, these phagocytic cells are enlarged and filled with leishmania species; many plasma cells are also present.</p>\n<p>The given slide shows <strong>macrophages</strong> infested with <strong>intracellular Leishmania donovani bodies</strong> (arrows) characterized by a kinetoplast and characteristic<strong> double dot appearance (Leishman stain).</strong></p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/cef49b3669fd4a6dae09e7ee1169a190x720x531.PNG\" alt=\"Explanation Image\"><hr><h3>Related Pearl: Classification of Vesiculobullous Disorders</h3><p><strong>According to Pathology</strong></p>\n<ul>\n<li><strong>Immunobullous disorders/ Primary blistering disease: </strong>occur due to autoimmunity</li>\n</ul>\n<table>\n<tbody>\n<tr>\n<td>\n<p><strong>Intraepidermal</strong></p>\n</td>\n<td>\n<p><strong>Subepidermal</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Pemphigus vulgaris</p>\n</td>\n<td>\n<p>Bullous pemphigoid</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Pemphigus foliaceous</p>\n</td>\n<td>Dermatitis herpetiformis</td>\n</tr>\n<tr>\n<td>\n<p>Pemphigus vegetans</p>\n</td>\n<td>Epidermolysis bullous acquisita</td>\n</tr>\n<tr>\n<td>&nbsp;Pemphigus erythematosus</td>\n<td>&nbsp;</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<ul>\n<li><strong>Mechanobullous disorders:</strong> Due to defect in the structure of epidermis\n<ul>\n<li>Epidermolysis bullosa</li>\n<li>Bullous ichthyosiform erythroderma</li>\n</ul>\n</li>\n<li><strong>Other disorders</strong>\n<ul>\n<li>Infections - VZV, HSV, Bullous impetigo, SSSS</li>\n<li>Metabolic - Porphyria, Diabetes, Hemodialysis</li>\n<li>Drug eruptions - Fixed drug eruption, Steven Johnson Syndrome, Erythema Multiforme</li>\n</ul>\n</li>\n</ul>\n<p><strong>According to Site</strong></p>\n<table>\n<tbody>\n<tr>\n<td>\n<p><strong>Intraepidermal</strong></p>\n</td>\n<td>\n<p><strong>Sub-epidermal (Dermo-epidermal)</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>1. Subcorneal (granular layer)</strong></p>\n<ul>\n<li>Pemphigus foliaceous &amp; erythematosus</li>\n<li>Staphylococcal scalded skin syndrome</li>\n<li>Miliaria crystalina</li>\n<li>Bullous impetigo</li>\n<li>Friction blister</li>\n<li>Subcorneal pustular dermatosis</li>\n</ul>\n<p><strong>2. Spinous layer</strong></p>\n<ul>\n<li>Eczematous (atopic) dermatitis</li>\n<li>HSV/VZV infection</li>\n<li>Molluscum contagiosum</li>\n<li>Familial benign pemphigus (Hailey-hailey disease)</li>\n</ul>\n<p><strong>3. Suprabasal</strong></p>\n<ul>\n<li>Pemphigus vulgaris</li>\n<li>Darrier&rsquo;s disease</li>\n</ul>\n<p><strong>4. Basal layer</strong></p>\n<ul>\n<li>Erythema multiforme</li>\n<li>Epidermolysis bullosa simplex</li>\n</ul>\n</td>\n<td>\n<p><strong>1. Junctional (at basal lamina)</strong></p>\n<ul>\n<li>Junctional epidermolysis bullosa</li>\n<li>Bullous pemphigoid</li>\n<li>Toxic epidermal necrolysis</li>\n</ul>\n<p><strong>2. Dermolytic (below basal lamina)</strong></p>\n<ul>\n<li>Epidermolysis bullosa acquisita</li>\n<li>Epidermolysis bullosa dystrophicans</li>\n<li>Deep burns</li>\n<li>Porphyria cutanea tarda</li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/c90a09d9f3304a6dbb1e8360614e4ba3.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF0813",
      "difficulty": "medium"
    },
    {
      "text": "A karyotyping image is given below. What are the clinical features most likely to be expected in such patients?",
      "choices": [
        {
          "id": 1,
          "text": "Gynecomastia and long limbs"
        },
        {
          "id": 2,
          "text": "Flat occiput"
        },
        {
          "id": 3,
          "text": "Webbing of neck and lymphedema"
        },
        {
          "id": 4,
          "text": "Short stature and polydactyly"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The given karyotyping image shows &lsquo;<strong>47,&nbsp;</strong><strong>XXY</strong>&rsquo; abnormality, which is seen in <strong>Klinefelter&rsquo;s</strong> <strong>syndrome</strong>. <strong>Gynecomastia</strong> and <strong>long limbs</strong> are seen in Klinefelter's syndrome.</p>\n<p>Other clinical features seen in Klinefelter&rsquo;s syndrome are:&nbsp;</p>\n<ul>\n<li>Disproportionately <strong>long arms and legs</strong>,</li>\n<li><strong>Gynecomastia</strong></li>\n<li>Eunuchoid body habitus</li>\n<li>Mitral valve prolapse</li>\n<li>Mental retardation; <strong>IQ: 60-80</strong>,</li>\n<li>Minor developmental and learning disabilities,</li>\n<li>Lack of secondary sexual characteristics (due to a&nbsp;decrease in androgen production)</li>\n<li>Higher risk of breast carcinoma</li>\n<li>Testicular dysgenesis with small penis</li>\n<li>Infertility/azoospermia</li>\n<li>Type 2 diabetes mellitus</li>\n<li>Metabolic syndrome</li>\n<li>Higher risk of extragonadal germ cell tumors</li>\n</ul>\n<p>Klinefelter syndrome:</p>\n<ul>\n<li>Most common sex aneuploidy in males</li>\n<li>Classically karyotype is <strong>47, XXY</strong>. Other variants can have <strong>48 XXXY; rarely, 49 XXXXY;</strong>&nbsp;or mosaics with some cells containing normal 46, XY and others 47, XXY</li>\n<li>Results from <strong>meiotic nondisjunction</strong> of sex chromosomes (mostly during 1<sup>st</sup> meiotic division)</li>\n</ul>\n<p><strong>Note</strong>:</p>\n<p>A variant of Klinefelter&rsquo;s syndrome&mdash;<strong>49, XXXXY</strong>&mdash;presents with <strong>short stature</strong></p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/4fc0eccac7584880a6a8c763a4419085x720x511.JPEG\" alt=\"Explanation Image\"><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/59e815279c4c46d0bd0d19a8d0b2eebax268x469.JPEG\" alt=\"Explanation Image\"><p>Other options:</p>\n<p>B) Flat occiput:</p>\n<p>It is usually seen in <strong>Down&rsquo;s syndrome</strong> or <strong>trisomy</strong> <strong>21</strong>.</p>\n<p>Clinical features: (Mnemonic:&nbsp;<strong>I C A PROBLEM </strong>Somewhere)</p>\n<ul>\n<li><strong>I</strong>ntellectual disability/<strong>Incurved or short fifth finger with clinodactyly</strong></li>\n<li><strong>C</strong>ongenital heart disease</li>\n<li><strong>Acute megakaryoblastic leukemia</strong>/<strong>Alzheimer's disease</strong>/Atlantoaxial instability/Atresia of the duodenum</li>\n<li><strong>P</strong>rotruding tongue</li>\n<li><strong>R</strong>ound face</li>\n<li><strong>O</strong>cciput flat/Open wide fontanelle/Open mouth</li>\n<li><strong>Brachycephalic/Brushfield's spots</strong></li>\n<li><strong>L</strong>ow (depressed) nasal bridge</li>\n<li><strong>Epicanthal fold/Ears low set and dysplastic</strong></li>\n<li><strong>M</strong>ongoloid slant (oblique palpebral fissure)</li>\n<li><strong>S</strong>imian palmar crease and a&nbsp;<strong>wider gap between first and second toes</strong></li>\n</ul>\n<p>&nbsp;</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/12f5b541fb8841149505616a9c0608f5x720x603.PNG\" alt=\"Explanation Image\"><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/9b402d5b2c0044878106afd9044b166dx720x1531.JPEG\" alt=\"Explanation Image\"><p>C) Webbing of neck and lymphedema:</p>\n<p>It is usually seen in <strong>Turner&rsquo;s syndrome.</strong></p>\n<p>Important features associated with Turner's syndrome: (mnemonic<strong>: See A Baby CLOWN Here)</strong></p>\n<ul>\n<li><strong>S</strong>hort stature,<strong> Short fourth metacarpal</strong>,&nbsp;<strong>S</strong>ensorineural hearing loss, <strong>S</strong>hield chest</li>\n<li><strong>A</strong>menorrhea (primary), infertility</li>\n<li><strong>B</strong>arr body absent</li>\n<li><strong>C</strong>ardiac defects, <strong>C</strong>ubitus valgus, <strong>C</strong>ongenital lymphedema</li>\n<li><strong>L</strong>:<strong>&nbsp;</strong>Learning disabilities</li>\n<li><strong>O</strong>varies underdeveloped (streak ovaries), <strong>Gonadoblastoma</strong> (increased risk if Y chromosome material is present)</li>\n<li><strong>W</strong>ebbed neck</li>\n<li><strong>N</strong>ipples widely spaced</li>\n<li><strong>H</strong>orseshoe kidneys</li>\n</ul><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/904a6b59370f41059059971e6a4d70b0x720x540.JPEG\" alt=\"Explanation Image\"><p>D) Short stature and polydactyly:</p>\n<p>Short stature with polydactyly is most commonly seen in <strong>Patau syndrome</strong> or <strong>trisomy 13</strong>.</p>\n<p>It's clinical features include:</p>\n<ul>\n<li>Cleft lip often midline</li>\n<li>Flexed fingers with postaxial polydactyly</li>\n<li>Ocular hypotelorism</li>\n<li>Bulbous nose</li>\n<li>Low-set, malformed ears</li>\n<li>Microcephaly</li>\n<li>Cerebral malformation, especially holoprosencephaly</li>\n<li>Microphthalmia</li>\n<li>Cardiac malformations</li>\n<li>Scalp defects</li>\n<li>Hypoplastic or absent ribs</li>\n<li>Visceral and genital anomalies</li>\n</ul><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/f347e51387ed48dcb3fdc6341aa774cax720x844.JPEG\" alt=\"Explanation Image\">",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/4f918d01686c47d6b4a6bf1fb4a4f3d1.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF0748",
      "difficulty": "easy"
    },
    {
      "text": "A 20-year-old athlete suddenly collapsed while playing football and was taken to the hospital where he was declared dead. His autopsy image is given below. Which of the following is the most likely cause of death?",
      "choices": [
        {
          "id": 1,
          "text": "Valvular heart disease due to RHD"
        },
        {
          "id": 2,
          "text": "Sudden cardiac death due to arrhythmia"
        },
        {
          "id": 3,
          "text": "Sudden cardiac death due to Hypertrophic cardiomyopathy"
        },
        {
          "id": 4,
          "text": "Sudden cardiac death due to atherosclerosis"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The given image shows <strong>asymmetric septal hypertrophy</strong> and along with the scenario, it is suggestive of&nbsp;<strong>sudden cardiac death</strong> due to <strong>arrhythmia</strong>. Patients with <strong>hypertrophic cardiomyopathy</strong> have an increased risk of <strong>sudden cardiac death</strong> from <strong>ventricular tachyarrhythmias</strong>. In fact, <strong>arrhythmias</strong> are the most important/<strong>most common cause of death</strong> in hypertrophic cardiomyopathy.</p>\n<p>Hypertrophic cardiomyopathy is one of the most common causes of <strong>sudden,</strong> otherwise unexplained <strong>death</strong> in <strong>young athletes</strong>. HCM is characterized by reduced stroke volume due to impaired diastolic filling, which is a consequence of the massively hypertrophic left ventricle. There is a dynamic obstruction to the left ventricular outflow as the anterior mitral leaflet moves towards the ventricular septum during systole. This compromised cardiac output in combination with a secondary increase in pulmonary venous pressure is the reason for exertional dyspnea at times of increased oxygen demand.</p>\n<p>Major clinical problems in <strong>HCM</strong> are <strong>atrial fibrillation</strong>, <strong>stroke</strong>, intractable cardiac failure,&nbsp;<strong>ventricular arrhythmias</strong> and also <strong>sudden death</strong>. There is a harsh systolic ejection murmur caused by the ventricular outflow obstruction.&nbsp;Mutations causing hypertrophic cardiomyopathy (HCM) are most commonly seen in the genes encoding <strong>&beta;-myosin heavy chain </strong>(MHC/MYH7)&nbsp;or&nbsp;<strong>myosin-binding protein C</strong> (MYBP-C).&nbsp;</p>\n<p>HCM is mostly an <strong>autosomal dominant disorder</strong>. The most important histologic features of HCM myocardium are as follows:</p>\n<ol>\n<li>Massive <strong>myocyte hypertrophy</strong> particularly of transverse myocyte diameters</li>\n<li><strong>Myofiber disarray</strong> including that of bundles of myocytes, individual myocytes, and contractile elements</li>\n<li>Interstitial and replacement <strong>fibrosis</strong></li>\n</ol>\n<p>Most of the patients can be treated with&nbsp;&beta; blockers to decrease heart rate and contractility. Implantable cardioverter-defibrillators are used in patients with increased risk of ventricular arrhythmias. Some patients can also be treated by surgical excision of the septal muscle or by carefully controlled septal infarction through a catheter-based infusion of alcohol.</p>\n<p>The below-given images show normal cardiac myocytes and myocytes in HCM respectively.&nbsp;</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/75728f31a92e4575b980e4b73df8943ax500x376.GIF\" alt=\"Explanation Image\"><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/83b6281f27e94608bf946c243db71c49x500x372.GIF\" alt=\"Explanation Image\"><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/ec580bb97ede4d4b90f3094f904e0501x600x1208.JPEG\" alt=\"Explanation Image\"><hr><h3>Related Pearl: Risk Factors for Sudden Death in HCM</h3><p>Risk factors for sudden death in HCM:</p>\n<ul>\n<li>History of cardiac arrest or spontaneous sustained ventricular tachycardia</li>\n<li>Syncope</li>\n<li>Family history of sudden cardiac death</li>\n<li>Spontaneous nonsustained ventricular tachycardia</li>\n<li>LV thickness &gt; 30mm</li>\n<li>Abnormal blood pressure response to exercise</li>\n</ul><hr><h3>Related Pearl: Dynamic auscultation of murmurs</h3><table>\n<tbody>\n<tr>\n<td><strong>Bedside Manoeuvre</strong></td>\n<td><strong>Effect</strong></td>\n</tr>\n<tr>\n<td>\n<p>Inspiration</p>\n<p>(&uarr;venous return to right atrium)</p>\n</td>\n<td>\n<ul>\n<li>&uarr; intensity of right-sided sounds</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>\n<p>Handgrip</p>\n<p>(&uarr;afterload )</p>\n</td>\n<td>\n<ul>\n<li>&uarr; intensity of MR, AR, and VSD murmurs</li>\n<li>&darr; hypertrophic cardiomyopathy and AS murmurs</li>\n<li>MVP: delayed onset of click/murmur</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>\n<p>Valsalva-Phase II, standing up</p>\n<p>(&darr; preload)</p>\n</td>\n<td>\n<ul>\n<li>&darr; intensity of most murmurs (including AS)</li>\n<li>&uarr;&nbsp;intensity of hypertrophic cardiomyopathy murmur</li>\n<li>MVP: earlier onset of click /murmur</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>\n<p>Rapid squatting</p>\n<p>(&uarr;venous return,&uarr;preload,<br />&uarr; afterload)</p>\n</td>\n<td>\n<ul>\n<li>&darr;intensity of hypertrophic cardiomyopathy murmur</li>\n<li>&uarr;&nbsp;intensity of AS, MR, and VSD murmurs</li>\n<li>MVP: later onset of click/murmur</li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/f12091d4b98d4972a0b1e50a057f100c.GIF"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF0741",
      "difficulty": "hard"
    },
    {
      "text": "Which of the following can be prevented by transfusing irradiated RBCs?",
      "choices": [
        {
          "id": 1,
          "text": "Graft versus host disease"
        },
        {
          "id": 2,
          "text": "HLA Alloimmunization"
        },
        {
          "id": 3,
          "text": "Immunomodulation"
        },
        {
          "id": 4,
          "text": "Transfusion Related Acute Lung Injury (TRALI)"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>Transfusion of irradiated RBCs prevent the incidence of <strong>graft versus host disease </strong>(GVHD) associated with the transfusion.</p>\n<p>GVHD occurs when immunologically competent cells or their precursors are transplanted into <strong>immunologically compromised</strong> recipients and the transferred cells recognize the alloantigens in the host and attack host tissues. It is seen most commonly during hematopoietic stem cell transplantation but may occur following transplantation of solid organs too.&nbsp;</p>\n<p>GVHD maybe of two types: acute and chronic.</p>\n<p><strong>Acute GVHD </strong>occurs within days to weeks after allogeneic hematopoietic stem cell transplantation. It mainly involves the <strong>immune system </strong>and the <strong>epithelia</strong> of the skin (in the form of generalized rash), <strong>liver</strong>( in the form of jaundice), and <strong>intestines</strong> (in the form of bloody diarrhea). But the affected tissues are not heavily infiltrated by lymphocytes.</p>\n<p><strong>Chronic GVHD</strong> may follow acute GVHD or may occur insidiously. These patients have extensive skin damage, with destruction of skin appendages and fibrosis of the dermis, resembling <strong>systemic sclerosis</strong>. Cholestatic jaundice and esophageal strictures are also common. There will be involution of the thymus and depletion of lymphocytes in the lymph nodes. There will also be recurrent bouts of <strong>life-threatening infections.</strong> Some may even develop <strong>autoimmunity</strong>, owing to the grafted CD4+ helper T cells reacting with host B cells and stimulating them, which may result in autoantibodies production.</p>\n<p>Depletion of donor T cells by irradiation, before transfusion can eliminate the occurrence of GVHD. But irradiation also has its side effects such as recurrence of tumor in leukemic patients, increased incidence of graft failures and EBV-related B-cell lymphoma.</p>\n<p>&nbsp;</p><hr><h3>Related Pearl: Transplant Rejection and Hypersensitivity</h3><table>\n<tbody>\n<tr>\n<td>Type of Rejection&nbsp;</td>\n<td>Type of Hypersensitivity</td>\n</tr>\n<tr>\n<td colspan=\"2\">\n<p><strong>Host vs Graft</strong></p>\n</td>\n</tr>\n<tr>\n<td>Hyperacute</td>\n<td>Type 2</td>\n</tr>\n<tr>\n<td>Acute</td>\n<td>Type 2 and 4</td>\n</tr>\n<tr>\n<td>Chronic</td>\n<td>Type 2 and 4</td>\n</tr>\n<tr>\n<td colspan=\"2\"><strong>Graft vs Host</strong></td>\n</tr>\n<tr>\n<td>Graft vs host reaction</td>\n<td>Type 4</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p>\n<p>The image given below explains the pathophysiology of hyperacute graft rejection (<strong>type II</strong> hypersensitivity).&nbsp;</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/988706e6c52640cabe45b6c598d1b709x1280x2089.JPEG\" alt=\"Pearl Image\"><p>The image below shows the mechanism of<strong> type IV</strong> hypersensitivity in graft rejection.&nbsp;</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/740d6c7dadda46d38620f36124adea54x1280x4218.JPEG\" alt=\"Pearl Image\"><hr><h3>Related Pearl: Blood Transfusion Reactions</h3><table>\n<tbody>\n<tr>\n<td colspan=\"4\"><span><strong>Immunological Transfusion Reactions</strong>&nbsp;&nbsp;&nbsp;&nbsp;</span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</td>\n</tr>\n<tr>\n<td>\n<p><span><strong>Reaction<br /></strong></span><span><strong>(Onset)</strong></span></p>\n</td>\n<td><span><strong>Mechanism</strong></span></td>\n<td><span><strong>Presentation</strong></span></td>\n<td><span><strong>Management</strong></span></td>\n</tr>\n<tr>\n<td>\n<p><span><strong>Anaphylactic transfusion reaction</strong></span></p>\n<p><span>(Seconds-minutes)</span></p>\n</td>\n<td>\n<p><span>Common in<strong> IgA</strong> deficient recipients&nbsp;</span></p>\n</td>\n<td>\n<p><span>Shock, respiratory distress, angioedema</span></p>\n</td>\n<td>\n<p>Stop transfusion immediately, give epinephrine</p>\n<p><span>Prevention &ndash; using IgA deficient plasma and washed cellular blood components</span></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><span><strong>Allergic/ Urticarial transfusion reaction</strong></span></p>\n<p><span>(Within 2-3 hours)</span></p>\n</td>\n<td>\n<p><span>Recipient <strong>IgE</strong> against donor components causing mast cell activation</span></p>\n</td>\n<td>\n<p><span>Urticaria, flushing, pruritus</span></p>\n</td>\n<td>\n<p><span>Stop transfusion immediately, aggressively manage with IV fluids</span></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><span><strong>Febrile non-hemolytic transfusion reaction</strong></span></p>\n<p><span>(within&nbsp;</span><span>6h)</span></p>\n<p>&nbsp;</p>\n<p><span><span>(Most common complication of blood transfusion)</span></span></p>\n</td>\n<td>\n<p><span>Antibodies against donor WBC and <strong>HLA</strong> antigens (sensitization)</span></p>\n<p><span>Cytokine accumulation during blood storage</span></p>\n<p><span>More common in multipally transfused patients and multiparous women</span></p>\n</td>\n<td>\n<p><span>Fever and chills sometimes with mild dyspnoea</span></p>\n</td>\n<td>\n<p><span>Antihistamines and antipyretics</span></p>\n<p><span>Transfusion can be stopped if symptoms are severe</span></p>\n<p>Prevention: Leukoreduced products</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><span><strong>Transfusion-related acute lung injury (TRALI)</strong></span></p>\n<p><span>(1-6 hours)</span></p>\n</td>\n<td>\n<p><span>Anti-HLA type 2 antibodies in donor plasma bind recipient WBCs, increase capillary permeability</span></p>\n</td>\n<td>\n<p><span>Hypoxia, non-cardiogenic pulmonary edema</span></p>\n<p><span>CXR: Bilateral interstitial infiltrates</span></p>\n</td>\n<td>\n<p><span>Stop transfusion immediately</span></p>\n<p><span>Supportive care</span></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><span><strong>Acute hemolytic transfusion reaction</strong></span></p>\n<p><span>(during transfusion to within 24h)</span></p>\n</td>\n<td>\n<p><span>ABO incompatibility</span></p>\n<p><span>(Type 2 hypersensitivity)</span></p>\n<p><span>Pre-existing high affinity IgM antibodies rapidly induce complement mediated lysis, intra-vascular hemolysis, and hemoglobinuria</span></p>\n</td>\n<td>\n<p><span>Fever, chills, flank/back pain</span></p>\n<p><span>Sense of impending doom</span></p>\n<p><span>Hemoglobinuria</span></p>\n<p><span>DIC, Renal failure</span></p>\n<p><span>Coomb&rsquo;s test positive, pink plasma</span></p>\n</td>\n<td>\n<p><span>Stop transfusion immediately, aggressively manage with IV fluids</span></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><span><strong>Delayed hemolytic transfusion reaction</strong></span></p>\n<p><span>occurs after 24 hours ( usually 2 weeks )</span></p>\n</td>\n<td>\n<p><span>Recipients have prior exposure to RBC antigens. </span><span>After the transfusion, anamnestic response results in antibody production</span></p>\n<p><span>Typically caused by IgG antibodies to foreign protein antigens and are associated with laboratory features of hemolysis.</span></p>\n</td>\n<td>\n<p><span>Mild fever, hemolytic anemia</span></p>\n<p><span>Coomb&rsquo;s test positive</span></p>\n<p><span>Screening for new antibodies positive</span></p>\n</td>\n<td>\n<p><span>Supportive care</span></p>\n<p><span>Additional transfusions if needed</span></p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p><span><strong>Non-immune</strong> mediated transfusion reactions are as follows:</span></p>\n<ul>\n<li><span>Transfusion-associated circulatory overload (TACO)</span></li>\n<li><span>Hypothermia</span></li>\n<li><span>Electrolyte abnormality- hyperkalemia, hypocalcemia</span></li>\n<li><span>Iron overload</span></li>\n<li><span>Transient hypotension</span></li>\n<li><span>Immunomodulation</span></li>\n<li><span>Blood-borne infections&nbsp;</span></li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF0798",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following statements are correct regarding the effect of Glucose-6-Phosphate Dehydrogenase deficiency?<div class='question-desc-html'><ol>\n<li>Decrease in reduced glutathione</li>\n<li>Decreased NADPH</li>\n<li>Decreased lipid peroxidation</li>\n<li>Decreased RBC membrane damage</li>\n</ol></div>",
      "choices": [
        {
          "id": 1,
          "text": "Only 1 is correct."
        },
        {
          "id": 2,
          "text": "1 & 2 are correct."
        },
        {
          "id": 3,
          "text": "2 & 3 are correct."
        },
        {
          "id": 4,
          "text": "1, 2 & 4 are correct."
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>Glucose-6-Phosphate Dehydrogenase (G6PD) deficiency causes <strong>decrease in reduced glutathione </strong>and<strong> decreased NADPH</strong>.</p>\n<p>G6PD is an important enzyme involved in the hexose monophosphate shunt. Defective enzyme function reduced the ability of red cells to protect themselves against oxidative injuries, thereby increasing lipid peroxidation and lead to hemolysis.&nbsp;</p>\n<ul>\n<li>G6PD reduces NADP to NADPH while oxidizing glucose-6-phosphate.</li>\n<li>This <strong>NADPH</strong> then provides reducing equivalents needed for conversion of oxidized glutathione to <strong>reduced glutathione</strong>.</li>\n<li>This reduced glutathione acts as a cofactor in reactions that neutralize compounds such as H2O2, thereby protecting against oxidant injury.</li>\n<li>Exposure of G6PD deficient red cells to oxidative stress leads to crosslinking of reactive sulfhydryl groups on globin chains, which then becomes denatured and form membrane-bound precipitates called &lsquo;<strong>Heinz</strong> <strong>bodies&rsquo;, </strong>thereby producing membrane damage.</li>\n<li>When these inclusion bearing RBCs pass through the splenic cords, macrophages pluck out these Heinz bodies.</li>\n<li>The resultant cells are called &lsquo;<strong>Bite cells</strong>&rsquo;.&nbsp;</li>\n</ul>\n<p>Clinical features:</p>\n<ul>\n<li>Episodic hemolysis, both intravascular and extravascular</li>\n<li>Hemolytic anaemia</li>\n<li>Hemoglobinemia</li>\n<li>Hemoglobinuria</li>\n</ul>\n<p>The episode of hemolysis is <strong>self-limiting</strong>, since only the older RBCs are at risk for lysis, leaving the G6PD-replete younger RBCs in circulation. The recovery phase is heralded by <strong>reticulocytosis</strong>.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF0729",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following is not likely to be seen in a patient with Paroxysmal Nocturnal Hemoglobinuria (PNH)?",
      "choices": [
        {
          "id": 1,
          "text": "Aplastic anemia"
        },
        {
          "id": 2,
          "text": "Leukemia"
        },
        {
          "id": 3,
          "text": "Thrombosis"
        },
        {
          "id": 4,
          "text": "Hemolysis"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><strong>Leukemia </strong>is least likely to be&nbsp;seen in patients with&nbsp;Paroxysmal Nocturnal Hemoglobinuria (PNH).</p>\n<p>Clinical manifestations of PNH include:</p>\n<ul>\n<li><strong>Hemolytic anemia</strong></li>\n<li>Pancytopenia</li>\n<li><strong>Intermittent hemoglobinuria</strong>- acute hemolytic episodes occur at night owing to a&nbsp;<strong>slight fall in pH</strong> during sleep</li>\n<li>Haemosiderinuria</li>\n<li><strong>Venous thrombosis </strong>(a leading cause of death in PNH)</li>\n<li>Patients diagnosed with PNH can later develop aplastic anemia and vice versa</li>\n</ul>\n<p>PNH is an acquired disorder resulting from the mutation in the phosphatidylinositol glycan complementation group A gene (PIGA), an enzyme that is essential for the synthesis of membrane-associated complement regulatory proteins. PNH blood cells are abnormally susceptible to <strong>lysis</strong> or <strong>injury</strong> by complement since they are deficient in three GPI- linked proteins that regulate complement activity:&nbsp;</p>\n<ul>\n<li><strong>Decay-accelerating factor</strong> or <strong>CD55</strong></li>\n<li><strong>Membrane inhibitor of reactive lysis</strong> or <strong>CD59</strong> (Inhibitor of C3 convertase) and</li>\n<li><strong>C8-binding protein&nbsp;</strong></li>\n</ul>\n<p><strong>Diagnosis:</strong></p>\n<ul>\n<li><strong>Ham&rsquo;s test</strong>: The abnormal sensitivity of red blood cells, leukocytes, and platelets to complement can be demonstrated in vitro using red cell lysis at <strong>acidic pH</strong>.</li>\n<li><strong>Flow cytometry</strong> detects the red cells that are deficient in GPI-linked proteins such as <strong>CD59</strong>.</li>\n</ul>\n<p>Treatment:</p>\n<p>Eculizumab, a monoclonal antibody, that prevents the conversion of C5 to C5a has been proven effective in PNH. The definitive treatment is hematopoietic stem cell transplantation.</p><p>Note:</p>\n<p>5-10% of PNH cases may develop myeloproliferative or myelodysplastic disorder and some may even develop <strong>acute myeloid leukemia. </strong>But since leukemia can develop only in a less fraction of patients, it is ruled out.</p><hr><h3>Related Pearl: Classification of Hemolytic Anemias</h3><p>Hemolytic anemias can be classified in 2 ways:</p>\n<p>1. Based on the <strong>type of defect</strong>:</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Type </strong></td>\n<td><strong>Intracorpuscular Defects</strong></td>\n<td><strong>Extracorpuscular Factors</strong></td>\n</tr>\n<tr>\n<td>Hereditary</td>\n<td>\n<p>Hemoglobinopathies</p>\n<p>Enzymopathies</p>\n<p>Membrane-cytoskeletal defects</p>\n</td>\n<td>Familial (atypical) hemolytic uremic syndrome</td>\n</tr>\n<tr>\n<td>Acquired</td>\n<td>Paroxysmal nocturnal hemoglobinuria (PNH)</td>\n<td>\n<p>Mechanical destruction (microangiopathic)</p>\n<p>Toxic agents</p>\n<p>Drugs</p>\n<p>Infectious</p>\n<p>Autoimmune</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>2. Based on the <strong>sites</strong> of <strong>hemolysis:</strong></p>\n<p><strong>Intravascular </strong>hemolysis<strong>:</strong></p>\n<ul>\n<li><span class=\"TextRun SCXW225898103\" lang=\"EN-GB\" xml:lang=\"EN-GB\"><span class=\"NormalTextRun SCXW225898103\">Mechanical injury</span></span>\n<ul>\n<li data-leveltext=\"%1.\" data-font=\"Calibri, sans-serif\" data-listid=\"2\" aria-setsize=\"-1\" data-aria-posinset=\"1\" data-aria-level=\"1\">Trauma caused by cardiac valves </li>\n<li data-leveltext=\"%1.\" data-font=\"\" data-listid=\"2\" aria-setsize=\"-1\" data-aria-posinset=\"2\" data-aria-level=\"1\">Microangiopathic hemolytic anaemias (hemolytic uremic syndrome, disseminated intravascular coagulation, thrombotic thrombocytopenic purpura) </li>\n<li data-leveltext=\"%1.\" data-font=\"\" data-listid=\"2\" aria-setsize=\"-1\" data-aria-posinset=\"3\" data-aria-level=\"1\">Repetitive physical trauma</li>\n</ul>\n</li>\n<li><span class=\"TextRun SCXW46333709\" lang=\"EN-GB\" xml:lang=\"EN-GB\"><span class=\"NormalTextRun SCXW46333709\">Complement fixation (antibody-mediated destruction)</span></span>\n<ul>\n<li data-leveltext=\"%1.\" data-font=\"Calibri, sans-serif\" data-listid=\"3\" aria-setsize=\"-1\" data-aria-posinset=\"1\" data-aria-level=\"1\">Hemolytic disease of the newborn- ABO incompatibility </li>\n<li data-leveltext=\"%1.\" data-font=\"Calibri, sans-serif\" data-listid=\"3\" aria-setsize=\"-1\" data-aria-posinset=\"2\" data-aria-level=\"1\">Transfusion reaction  </li>\n<li data-leveltext=\"%1.\" data-font=\"\" data-listid=\"3\" aria-setsize=\"-1\" data-aria-posinset=\"4\" data-aria-level=\"1\">Drug-induced </li>\n</ul>\n</li>\n<li><span class=\"TextRun SCXW127641793\" lang=\"EN-GB\" xml:lang=\"EN-GB\"><span class=\"NormalTextRun SCXW127641793\">Infections of red blood cells </span></span>\n<ul>\n<li><span class=\"TextRun SCXW127641793\" lang=\"EN-GB\" xml:lang=\"EN-GB\"><span class=\"NormalTextRun SCXW127641793\">Malaria</span></span></li>\n<li><span class=\"TextRun SCXW127641793\" lang=\"EN-GB\" xml:lang=\"EN-GB\"><span class=\"NormalTextRun SCXW127641793\">B</span></span><span class=\"TextRun SCXW127641793\" lang=\"EN-GB\" xml:lang=\"EN-GB\"><span class=\"SpellingError SCXW127641793\">abesiosis</span></span></li>\n</ul>\n</li>\n<li><span class=\"EOP SCXW127641793\" data-ccp-props=\"{&quot;134233279&quot;:true,&quot;201341983&quot;:0,&quot;335559739&quot;:160,&quot;335559740&quot;:259}\"><span class=\"TextRun SCXW261552469\" lang=\"EN-GB\" xml:lang=\"EN-GB\"><span class=\"NormalTextRun SCXW261552469\">Exogenous toxic factors - c</span></span></span><span class=\"EOP SCXW127641793\" data-ccp-props=\"{&quot;134233279&quot;:true,&quot;201341983&quot;:0,&quot;335559739&quot;:160,&quot;335559740&quot;:259}\"><span class=\"TextRun SCXW261552469\" lang=\"EN-GB\" xml:lang=\"EN-GB\"><span class=\"SpellingError SCXW261552469\">lostridial</span></span><span class=\"TextRun SCXW261552469\" lang=\"EN-GB\" xml:lang=\"EN-GB\"><span class=\"NormalTextRun SCXW261552469\"> sepsis</span></span></span></li>\n</ul>\n<div class=\"ng-scope\">\n<div class=\"ng-scope\">\n<p class=\"ng-binding\"><strong>Extravascular </strong>hemolysis<strong>:</strong></p>\n<ul>\n<li>Hereditary spherocytosis</li>\n<li>Thalassemia</li>\n<li>Sickle cell anemia</li>\n<li>Hemolytic disease of the newborn- Rh incompatibility</li>\n</ul>\n<p><strong>Both</strong> intravascular and extravascular hemolysis:</p>\n<ul>\n<li>G6PD deficiency</li>\n<li>Autoimmune hemolytic anemia</li>\n</ul>\n</div>\n</div><hr><h3>Related Pearl: Complement deficiency and associated diseases</h3><p>&nbsp;</p>\n<table>\n<tbody>\n<tr>\n<td>Complement protein</td>\n<td>Effects of deficiency</td>\n</tr>\n<tr>\n<td>C1, C2, C4</td>\n<td>Immune- complex disease (SLE)</td>\n</tr>\n<tr>\n<td>C3, Factor I</td>\n<td>Susceptibility to capsulated bacteria</td>\n</tr>\n<tr>\n<td>C5-C9</td>\n<td>Susceptibility to Neisseria</td>\n</tr>\n<tr>\n<td>Factor D. properdin (factor P)</td>\n<td>Susceptibility to capsulated bacteria and Neisseria.</td>\n</tr>\n<tr>\n<td>\n<p>DAF (Decay accelerating factor)</p>\n<p>CD 59</p>\n</td>\n<td>Paroxysmal nocturnal hemoglobinuria</td>\n</tr>\n<tr>\n<td>C1-inhibitor</td>\n<td>Hereditary angioneurotic edema</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF0716",
      "difficulty": "medium"
    },
    {
      "text": "Given below is an electron microscopic image of the lung tissue. A patient infected with SARS-COV2 presents with ARDS. The infection would affect and expand which of the labeled layers?",
      "choices": [
        {
          "id": 1,
          "text": "B"
        },
        {
          "id": 2,
          "text": "A"
        },
        {
          "id": 3,
          "text": "C"
        },
        {
          "id": 4,
          "text": "D"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The image given in the question demonstrates the electron microscopic image of the blood-air barrier in the lungs. Acute respiratory distress syndrome (ARDS) has been set in this patient with COVID-19.&nbsp;<strong>Damage to the endothelial</strong>&nbsp;(Labelled as<strong> </strong>A)&nbsp;cells, with inflammation, is the&nbsp;<strong>key initiating event</strong>&nbsp;and the basis of lung damage. Neutrophils&nbsp;play a significant role in tissue injury in this condition.</p>\n<p><strong>Shock lung</strong>&nbsp;also known as ARDS/HMD/ALI (acute lung injury)&nbsp; is characterized histologically by&nbsp;<strong>diffuse alveolar damage&nbsp;</strong>(DAD). The characteristic histological picture is that of a&nbsp;<strong>hyaline membrane lining</strong>&nbsp;the alveolar walls. Edema, scattered neutrophils and macrophages, and necrotic epithelial cells are also present.</p>\n<p>Histologic findings in COVID-19 patients :</p>\n<ul>\n<li><strong>Diffuse alveolar damage</strong></li>\n<li>Inflammation with mononuclear cells</li>\n</ul>\n<p><span data-preserver-spaces=\"true\">The given HP slide shows <strong>diffuse alveolar damage&nbsp;</strong>which&nbsp;is the <strong>most common finding</strong> in the histopathological analysis of COVID-19 infected lungs with ARDS.&nbsp;</span></p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/a687ad3d60144eb796fa01b338731f13x720x540.JPEG\" alt=\"Explanation Image\"><p>&nbsp;</p>\n<p>The image given in the question demonstrates the electron microscopic image of the blood-air barrier in the lungs. The structures that form the same are labeled in the image given below. The side of location of endothelium can be deduced by the location of the RBC.&nbsp;</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/95a965f84ccc475c8fe931a059a4fabax1280x1486.JPEG\" alt=\"Explanation Image\">",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/0fd8d386af03403b9911629b0e0dae84.PNG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF0712",
      "difficulty": "medium"
    },
    {
      "text": "What is the gold standard investigation for the diagnosis of myocarditis?",
      "choices": [
        {
          "id": 1,
          "text": "Endo-myocardial biopsy"
        },
        {
          "id": 2,
          "text": "Magnetic Resonance Imaging"
        },
        {
          "id": 3,
          "text": "Brain Natriuretic Peptide"
        },
        {
          "id": 4,
          "text": "LDH1 to LDH2 ratio"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p><strong>An endo-myocardial biopsy</strong> is the <strong>gold standard</strong> investigation for the diagnosis of <strong>myocarditis</strong>.</p>\n<p>Myocarditis can be due to&nbsp;</p>\n<ul>\n<li>Infections: Coxsackie A and B, HIV, C.diphtheriae, Ricketssiae, Candida, Protozoa and helminths.</li>\n<li>Immune-mediated reactions: Post-viral, post-streptococcal, drug hypersensitivity (e.g: methyl dopa, sulfinamides), transplant rejection, etc.,</li>\n<li>Unknown: Sarcoidosis, Giant cell myocarditis</li>\n</ul>\n<p>Active myocarditis is characterized by an interstitial inflammatory infiltrate associated with degenerating or apoptotic myocytes.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF0731",
      "difficulty": "medium"
    },
    {
      "text": "A child presented with bilateral proptosis. From the peripheral smear, he was suspected to have chloroma. What is the next investigation of choice?",
      "choices": [
        {
          "id": 1,
          "text": "Platelet count"
        },
        {
          "id": 2,
          "text": "WBC count"
        },
        {
          "id": 3,
          "text": "Flow cytometry"
        },
        {
          "id": 4,
          "text": "Bone marrow biopsy"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>The next investigation of choice, in a child suspected to have a<strong> chloroma</strong>, is a <strong>bone marrow biopsy</strong>.</p>\n<div class=\"page\" title=\"Page 4947\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p><strong>Chloroma, </strong>also called <strong>myeloid sarcoma</strong>,&nbsp;<strong>granulocytic sarcoma</strong>, or&nbsp;<strong>myeloblastoma</strong>&nbsp;is an <strong>extramedullary tumor</strong> that occurs in 2% to 14% of patients with <strong>acute myeloid leukemia (AML)</strong>. Frequent sites of involvement are the skin, lymph nodes, gastrointestinal tract, bone, soft tissue, testis, and peritoneum.</p>\n<p>Isolated orbital involvement of myeloid sarcoma is rare.&nbsp;<strong>Proptosis</strong> is the most common presentation. Other symptoms include lacrimal swelling, conjunctival mass lesion, retinal hemorrhages, ptosis, dystopia.&nbsp;<sup id=\"cite_ref-21\" class=\"reference\"></sup><sup id=\"cite_ref-22\" class=\"reference\"></sup>Decreased visual acuity and ocular movement restriction have also been reported.</p>\n<p>Most cases of chloroma can be diagnosed on <strong>peripheral smear</strong> examination, which is easily available and is relatively inexpensive. Sometimes it may not be associated with any peripheral smear abnormality, and hence <strong>bone marrow aspirate</strong> and <strong>biopsy</strong> should be done to confirm AML.&nbsp;The diagnosis can also be made if Auer rods are detected.&nbsp;Myeloid sarcomas have immunophenotypic features that are identical to AML.</p>\n<p>Although myeloid sarcomas are <strong>radiosensitive</strong>, they are managed with systemic <strong>chemotherapy</strong> in most cases, even in the absence of bone marrow involvement. <strong>Surgery</strong> and/or <strong>radiation</strong> therapy may be indicated for <strong>symptomatic</strong> lesions or tumors causing local organ dysfunction or obstruction.</p>\n<p>The image shows <strong>Auer&nbsp;rods</strong> contained within myeloblasts.&nbsp;</p>\n</div>\n</div>\n</div><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/831bac512bc84d9aa0fe758b3c63d5dex352x512.JPEG\" alt=\"Explanation Image\"><hr><h3>Related Pearl: Important Translocations in AML</h3><table>\n<tbody>\n<tr>\n<td>Translocation</td>\n<td>t(8,21)\n<p>(most common)&nbsp;</p>\n</td>\n<td>t(15,17)</td>\n<td>t(16,16) or inv(16)</td>\n</tr>\n<tr>\n<td>Fusion gene</td>\n<td>\n<p>RUNX1-RUNX1T1</p>\n</td>\n<td>PML-RAR&alpha;</td>\n<td>CBF-&beta; (Core binding factor)</td>\n</tr>\n<tr>\n<td>FAB classification</td>\n<td>\n<p>Blasts with maturation/M2</p>\n</td>\n<td>Acute promyelocytic leukemia/M3</td>\n<td>Myelomonocytic/M4</td>\n</tr>\n<tr>\n<td>Clinical association</td>\n<td>Myeloid sarcoma/ chloroma</td>\n<td>DIC</td>\n<td>Eosinophilia</td>\n</tr>\n<tr>\n<td>Prognosis</td>\n<td>Good</td>\n<td>Very good</td>\n<td>Good</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><hr><h3>Related Pearl: Cytochemistry of Acute Leukemias</h3><table>\n<tbody>\n<tr>\n<td><strong>Stain</strong></td>\n<td><strong>AML</strong></td>\n<td><strong>ALL</strong></td>\n</tr>\n<tr>\n<td>Myeloperoxidase</td>\n<td>+</td>\n<td>-</td>\n</tr>\n<tr>\n<td>Sudan black</td>\n<td>+</td>\n<td>-</td>\n</tr>\n<tr>\n<td>Non-specific esterase</td>\n<td>\n<p>Strongly +ve: M4, M5</p>\n<p>Weakly +ve: M3, M7</p>\n</td>\n<td>_</td>\n</tr>\n<tr>\n<td>Periodic acid Schiff</td>\n<td>+ve in AML M6</td>\n<td>+</td>\n</tr>\n<tr>\n<td>Acid phosphatase</td>\n<td>-</td>\n<td>+ (T-cell)</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><hr><h3>Related Pearl: Malignancies, Translocations and Affected Genes</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Malignancy </strong></p>\n</td>\n<td>\n<p><strong>Translocation</strong></p>\n</td>\n<td>\n<p><strong>Affected Genes</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>CLL/ Small lymphocytic lymphoma</p>\n</td>\n<td>\n<p>t(14;19)</p>\n</td>\n<td>\n<p><em>-</em></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Chronic myelogenous leukemia (CML)</p>\n</td>\n<td>\n<p>t(9;22)</p>\n</td>\n<td>\n<p><em>ABL </em>9q34</p>\n<p><em>BCR </em>22q11</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Acute myeloid leukemia (AML)</p>\n</td>\n<td>\n<p>t(8; 21), t(15; 17)</p>\n</td>\n<td>\n<p><em>AML1 21</em>q22</p>\n<p><em>ETO 8</em>q22</p>\n<p><em>PML </em>15q22</p>\n<p><em>RARA </em>17q21</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Precursor B cell ALL</p>\n</td>\n<td>\n<p>t(9;22), t(4;11)</p>\n</td>\n<td>&nbsp;\n<p>BCR/ABL</p>\n<p>AF4, ALLI</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Burkitt lymphoma</p>\n</td>\n<td>\n<p>t(8; 14), t(2;8) t(8;22)</p>\n</td>\n<td>\n<p><em>c-myc&nbsp;</em>8q24</p>\n<p><em>IGH </em>14q32</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Mantle cell lymphoma</p>\n</td>\n<td>\n<p>t(11; 14)</p>\n</td>\n<td>\n<p><em>CCND1 </em>11q13</p>\n<p><em>IGH </em>14q32</p>\n<p><em>BCL1</em></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Follicular lymphoma</p>\n</td>\n<td>\n<p>t(14; 18)</p>\n</td>\n<td>\n<p><em>IGH </em>14q32</p>\n<p><em>BCL2 </em>18q21</p>\n<p>&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Ewing sarcoma</p>\n</td>\n<td>\n<p>t(11; 22)</p>\n</td>\n<td>\n<p><em>FLI1 </em>11q24</p>\n<p><em>EWSR1 </em>22q12</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Prostatic adenocarcinoma</p>\n</td>\n<td>\n<p>t(7; 21), t(17; 21)</p>\n</td>\n<td>\n<p><em>TMPRSS2 </em>(21q22.3)</p>\n<p><em>ETV1</em> (7p21.2)</p>\n<p><em>ETV4 </em>(17q21)</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Diffuse large B-cell lymphoma</p>\n</td>\n<td>&nbsp;t(14;18)</td>\n<td>&nbsp;\n<p><em>BCL-6</em>,&nbsp;p53</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>MALT lymphoma</p>\n</td>\n<td>t(11;18)</td>\n<td><em>API2/MALT</em>, <em>BCL-10</em></td>\n</tr>\n<tr>\n<td>\n<p>CD30+ Anaplastic large cell lymphoma</p>\n</td>\n<td>t(2;5)</td>\n<td><em>ALK</em></td>\n</tr>\n<tr>\n<td>\n<p>Lymphoplasmacytoid lymphoma</p>\n</td>\n<td>t(9;14)</td>\n<td><em>PAX5, IGH</em></td>\n</tr>\n<tr>\n<td>\n<p>Synovial sarcoma</p>\n</td>\n<td>t(X;18)(p11;q11)&nbsp;</td>\n<td>&nbsp;\n<p><em>SS18-SSX2</em></p>\n<p><em>SS18-SSX4</em></p>\n</td>\n</tr>\n<tr>\n<td>&nbsp;Alveolar soft-part sarcoma</td>\n<td>&nbsp;t(X;17)(p11.2;q25)</td>\n<td>&nbsp;<em>TFE3-ASPL</em></td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF2267",
      "difficulty": "hard"
    },
    {
      "text": "A person working in an industry for a long time developed progressive breathlessness. The histopathological image of his lung biopsy is given below. What industry was he most likely working in?",
      "choices": [
        {
          "id": 1,
          "text": "Silica"
        },
        {
          "id": 2,
          "text": "Asbestos"
        },
        {
          "id": 3,
          "text": "Coal dust"
        },
        {
          "id": 4,
          "text": "Cotton"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>From the clinical history of progressive breathlessness and the histopathological image showing asbestos bodies, ferruginous bodies, and fibrosis, the patient is most likely working in the&nbsp;<strong>asbestos</strong> industry.</p>\n<p><strong>Asbestosis&nbsp;</strong>occurs due to the inhalation of crystalline hydrated silicates (asbestos). It is characterized by diffuse <strong>parenchymal interstitial fibrosis</strong>. It usually begins in the&nbsp;<strong>lower lobes</strong> of the lungs and may present with dyspnoea and cough, usually after 20-30 years of exposure. Other asbestos-related diseases include pleural plaques, recurrent pleural effusions, lung carcinoma, and mesothelioma.</p>\n<p><strong>Asbestos bodies</strong> are a hallmark finding. They appear as <strong>golden brown, fusiform, or beaded rods</strong>. These are formed when the asbestos fibers are phagocytosed by the macrophages and are coated by iron-containing proteinaceous material derived from phagocyte ferritin. Similar iron-protein complexes coat other inorganic particulates other than asbestos which are termed as<strong> ferruginous bodies</strong>.</p>\n<p>The image&nbsp;below shows&nbsp;<strong>asbestos bodies.</strong></p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/5217156371654e7abdda0d2c6b9916c8x1280x896.JPEG\" alt=\"Explanation Image\"><p>Other options:</p>\n<p>Option A:&nbsp;<strong>Silicosis&nbsp;</strong>is due to the inhalation of crystalline silicon dioxide (silica) as seen in individuals employed in sandblasting or rock mining. Macrophages phagocytose inhaled silica particles, thereby activating and releasing inflammatory mediators (IL-1, IL-8) that cause fibroblast recruitment. Subsequently, collagen is deposited in the interstitium.</p>\n<p>Microscopy reveals coalescent <strong>nodules of whorled collagen fibers</strong> surrounded by a peripheral zone of silica-laden macrophages.&nbsp;</p>\n<p>Shown below is an image of a silicotic <strong>nodule with collagen whorls</strong> as seen in this condition.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/fb2407423eeb4baba654821bd01eb5cax1280x856.JPEG\" alt=\"Explanation Image\"><p>&nbsp;</p>\n<p>Option C:<strong>&nbsp;Anthracosis/</strong><strong>coal workers' pneumoconiosis </strong>is&nbsp;a pulmonary condition seen in coal miners. The inhaled carbon pigment is engulfed by alveolar or interstitial macrophages, which accumulate in the connective tissue. Initially it causes simple coal workers pneumoconiosis with little or no pulmonary dysfunction.&nbsp;With continued exposure, lung tissue undergoes <strong>progressive massive fibrosis </strong>which is called as<strong> complicated coal workers pneumoconiosis</strong>.&nbsp;The <strong>upper lobes</strong> of the lungs are commonly involved.</p>\n<p>Microscopic features consist of&nbsp;<strong>coal-laden macrophages,&nbsp;</strong>black pigment, and dense collagenous interstitial fibrosis.&nbsp;</p>\n<p>The image below shows <strong>anthracosis</strong>- black pigment engulfed within macrophages as well as in the form of deposits.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/6e51281fd81f4c8a99e5d632f32bf314x1280x859.JPEG\" alt=\"Explanation Image\"><p>&nbsp;</p>\n<p>Option D: <strong>Cotton dust</strong> causes <strong>byssinosis</strong> and can induce occupational asthma.</p><hr><h3>Related Pearl: Some common pneumoconiosis</h3><div class=\"page\" title=\"Page 695\">\n<table><colgroup><col /><col /><col /></colgroup>\n<tbody>\n<tr>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p><strong>Agent</strong></p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p><strong>Disease</strong></p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p><strong>Exposure</strong></p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td colspan=\"3\" rowspan=\"1\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p><strong>Mineral Dusts</strong></p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Coal dust</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Anthracosis<br />Macules</p>\n<p>Progressive massive fibrosis</p>\n<p>Caplan syndrome</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Coal mining (particularly hard coal)</p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Silica</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Silicosis</p>\n<p>Caplan syndrome</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Metal casting work, sandblasting, hard rock mining, stone cutting, others</p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Asbestos</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Asbestosis<br />Pleural plaques<br />Caplan syndrome<br />Mesothelioma</p>\n<p>Carcinoma of the lung, larynx, stomach, colon</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Mining, milling, manufacturing, and installation and removal of insulation</p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Beryllium</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Acute berylliosis</p>\n<p>Beryllium granulomatosis</p>\n<p>Lung carcinoma (?)</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Mining, manufacturing</p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Iron oxide</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Siderosis</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Welding</p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Barium sulfate</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Baritosis</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Mining</p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Tin oxide</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Stannosis</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Mining</p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td colspan=\"3\" rowspan=\"1\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p><strong>Organic Dusts</strong></p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Moldy hay</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Farmer’s lung</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Farming  </p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Bagasse</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Bagassosis</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Manufacturing wallboard, paper</p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Bird droppings</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Bird-breeder’s lung</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Bird handling</p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Cotton, flax, hemp</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Byssinosis</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Textile manufacturing</p>\n</div>\n</div>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n</div><hr><h3>Related Pearl: Named lung diseases</h3><table>\n<tbody>\n<tr>\n<td>\n<p>Bagassosis</p>\n</td>\n<td>Pneumoconiosis due to sugarcane</td>\n</tr>\n<tr>\n<td>Byssinosis (brown lung disease/ Monday fever)</td>\n<td>Pneumoconiosis due to cotton fiber</td>\n</tr>\n<tr>\n<td>Farmer&rsquo;s lung</td>\n<td>Pneumoconiosis due to Thermophilic actinomycetes</td>\n</tr>\n<tr>\n<td>Bird Fancier&rsquo;s lung</td>\n<td>Hypersensitivity pneumonitis caused by bird droppings</td>\n</tr>\n<tr>\n<td>Chalicosis (flint disease)&nbsp;</td>\n<td>In stonecutters, due to inhalation of fine particles of stone</td>\n</tr>\n<tr>\n<td>Caplan&rsquo;s syndrome</td>\n<td>&nbsp;RA + pneumoconiosis</td>\n</tr>\n<tr>\n<td>Lofgren's syndrome</td>\n<td>An acute presentation of sarcoidosis, consisting of arthritis, erythema nodosum, and bilateral hilar adenopathy</td>\n</tr>\n<tr>\n<td>Bornholm&rsquo;s disease (epidemic pleurodynia)</td>\n<td>associated with Coxsackie B virus</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/8852b65881564881b51cf614d88a5ad7.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF2152",
      "difficulty": "easy"
    },
    {
      "text": "A patient presented with complaints of dyspnea on exertion for 1 month. Echocardiography showed the presence of mitral stenosis and left ventricular hypertrophy. Identify the histopathological finding given below and the probable diagnosis.",
      "choices": [
        {
          "id": 1,
          "text": "Aschoff body; Rheumatic heart disease"
        },
        {
          "id": 2,
          "text": "Calcification of valve; Mitral stenosis"
        },
        {
          "id": 3,
          "text": "Granuloma; Sarcoidosis"
        },
        {
          "id": 4,
          "text": "Non-caseating granuloma; Tuberculosis"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The lesion shown in the histopathological slide is <strong>Aschoff's body&nbsp;</strong>and the most probable diagnosis is <strong>rheumatic heart disease (RHD).</strong></p>\n<p><strong>Aschoff's bodies</strong> are the lesions found in the heart during <strong>acute rheumatic fever</strong>. They are composed of foci of T lymphocytes, activated macrophages called <strong>Anitschkow cells</strong>, and&nbsp;occasional plasma cells.&nbsp;Anitschkow cells have abundant cytoplasm and central round-to-ovoid nuclei with chromatin that is centrally condensed into a slender, wavy ribbon. Hence, they are also called caterpillar cells.</p>\n<div class=\"page\" title=\"Page 1860\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Rheumatic fever is the leading cause of mitral stenosis. During acute rheumatic fever, Aschoff bodies may be found in any of the three layers of the heart that results in pericarditis, myocarditis, or endocarditis.&nbsp;</p>\n</div>\n</div>\n</div>\n</div>\n<p>Chronic inflammation leads to diffuse thickening and fibrosis of the valve leaflets, often with calcific deposits. <strong>Fibrinoid necrosis</strong> occurs due to inflammation of the endocardium and the left-sided valves. Over these areas of necrosis, small vegetations called <strong>verrucae</strong> develop along the lines of closure. Irregular thickenings present in the subendocardium are called <strong>MacCallum plaques.</strong></p>\n<p>In chronic RHD, the mitral valve leaflet is thickened, with commissural fusion and shortening. There is thickening and fusion of the tendinous cords. This can lead to narrowing the mitral orifice, leading to a <strong>fish mouth appearance (button hole)</strong>.</p>\n<p>Some major manifestations of rheumatic Fever are:</p>\n<ul>\n<li>Migratory polyarthritis of the large joints&nbsp;</li>\n<li>Pancarditis (myocarditis, pericarditis, or endocarditis)</li>\n<li>Subcutaneous nodules (typically on extensor surfaces of extremities)</li>\n<li>Erythema marginatum, an irregular circinate skin rash&nbsp;</li>\n<li>Sydenham chorea, a neurologic disorder with involuntary&nbsp;rapid movements</li>\n</ul>\n<p>Image showing button hole appearance seen in mitral stenosis in case of rheumatic heart disease.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/6031e6ed44f24170b9cdea19937062dax1280x925.JPEG\" alt=\"Explanation Image\"><p>Image show Aschoff bodies seen in RHD.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/6fe4b58cde5642e99d945ade7d697924x1280x853.JPEG\" alt=\"Explanation Image\"><div class=\"page\" title=\"Page 564\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Other options:</p>\n<p>Option B: Degenerative <strong>calcific deposits</strong> in the <strong>mitral valve</strong> typically develop in the fibrous annulus. They are seen grossly as irregular, stony hard, occasionally ulcerated nodules at the base of the leaflets. Usually, it does not affect valvular function. However, occasionally it can lead to regurgitation, <strong>stenosis</strong>, or arrhythmias.</p>\n<p>The image below shows severe calcification of the mitral valve annulus with focally thickened shortened and fused chordae.</p>\n</div>\n</div>\n</div>\n</div><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/42888aed972b47a5be96f054daac716ax634x476.PNG\" alt=\"Explanation Image\"><div class=\"page\" title=\"Page 700\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Option C: In <strong>sarcoidosis</strong>, the involved tissues contain well-formed <strong>non-necrotizing granulomas</strong>. They are composed of aggregates of tightly clustered epithelioid macrophages, often with giant cells, usually without central necrosis. As the lesions become chronic, fibrous rims or hyaline fibrous scars enclose the granulomas.</p>\n<p>The image below shows non-necrotizing granulomas in the wall of a bronchiole in sarcoidosis.</p>\n</div>\n</div>\n</div>\n</div><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/11aee33119ad4b2ea7dd11d44d86414bx1280x860.JPEG\" alt=\"Explanation Image\"><p>Option D: In <strong>tuberculosis,</strong> sites of active involvement of tuberculosis are marked histologically by a characteristic granulomatous inflammatory reaction composed of both <strong>caseating</strong> and <strong>non-caseating tubercles.</strong> Usually, granuloma shows central granular caseation surrounded by multinucleate giant cells. Central caseation may be absent in non-caseating granulomas. Staining should be done to detect acid-fast bacilli when granulomas are present.&nbsp;</p>\n<div class=\"page\" title=\"Page 380\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>The image below shows a caseating granulomatous lesion with areas of caseation (on the right half) bordered by collections of epithelioid cells, Langhans giant cells, and lymphocytes.</p>\n</div>\n</div>\n</div>\n</div><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/47dc789d288b4e18994e5f746afd2b8bx640x481.JPEG\" alt=\"Explanation Image\"><p>Image showing non-necrotizing granuloma seen in&nbsp;pulmonary tuberculosis.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/0f0673ea9e7c4ac5b7ccef5cf8dbc8a3x1280x976.JPEG\" alt=\"Explanation Image\"><hr><h3>Related Pearl: Named Cells in Histopathology</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Named cells</strong></p>\n</td>\n<td>\n<p><strong>Condition</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Anitschkow or caterpillar cells</p>\n</td>\n<td>\n<p>Rheumatic heart disease</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Globoid cells</p>\n</td>\n<td>\n<p>Krabbe disease</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Kulchitsky cells</p>\n</td>\n<td>\n<p>Small cell carcinoma of lung</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Signet ring cells</p>\n</td>\n<td>\n<p>Signet ring cell carcinoma</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Crumpled tissue paper macrophages</p>\n</td>\n<td>\n<p>Gauchers disease</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Clue cells</p>\n</td>\n<td>\n<p>Bacterial vaginosis</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Fried egg cells</p>\n</td>\n<td>\n<p>Oligodendroglioma</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Hallmark cells</p>\n</td>\n<td>\n<p>Anaplastic large cell lymphoma</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Shadow cells</p>\n</td>\n<td>\n<p>Pilomatricoma</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Mott cells</p>\n</td>\n<td>\n<p>Plasma cell myeloma</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Lepidic cells</p>\n</td>\n<td>\n<p>Cardiac myxoma</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Spider cells</p>\n</td>\n<td>\n<p>Rhabdomyoma</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><hr><h3>Related Pearl: Vegetations in Various Types of Endocarditis</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>&nbsp;</strong></p>\n</td>\n<td>\n<p><strong>RHD</strong></p>\n</td>\n<td>\n<p><strong>Infective endocarditis</strong></p>\n</td>\n<td>\n<p><strong>Non- bacterial thrombotic or marantic endocarditis</strong></p>\n</td>\n<td>\n<p><strong>Libman&ndash;Sacks endocarditis</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Etiology</strong></p>\n</td>\n<td>\n<p>Rheumatic</p>\n<p>heart disease</p>\n</td>\n<td>\n<p>Infective endocarditis</p>\n</td>\n<td>\n<p>Malignancy</p>\n<p>(M3-AML, pancreatic</p>\n<p>carcinoma), deep</p>\n<p>vein thrombosis,</p>\n<p>Trosseau syndrome</p>\n</td>\n<td>\n<p>Systemic lupus erythematosus</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Vegetations</strong></p>\n</td>\n<td>\n<p>Small, warty</p>\n<p>Firm</p>\n<p>Friable</p>\n</td>\n<td>\n<p>Large</p>\n<p>Bulky</p>\n<p>friable,</p>\n<p>destructive</p>\n</td>\n<td>\n<p>Small, single or multiple, non- destructive</p>\n</td>\n<td>\n<p>Small to medium-sized, flat, verrucuous</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Site</strong></p>\n</td>\n<td>\n<p>Along lines of closure</p>\n</td>\n<td>\n<p>Cusps of valves, mural endocardium</p>\n</td>\n<td>\n<p>Line of closure</p>\n</td>\n<td>\n<p>Either or</p>\n<p>both sides of the valve leaflets.</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Sterile/Infective</strong></p>\n</td>\n<td>\n<p>Sterile</p>\n</td>\n<td>\n<p>Non-sterile</p>\n</td>\n<td>\n<p>Sterile</p>\n</td>\n<td>\n<p>Sterile</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Embolisation</strong></p>\n</td>\n<td>\n<p>Uncommon</p>\n</td>\n<td>\n<p>Very common</p>\n</td>\n<td>\n<p>Common</p>\n</td>\n<td>\n<p>Uncommon</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/8cbba8132d2c40e08cdaa19e5a970968x1280x2262.JPEG\" alt=\"Pearl Image\"><hr><h3>Related Pearl: Pathological Named Bodies</h3><table>\n<tbody>\n<tr>\n<td><strong>Bodies</strong></td>\n<td><strong>Found in</strong></td>\n</tr>\n<tr>\n<td>Asteroid bodies</td>\n<td>Sarcoidosis, Sporotrichosis</td>\n</tr>\n<tr>\n<td>\n<p>Halberstaedter&ndash;Prowazek bodies</p>\n</td>\n<td>Trachoma&nbsp;</td>\n</tr>\n<tr>\n<td>Miyagawa bodies</td>\n<td>Lymphogranuloma venereum&nbsp;</td>\n</tr>\n<tr>\n<td>Levinthal&ndash;Cole&ndash;Lillie bodies</td>\n<td>Psittacosis</td>\n</tr>\n<tr>\n<td>Leishman&ndash;Donovan bodies</td>\n<td>Kala-azar&nbsp;</td>\n</tr>\n<tr>\n<td>Negri bodies</td>\n<td>Rabies</td>\n</tr>\n<tr>\n<td>Guarnieri bodies</td>\n<td>Vaccinia</td>\n</tr>\n<tr>\n<td>Bollinger bodies</td>\n<td>Fowl pox</td>\n</tr>\n<tr>\n<td>Henderson&ndash;Paterson bodies</td>\n<td>Molluscum contagiosum&nbsp;</td>\n</tr>\n<tr>\n<td>Cowdry type-A bodies</td>\n<td>Yellow fever, Herpes virus infection&nbsp;</td>\n</tr>\n<tr>\n<td>Cowdry type-B bodies</td>\n<td>Adenovirus, poliovirus</td>\n</tr>\n<tr>\n<td>Rusell bodies</td>\n<td>Multiple myeloma&nbsp;</td>\n</tr>\n<tr>\n<td>Aschoff bodies</td>\n<td>Rheumatic fever&nbsp;</td>\n</tr>\n<tr>\n<td>Call&ndash;Exner bodies</td>\n<td>Granulosa cell tumor of the&nbsp;ovary&nbsp;</td>\n</tr>\n<tr>\n<td>Civatte (colloid) bodies</td>\n<td>Lichen planus&nbsp;</td>\n</tr>\n<tr>\n<td>Michaelis&ndash;Gutmann bodies</td>\n<td>Malakoplakia&nbsp;</td>\n</tr>\n<tr>\n<td>Lewy bodies</td>\n<td>Parkinson's disease&nbsp;</td>\n</tr>\n<tr>\n<td>Pappenheimer bodies</td>\n<td>Non-heme iron pigments in siderocytes&nbsp;</td>\n</tr>\n<tr>\n<td>Howell&ndash;Jolly bodies</td>\n<td>Splenectomy, Megaloblastic Anemia, Hemolytic anemia&nbsp;</td>\n</tr>\n<tr>\n<td>Heinz bodies</td>\n<td>G-6-PD deficiency&nbsp;</td>\n</tr>\n<tr>\n<td>Gamna&ndash;Gandy bodies</td>\n<td>Congestive splenomegaly&nbsp;</td>\n</tr>\n<tr>\n<td>Mallory bodies</td>\n<td>Hyaline inclusions in hepatocytes seen in alcoholic cirrhosis, Indian childhood cirrhosis</td>\n</tr>\n<tr>\n<td>Councilman bodies</td>\n<td>Hepatocytes undergoing apoptosis,&nbsp;seen mainly in acute viral hepatitis.</td>\n</tr>\n<tr>\n<td>Psammoma bodies</td>\n<td>Dystrophic calcification in meningioma, papillary serous cystadenoma of ovary &amp; papillary carcinoma of thyroid, papillary type of renal cell carcinoma.</td>\n</tr>\n<tr>\n<td>Donovan bodies</td>\n<td>Granuloma inguinale&nbsp;</td>\n</tr>\n<tr>\n<td>Nissl's bodies</td>\n<td>Cytoplasmic inclusions in neurons&nbsp;</td>\n</tr>\n<tr>\n<td>Mooser bodies</td>\n<td>Typhus fever</td>\n</tr>\n<tr>\n<td>Creola bodies</td>\n<td>Asthma&nbsp;</td>\n</tr>\n<tr>\n<td>Verocay bodies</td>\n<td>Schwannoma&nbsp;</td>\n</tr>\n<tr>\n<td>Schiller&ndash;Duval bodies</td>\n<td>Endodermal sinus tumor&nbsp;</td>\n</tr>\n<tr>\n<td>\n<p>Hirano bodies</p>\n</td>\n<td>&nbsp;Alzheimer&rsquo;s disease</td>\n</tr>\n<tr>\n<td>\n<p>Ferruginous bodies</p>\n</td>\n<td>Asbestosis&nbsp;</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/2e80d11c6fcb467fa393e8d49d531ee3.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF2227",
      "difficulty": "easy"
    },
    {
      "text": "A patient with lytic lesions on the skull is suspected of a diagnosis of Langerhan cell histiocytosis. Which of the following is a characteristic finding on electron microscopy?",
      "choices": [
        {
          "id": 1,
          "text": "Histiocytes"
        },
        {
          "id": 2,
          "text": "Birbeck granules"
        },
        {
          "id": 3,
          "text": "Eosinophils"
        },
        {
          "id": 4,
          "text": "Giant cells"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The presence of<strong> Birbeck granules</strong>&nbsp;in the cytoplasm is a characteristic finding of Langerhans cell histiocytosis (LCH) on electron microscopy.</p>\n<p>Birbeck granules have a dilated terminal end producing a <strong>tennis racket&ndash;like appearance</strong>. It&nbsp;contains the protein&nbsp;<strong>langerin (CD207). </strong>It is&nbsp;seen on electron microscopy.</p>\n<p>The image below shows&nbsp;<strong>Birbeck granules </strong>on electron microscopy seen in LCH.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/73c07f01368c4588a1294a2217042c96x720x803.JPEG\" alt=\"Explanation Image\"><p>&nbsp;</p>\n<p>Histopathologically,&nbsp;Langerhans cells have a single large nucleus with a characteristic folded or grooved nucleus (<strong>coffee-bean</strong>&nbsp;appearance) with small inconspicuous nucleoli.&nbsp;<strong>Birbeck granules</strong> are seen in the cytoplasm.&nbsp;The tumor cells specifically express <strong>HLA-DR, S-100, and CD1a </strong>and <strong>langerin (CD207) </strong>markers.</p>\n<p>The image below shows histopathological image of Langerhan cells with folded nuclei.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/1be94f63d5ae4abba214ad728db1130ex1280x864.JPEG\" alt=\"Explanation Image\"><p>&nbsp;</p>\n<p>Langerhans cell histiocytosis occurs due to the proliferation of a special type of immature dendritic cells, called&nbsp;<strong>Langerhans cells.&nbsp;</strong>Their&nbsp;normal function is to present antigens. The most common mutation is BRAFV600E gain-of-function mutation.</p>\n<p>It is characterized by <strong>single or multiple osteolytic bone lesions </strong>and<strong>&nbsp;</strong>can also infiltrate nearly every organ, like the skin (of the scalp), lungs, liver, spleen, bone marrow, or the central nervous system.&nbsp;</p>\n<p class=\"p1\">LCH can present as the following clinical entities:</p>\n<ul>\n<li class=\"p1\">Multifocal multisystem Langerhans cell histiocytosis <strong>(Letterer-Siwe disease)</strong></li>\n<li class=\"p1\">Unifocal and multifocal unisystem Langerhans cell histiocytosis <strong>(eosinophilic granuloma)-</strong>&nbsp;The combination of bone defects, diabetes insipidus, and exophthalmos is called the <strong>Hand-Sch&uuml;ller-Christian triad.</strong></li>\n<li class=\"p1\">Pulmonary Langerhans cell histiocytosis</li>\n</ul>\n<p>The below image shows lytic lesion of skull seen in LCH.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/7b7ee9fc8f434279b6853e9fde20ca4bx720x828.JPEG\" alt=\"Explanation Image\"><hr><h3>Related Pearl: Skeletal and Radiological manifestation of  Langerhan’s Cell Histiocytosis</h3><p><strong>Skull:</strong></p>\n<p>Solitary or multiple punched out lytic lesion without sclerotic rim.<br />Double contour or beveled edge appearance may be seen due to asymmetrical involvement of the inner and outer table (hole within a hole sign).<br />Button sequestra representing residual bone.<br />Geographic skull.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/504d808c549645b0bcadbcefbb529c39x720x655.JPEG\" alt=\"Pearl Image\"><p><strong>Spine:</strong></p>\n<p><strong>Vertebra Plana</strong>:it is the most common cause of vertebra plana in children;mostly seen in the thoracic spine.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/0469c0ef21f44d53aefb652fcca8f295x720x845.PNG\" alt=\"Pearl Image\"><p><strong>Mandible:</strong></p>\n<p>Irregular radiolucent areas mostly involving superficial alveolar bone.</p>\n<p><strong>Floating tooth</strong>: loss of lamina dura.</p>\n<p><strong>Long Bones:</strong></p>\n<ul>\n<li>Permeative and aggressive appearing lesions occur</li>\n<li>Mainly involves <strong>diaphysis</strong> or <strong>meta diaphysis</strong></li>\n<li>Endosteal scalloping, Periosteal reaction(in healing phase),cortical thinning,intracortical tunneling and associated soft tissue mass can be seen.</li>\n</ul><hr><h3>Related Pearl: Causes of lytic lesions in the skull</h3><ul>\n<li>Eosinophilic granuloma (geographic lytic lesions in the vault of skull with beveled edges)</li>\n<li>Multiple myeloma (punched out lytic lesion)</li>\n<li>Langerhans Cell Histiocytosis (permeative lesions)</li>\n<li>Hyperparathyroidism (salt and pepper skull)</li>\n<li>Metastasis</li>\n<li>Lymphoma</li>\n<li>Tuberculosis&nbsp;</li>\n<li>Osteomyelitis&nbsp;</li>\n<li>Radiation&nbsp;</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF2222",
      "difficulty": "easy"
    },
    {
      "text": "A 60-year-old patient presented with scrotal swelling and ataxia. Which among the following could likely be a cause?",
      "choices": [
        {
          "id": 1,
          "text": "Glioblastoma multiforme"
        },
        {
          "id": 2,
          "text": "Hodgkin lymphoma"
        },
        {
          "id": 3,
          "text": "Non-Hodgkin lymphoma"
        },
        {
          "id": 4,
          "text": "Non seminomatous germ cell tumor"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p class=\"p1\">The most likely cause in the following case is <strong>N</strong><strong>on-Hodgkin lymphoma(NHL)</strong>.&nbsp;Diffuse large B cell lymphoma (DLBCL), a type of NHL is the most common lymphoma. NHL affects the <strong>elderly age group</strong> and <strong>extranodal presentation</strong> is common. DLBCL can involve CNS, and <strong>CNS involvement</strong> is particularly <strong>common</strong> if there is involvement of the <strong>testes</strong>, paranasal sinuses, or bone marrow as well.</p>\n<p class=\"p1\"><strong>Primary testicular lymphoma</strong> is common in NHL when compared to Hodgkin lymphoma. Primary testicular lymphoma(PTL) is an aggressive and uncommon form of non-Hodgkin lymphoma(NHL) usually affecting the elderly age group(&gt;60y). It typically presents as a painless, firm testicular mass. Constitutional symptoms are uncommon, and if present, warrant a systemic involvement. Metastasis involves the central nervous system (CNS), skin, contralateral testis, and pleura resulting in local complications.</p>\n<p class=\"p1\">Even though <strong>ataxia</strong> is seen as a paraneoplastic symptom due to cerebellar degeneration in <strong>Hodgkin lymphoma</strong>, testicular involvement is very rare and so far only <strong>5 cases</strong> have been reported. Hodgkin lymphoma arises in a single node or chain of nodes and spreads first to anatomically contiguous lymphoid tissues. The <strong>extranodal</strong> presentation is <strong>rare</strong>. The extranodal disease can occur at any site like lung, liver, bone, and bone marrow is most common if it occurs. The central nervous system and the testis are exceptionally rare sites for Hodgkin's lymphoma. Thus Hodgkin's lymphoma can be ruled out.</p>\n<p class=\"p1\">Other options:</p>\n<p class=\"p1\">A) <strong>Glioblastoma multiforme</strong> is a highly malignant tumor,&nbsp;common in older adults in the fifth and sixth decades. The most common locations are the <strong>frontal</strong> and <strong>temporal lobes</strong>. The tumor may spread and invade the other hemisphere, resulting in a characteristic <strong>butterfly</strong>&nbsp;appearance.&nbsp;Extracranial metastases of malignant gliomas are extremely rare due to:</p>\n<ul>\n<li class=\"p1\">Absence of a lymphatic system in the brain and spinal cord for systemic dissemination</li>\n<li class=\"p1\">Dense dura around intracranial veins, preventing the penetration of the tumor</li>\n<li class=\"p1\">Lack of nurturing stroma in other organs prevents the proliferation of glioblastoma cells</li>\n</ul>\n<p>Therefore the tumor metastasizing to the testis is very much unlikely and glioblastoma can be ruled out.</p>\n<p>Image showing MRI(magnetic resonance imaging) of glioblastoma</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/c8efdb1304bf46e8a49b9c923822727ex720x900.JPEG\" alt=\"Explanation Image\"><p>Option D) Testicular cancer is the most common cancer in men aged from <strong>15 to 35 years</strong>. <strong>Germ cell tumors(GCT)</strong> account for 90%&ndash;95% of cases.&nbsp; Non-seminomatous form (NSGCT) metastasizes to the lungs, liver, central nervous system, and bone in order of frequency. The frequency of brain metastases is <strong>very low</strong>, not exceeding 1.2%.&nbsp;</p><p>Note: This is a <strong>controversial question</strong>. A more detailed clinical history and examination than what is provided in the stem are required for us to arrive at a definitive diagnosis.&nbsp;</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF2449",
      "difficulty": "hard"
    },
    {
      "text": "A patient with cirrhosis and ascites presented to you. The gross appearance of his liver is as shown below. Which among the following is true about it?",
      "choices": [
        {
          "id": 1,
          "text": "Dark areas represent necrosis, white areas represent viable liver tissue"
        },
        {
          "id": 2,
          "text": "Dark areas represent viable liver tissue, white areas represent necrosis"
        },
        {
          "id": 3,
          "text": "White areas represent central hepatocytes"
        },
        {
          "id": 4,
          "text": "Dark areas represent peri-portal hepatocytes"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The gross image of the liver shows a <strong>nutmeg appearance, </strong>seen in <strong>heart failure.</strong> The <strong>dark areas </strong>represent <strong>necrosis, white areas </strong>represent<strong> viable liver tissue.</strong></p>\n<p><strong>Nutmeg liver</strong> refers to the mottled appearance of the liver which resembles the cut section of nutmeg. This occurs as a result of hepatic venous congestion following <strong>right heart failure.</strong> The <strong>dark centrilobular zones</strong> reflect <strong>sinusoidal congestion.</strong> Congestion is seen around the central veins usually from right-sided heart failure. The <strong>pale periportal zones</strong> reflect <strong>normal</strong> or <strong>fatty liver</strong> tissue.</p>\n<p>The liver derives its blood supply from the portal venous system and the hepatic artery. The <strong>portal triad</strong> constitutes:</p>\n<ul>\n<li>Branches of the hepatic artery</li>\n<li>Portal vein </li>\n<li>Bile duct</li>\n</ul>\n<p>The blood from the portal vein and the hepatic artery flow through the intervening sinusoids and drains into the central vein. The central veins from adjacent lobules form interlobular veins, which then unite as hepatic veins and finally drain into the inferior vena cava. </p>\n<p>The hepatic lobule is divided into three zones:</p>\n<div class=\"page\" title=\"Page 1621\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<ul>\n<li>Zone 1 is the periportal area </li>\n<li>Zone 2 is the intermediate zone</li>\n<li>Zone 3 is the area closest to the central vein</li>\n</ul>\n</div>\n</div>\n</div>\n<div class=\"page\" title=\"Page 866\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Right-sided cardiac failure leads to passive congestion of the liver. Left-sided cardiac failure leads to hypoperfusion and hypoxia of hepatocytes around central veins. The combination of <strong>hypoperfusion</strong> and <strong>retrograde congestion</strong> causes centrilobular hemorrhagic necrosis, leading to this mottled appearance of the liver, known as nutmeg liver. </p>\n<p>The microscopic image below of a nutmeg liver shows perisinusoidal fibrosis, hepatic venule dilation, and dilation of the sinusoids in zone III.</p>\n</div>\n</div>\n</div>\n</div><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/74a49312f1bd48ada98a6435e3786bd2x1280x853.JPEG\" alt=\"Explanation Image\">",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/afba0c25e3be43de9a2f6a823ba1705e.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF2270",
      "difficulty": "medium"
    },
    {
      "text": "A 6-year-old boy came with bilateral cervical lymphadenopathy. What is the probable diagnosis, cell, and virus associated with the image given below?<div class='question-desc-html'><p>RS cell: Reed-Sternberg cell</p>\n<p>HIV: Human immunodeficiency virus</p>\n<p>CMV: Cytomegalovirus</p>\n<p>EBV: Epstein-Barr virus</p></div>",
      "choices": [
        {
          "id": 1,
          "text": "Non-Hodgkin's lymphoma, RS cell, EBV"
        },
        {
          "id": 2,
          "text": "Kaposi sarcoma, Giant cell, HIV"
        },
        {
          "id": 3,
          "text": "Hodgkin's lymphoma, RS cell, EBV"
        },
        {
          "id": 4,
          "text": "Infectious mononucleosis, RS cell, CMV"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p class=\"p1\">The probable diagnosis, cell, and virus from the given clinical scenario and the histopathological image are <strong>Hodgkin's lymphoma</strong>, <strong>Reed-Sternberg cells</strong> (RS cells), and <strong>Epstein-Barr virus </strong>(EBV) respectively.</p>\n<div class=\"page\" title=\"Page 616\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Hodgkin's lymphoma arises in a single lymph node or chain of nodes and spreads first to anatomically contiguous lymphoid tissues. It usually presents as painless lymphadenopathy. The distinctive feature of Hodgkin's lymphoma is the presence of <strong>Reed-Sternberg cells</strong>.</p>\n<p>RS cells are giant neoplastic cells derived from germinal centre or post–germinal centre B cells. They appear as large cells with multiple nuclei or a single nucleus with multiple nuclear lobes. Each cell contains large inclusion-like prominent nucleoli, and abundant, usually slightly eosinophilic, cytoplasm,<strong> </strong>depicting an<strong> owl-eye appearance, </strong>as shown in the image below<strong>.</strong></p>\n</div>\n</div>\n</div>\n</div><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/ebf2e6c614de4074bdcd9413794ac0e6x650x487.JPEG\" alt=\"Explanation Image\"><div class=\"page\" title=\"Page 616\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>WHO classifies Hodgkin's lymphoma into 5 subtypes:</p>\n</div>\n</div>\n</div>\n</div>\n<div class=\"page\" title=\"Page 616\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<ul>\n<li>Nodular sclerosis: Frequent lacunar cells</li>\n<li>Mixed cellularity</li>\n<li>Lymphocyte-rich</li>\n<li>Lymphocyte depletion</li>\n<li>Nodular lymphocyte predominance</li>\n</ul>\n<p>The first 4 subtypes are considered classical Hodgkin's lymphoma. The RS cells are CD 15+ and CD30+. The lymphocyte predominant type is considered non-classical Hodgkin's lymphoma with CD15-, CD30-, CD20+ and EB -.</p>\n<table>\n<tbody>\n<tr>\n<td>Type</td>\n<td>RS-cell</td>\n<td>EB Virus</td>\n<td>Prognosis</td>\n</tr>\n<tr>\n<td>1. Nodular sclerosis (most common in the world)</td>\n<td>Frequent lacunar cells and occasional diagnostic RS cells</td>\n<td>Rare</td>\n<td>Very good</td>\n</tr>\n<tr>\n<td>2. Mixed cellularity (most common in India)</td>\n<td>Frequent mononuclear and diagnostic RS cells</td>\n<td>70%</td>\n<td>Good</td>\n</tr>\n<tr>\n<td>3.Lymphocyte Rich</td>\n<td>\n<p class=\"p2\">Frequent mononuclear and diagnostic RS cells</p>\n</td>\n<td>40%</td>\n<td>Very good</td>\n</tr>\n<tr>\n<td>4.Lymphocyte depleted</td>\n<td>Reticular variant: frequent diagnostic RS cells and variants and a paucity of background reactive cell</td>\n<td>90%(Max)</td>\n<td>Poorest</td>\n</tr>\n<tr>\n<td><br />5.Lymphocyte predominant</td>\n<td>L&amp;H variant (Popcorn cell) variants in the background of follicular dendritic cells</td>\n<td>0%(Min)</td>\n<td>Excellent</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n</div>\n</div>\n</div>\n</div>\n<p>The image below shows a <strong>popcorn cell</strong> seen in lymphocytic predominant Hodgkin's lymphoma.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/91368ad29c9944bd9e774a9a2cc2ea23x1280x930.JPEG\" alt=\"Explanation Image\"><p>Other options: </p>\n<p>Option A: RS cells are diagnostic of Hodgkin's lymphoma, not non-Hodgkin's lymphoma. The histopathologic findings in non-Hodgkin lymphoma (NHL) are varied and depend on the subtype.</p>\n<p>Option B: <strong>Kaposi sarcoma </strong>is a vascular neoplasm caused by <strong>human herpesvirus 8 (HHV8)</strong>, also known as <strong>Kaposi sarcoma herpesvirus</strong>. Cutaneous lesions of Kaposi sarcoma are composed of <strong>spindle cells</strong>, mostly in the dermis or subcutaneous tissues, with small vessels and slit-like spaces with red cells.</p>\n<p>The image shows lesions seen in Kaposi's sarcoma.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/e065ff6dd2594a9285cd40a505874684x1012x675.JPEG\" alt=\"Explanation Image\"><p>Option D: <strong>Infectious mononucleosis</strong> is caused by <strong>EBV</strong>. The peripheral blood smear shows absolute lymphocytosis with <strong>mononucleosis cells</strong> which are <strong>atypical activated T lymphocytes</strong>. They have abundant cytoplasm with multiple vacuolations and azurophilic granules, and an oval, indented, or folded nucleus and are shown below.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/6196846b96d54a3b9e881966c1dccd7ax1024x768.JPEG\" alt=\"Explanation Image\"><p>About 5-7% of the cases of infectious mononucleosis can be caused by the cytomegalovirus (<strong>CMV</strong>), which can also cause pneumonia. CMV-infected pneumocytes with large, <strong>intranuclear</strong>, <strong>basophilic</strong> inclusions with <strong>haloes</strong> at their periphery as well as small, granular <strong>cytoplasmic inclusions</strong> are seen below with an <strong>owl-eye appearance.</strong></p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/ef47954567d84dbbab85e282ac36faf3x1280x841.JPEG\" alt=\"Explanation Image\"><hr><h3>Related Pearl: Hodgkin v/s Non-Hodgkin Lymphoma</h3><table>\n<tbody>\n<tr>\n<td><strong>Features</strong></td>\n<td><strong>Hodgkin Lymphoma&nbsp;</strong></td>\n<td><strong>Non-Hodgkin&nbsp;Lymphoma</strong></td>\n</tr>\n<tr>\n<td>Lymph nodes&nbsp;</td>\n<td>Single axial group of lymph nodes</td>\n<td>Multiple peripheral lymph nodes&nbsp;</td>\n</tr>\n<tr>\n<td>Spread</td>\n<td>Contiguous</td>\n<td>Non-contiguous</td>\n</tr>\n<tr>\n<td>Mesenteric nodes and Waldeyer ring&nbsp;</td>\n<td>Rarely involved</td>\n<td>Commonly involved</td>\n</tr>\n<tr>\n<td>Extra-nodal involvement</td>\n<td>Uncommon</td>\n<td><strong>&nbsp;</strong>Common</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><hr><h3>Related Pearl: Types of giant cells</h3><table>\n<tbody>\n<tr>\n<td><strong>Giant cells</strong></td>\n<td><strong>Seen in</strong></td>\n</tr>\n<tr>\n<td>Langhans giant cells</td>\n<td>TB Granuloma</td>\n</tr>\n<tr>\n<td>Reed Sternberg&nbsp;cells</td>\n<td>Hodgkin lymphoma</td>\n</tr>\n<tr>\n<td>Aschoff&nbsp;giant cells</td>\n<td>Rheumatic fever</td>\n</tr>\n<tr>\n<td>Touton giant cells</td>\n<td>\n<p>Juvenile xanthogranuloma,</p>\n<p>Xanthoma disseminatum,</p>\n<p>dermatofibroma</p>\n</td>\n</tr>\n<tr>\n<td>Warthin Finkeldey giant cells</td>\n<td>Measles</td>\n</tr>\n<tr>\n<td>Physiological giant cells</td>\n<td>Bone marrow osteoclast cells and megakaryocytes</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><hr><h3>Related Pearl: Variants of Reed Sternberg Cells</h3><p><strong>Variant Reed–Sternberg cells and the corresponding subtype of Hodgkin's Lymphoma</strong></p>\n<ul>\n<li><strong>Lacunar Variant:</strong> Nodular Sclerosis</li>\n<li><strong>Mononuclear variant:</strong> Mixed cellularity and Lymphocyte rich </li>\n<li><strong>Pleomorphic/Necrotic/Mummified Variant:</strong> Lymphocyte depleted </li>\n<li><strong>L&amp;H/Lymphohistiocytic/Popcorn Variant:</strong> Lymphocyte predominant</li>\n</ul>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/c93fd3b966e9456eac0187d14cc9a32e.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF2212",
      "difficulty": "easy"
    },
    {
      "text": "A person was brought to the emergency department with facial swelling, itching, and hypotension following a bee sting. The mentioned clinical features are due to the increase in which immunoglobulin?",
      "choices": [
        {
          "id": 1,
          "text": "IgA"
        },
        {
          "id": 2,
          "text": "IgE"
        },
        {
          "id": 3,
          "text": "IgM"
        },
        {
          "id": 4,
          "text": "IgG"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The given clinical features suggest <strong>type 1 hypersensitivity reaction</strong> and are mediated by immunoglobulin E (<strong>IgE</strong>).</p>\n<p><strong>Immediate (Type I) hypersensitivity</strong>&nbsp;reactions refer to allergic reactions or allergies.</p>\n<p>It is a rapid immunologic reaction that is triggered by the binding of an antigen to IgE antibody on the surface of mast cells. It occurs&nbsp;in a previously sensitized individual.&nbsp;These reactions are induced by environmental antigens (allergens) that stimulate strong TH<sub>2</sub> responses and IgE production in genetically susceptible individuals.&nbsp;</p>\n<p>Activation of TH<sub>2</sub> cells is mediated by IL-4 and in turn, TH<sub>2</sub> cells produce IL-4, IL-5, and IL-13.&nbsp;These cytokines act on B cells to stimulate IgE and activation of eosinophils.&nbsp;IgE coats mast cells by binding to the <strong>Fc&epsilon;RI</strong>&nbsp;receptor. Re-exposure to the allergen leads to cross-linking of the IgE and Fc&epsilon;RI which in turn causes activation of mast cells releasing powerful mediators.&nbsp;The principal mediators are:</p>\n<ul>\n<li><strong>Histamine</strong></li>\n<li><strong>Proteases</strong></li>\n<li><strong>Prostaglandins</strong></li>\n<li><strong>Leukotrienes</strong></li>\n<li><strong>Cytokines</strong> like&nbsp;TNF, IL-1, and chemokines.&nbsp;</li>\n</ul>\n<p>The clinical manifestations may be local or systemic&nbsp;and range from mildly annoying rhinitis to fatal anaphylaxis.</p>\n<p>It occurs in two phases:<strong>&nbsp;</strong></p>\n<ul>\n<li>The immediate phase is characterized by vasodilation, vascular leakage, smooth muscle spasm (in asthma), or glandular secretions. These changes occur within minutes after exposure to an allergen and subside in a few hours.</li>\n<li>Late-phase reaction is characterized by infiltration of tissues with eosinophils, neutrophils, basophils, monocytes, and CD4+ T cells. Late-phase reaction sets in 2 to 24 hours later and may last for several days.</li>\n</ul>\n<p>Image: Sequence of events in immediate (type 1) hypersensitivity.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/957777893ca84d688544dd560439d13ex1280x2558.JPEG\" alt=\"Explanation Image\"><hr><h3>Related Pearl: Disorders Caused by Immediate Hypersensitivity</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Clinical Syndrome</strong></p>\n</td>\n<td>\n<p><strong>Clinical and Pathologic Manifestations</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Anaphylaxis (may be caused by drugs, bee sting, food)</p>\n</td>\n<td>\n<p>Fall in blood pressure (shock) caused by vascular dilation; airway obstruction due to laryngeal edema</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Bronchial asthma</p>\n</td>\n<td>\n<p>Airway obstruction caused by bronchial smooth muscle hyperactivity; inflammation and tissue injury caused by late-phase reaction</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Allergic rhinitis, sinusitis (hay fever)</p>\n</td>\n<td>\n<p>Increased mucus secretion; inflammation of upper airways, sinuses</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Food allergies</p>\n</td>\n<td>\n<p>Increased peristalsis due to contraction of intestinal muscles</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><hr><h3>Related Pearl: Types of Hypersensitivity</h3><table>\n<tbody>\n<tr>\n<td><strong>Type of reaction</strong></td>\n<td><strong>Clinical Syndrome</strong></td>\n<td><strong>Time for manifestation</strong></td>\n<td><strong>Mediators</strong></td>\n</tr>\n<tr>\n<td><strong>Type I</strong>: <br />IgE type</td>\n<td>\n<p>1. Anaphylaxis</p>\n<p>2. Atopy</p>\n</td>\n<td>Minutes</td>\n<td>IgE: histamine and other pharmacological agents</td>\n</tr>\n<tr>\n<td><strong>Type II</strong>: <br />Cytolytic, cytotoxic</td>\n<td>\n<p>Antibody-mediated damage: e.g. thrombocytopenia, agranulocytosis, hemolytic anemia</p>\n</td>\n<td>Hours to days</td>\n<td>IgG, IgM</td>\n</tr>\n<tr>\n<td><strong>Type III</strong>:<br /> Immune complex</td>\n<td>\n<p>1.Arthus-reaction</p>\n<p>2.Serum-sickness</p>\n</td>\n<td>Hours to days</td>\n<td>IgG, IgM, leucocytes</td>\n</tr>\n<tr>\n<td><strong>Type IV</strong>: <br />Delayed hypersensitivity</td>\n<td>\n<p>1. Tuberculin</p>\n<p>2. Contact dermatitis</p>\n</td>\n<td>Hours to days</td>\n<td>T cells, lymphokines, macrophages.</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><hr><h3>Related Pearl: Properties of immunoglobulin classes</h3><p><strong>IgG:</strong></p>\n<ul>\n<li>Half-life- 23 days</li>\n<li>Appears late, indicates <strong>chronic infection</strong></li>\n<li>It is the only maternal Ig to cross the placenta.</li>\n<li>Has 4 subclasses.</li>\n<li>Causes complement fixation, precipitation, and neutralization of toxins and virus.</li>\n</ul>\n<p><strong>IgM</strong>:</p>\n<ul>\n<li>Half-life- 5 days</li>\n<li>Has the highest molecular weight and is a pentamer.</li>\n<li>Polysaccharides and lipids mainly stimulate IgM secretion.</li>\n<li>Intravascular distribution.</li>\n<li>Appears early, indicates <strong>recent infection.</strong></li>\n<li>Acts<strong>&nbsp;</strong>as surface immunoglobulin on the B cells.</li>\n<li>It causes agglutination, hemolysis, complement fixation and opsonization.</li>\n</ul>\n<p><strong>IgD:</strong></p>\n<ul>\n<li>Half-life- 2-8 days.</li>\n<li>Acts as a surface immunoglobulin on the B cells.</li>\n<li>Serves as recognition receptors for antigens.</li>\n</ul>\n<p><strong>IgE:</strong></p>\n<ul>\n<li>Half-life- 1-5 days</li>\n<li>Causes type I hypersensitivity.</li>\n<li>It is the only heat labile antibody.</li>\n<li>Levels are raised in helminthic infections.</li>\n</ul>\n<p><strong>IgA:</strong></p>\n<ul>\n<li>Half-life- 6 days</li>\n<li>It is of 2 types- Serum IgA and Secretory IgA&nbsp;</li>\n<li>Secretory IgA (A dimer) results in mucosal immunity.</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF2249",
      "difficulty": "easy"
    },
    {
      "text": "All of the following are associated with massive splenomegaly except :",
      "choices": [
        {
          "id": 1,
          "text": "Chronic myeloid leukemia"
        },
        {
          "id": 2,
          "text": "Aplastic anemia"
        },
        {
          "id": 3,
          "text": "Hairy cell leukemia"
        },
        {
          "id": 4,
          "text": "Lymphoma"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>All the above are associated with massive splenomegaly except aplastic anemia.</p>\n<div class=\"page\" title=\"Page 663\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p><strong>Aplastic anemia</strong> is a syndrome of chronic primary <strong>hematopoietic failure</strong>. This results in <strong>pancytopenia</strong> (anemia, neutropenia, and thrombocytopenia). Important causes include&nbsp;</p>\n<div class=\"page\" title=\"Page 7\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<ul>\n<li>Alkylating agents, antimetabolites</li>\n<li>Benzene</li>\n<li>Whole-body irradiation</li>\n<li>Viral infections: Hepatitis (unknown virus), Cytomegalovirus, Epstein-Barr virus, Herpes zoster</li>\n<li>Fanconi anemia</li>\n</ul>\n<div class=\"page\" title=\"Page 8\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>The patient will have</p>\n<ul>\n<li>Decreased red blood cells leading to&nbsp;<strong>anemia</strong></li>\n<li>Decreased white blood cells leading to recurrent <strong>infections</strong></li>\n<li>Decreased platelets leading to&nbsp;<strong>petechiae</strong> and ecchymoses.</li>\n</ul>\n<p>Many other leukemias and lymphomas may have a similar presentation. However, <strong>splenomegaly</strong> is <strong>characteristically absent</strong> in these patients.&nbsp;</p>\n<p>The bone marrow is markedly hypocellular. It is largely devoid of hematopoietic cells. Marrow aspirates yield a <strong>dry tap</strong> having <strong>only fat cells</strong>, fibrous stroma, lymphocytes, and plasma cells. Aplasia is best appreciated in <strong>marrow biopsies.&nbsp;</strong>The following image shows a <strong>hypocellular bone marrow</strong> with little hematopoiesis and several fat cells.</p>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/4b4583bb82df48aaa3989ceacb840475x800x600.PNG\" alt=\"Explanation Image\"><div class=\"page\" title=\"Page 663\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<div class=\"page\" title=\"Page 7\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<div class=\"page\" title=\"Page 8\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<div class=\"page\" title=\"Page 9\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p><strong>Stem cell transplantation</strong> is the treatment of choice in those with a suitable donor. <strong>Immunosuppressive therapy</strong> is responsive in old patients or in patients without suitable donors.</p>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n<p>Other options:</p>\n<p>Option A-&nbsp;<strong>Chronic myeloid leukemia (CML)</strong> is a myeloproliferative neoplasm with the presence of<strong> BCR-ABL fusion gene&nbsp;translocation mutation.&nbsp;</strong>The marrow is markedly hypercellular because of increased numbers of maturing granulocytic precursor cells. This results in decreased hematopoiesis within the bone marrow. The <strong>spleen</strong> is often greatly <strong>enlarged</strong> as a result of extensive extramedullary hematopoiesis. Extramedullary hematopoiesis can also produce mild <strong>hepatomegaly</strong> and <strong>lymphadenopathy.</strong></p>\n<p>Option C- Hairy cell leukemia is a <strong>memory B-cell</strong> neoplasm predominantly seen in <strong>middle-aged male</strong> patients. It occurs due to activating <strong>BRAF</strong> mutations. Infiltration of the bone marrow, liver, and spleen with tumor cells result in&nbsp;<strong>splenomegaly.</strong> Sometimes, this can be the only finding in the patient. Pancytopenia results from marrow involvement.</p>\n<div class=\"page\" title=\"Page 3\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<div class=\"page\" title=\"Page 3\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Hairy cells have round, oblong, or reniform nuclei and moderate amounts of pale blue cytoplasm with thread-like or bleb-like extensions. Immunophenotyping shows hairy cell leukemias typically express the pan-B-cell markers CD19 and CD20 and certain relatively distinctive markers, such as<strong> CD11c</strong>, <strong>CD25</strong>, <strong>CD103</strong>, and <strong>annexin A1</strong>.</p>\n<p>&nbsp;Option D- <strong>Lymphomas</strong> cause splenomegaly due to the <strong>infiltration</strong> of neoplastic cells in the spleen.</p>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div><hr><h3>Related Pearl: Malignancies, Translocations and Affected Genes</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Malignancy </strong></p>\n</td>\n<td>\n<p><strong>Translocation</strong></p>\n</td>\n<td>\n<p><strong>Affected Genes</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>CLL/ Small lymphocytic lymphoma</p>\n</td>\n<td>\n<p>t(14;19)</p>\n</td>\n<td>\n<p><em>-</em></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Chronic myelogenous leukemia (CML)</p>\n</td>\n<td>\n<p>t(9;22)</p>\n</td>\n<td>\n<p><em>ABL </em>9q34</p>\n<p><em>BCR </em>22q11</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Acute myeloid leukemia (AML)</p>\n</td>\n<td>\n<p>t(8; 21), t(15; 17)</p>\n</td>\n<td>\n<p><em>AML1 21</em>q22</p>\n<p><em>ETO 8</em>q22</p>\n<p><em>PML </em>15q22</p>\n<p><em>RARA </em>17q21</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Precursor B cell ALL</p>\n</td>\n<td>\n<p>t(9;22), t(4;11)</p>\n</td>\n<td>&nbsp;\n<p>BCR/ABL</p>\n<p>AF4, ALLI</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Burkitt lymphoma</p>\n</td>\n<td>\n<p>t(8; 14), t(2;8) t(8;22)</p>\n</td>\n<td>\n<p><em>c-myc&nbsp;</em>8q24</p>\n<p><em>IGH </em>14q32</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Mantle cell lymphoma</p>\n</td>\n<td>\n<p>t(11; 14)</p>\n</td>\n<td>\n<p><em>CCND1 </em>11q13</p>\n<p><em>IGH </em>14q32</p>\n<p><em>BCL1</em></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Follicular lymphoma</p>\n</td>\n<td>\n<p>t(14; 18)</p>\n</td>\n<td>\n<p><em>IGH </em>14q32</p>\n<p><em>BCL2 </em>18q21</p>\n<p>&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Ewing sarcoma</p>\n</td>\n<td>\n<p>t(11; 22)</p>\n</td>\n<td>\n<p><em>FLI1 </em>11q24</p>\n<p><em>EWSR1 </em>22q12</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Prostatic adenocarcinoma</p>\n</td>\n<td>\n<p>t(7; 21), t(17; 21)</p>\n</td>\n<td>\n<p><em>TMPRSS2 </em>(21q22.3)</p>\n<p><em>ETV1</em> (7p21.2)</p>\n<p><em>ETV4 </em>(17q21)</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Diffuse large B-cell lymphoma</p>\n</td>\n<td>&nbsp;t(14;18)</td>\n<td>&nbsp;\n<p><em>BCL-6</em>,&nbsp;p53</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>MALT lymphoma</p>\n</td>\n<td>t(11;18)</td>\n<td><em>API2/MALT</em>, <em>BCL-10</em></td>\n</tr>\n<tr>\n<td>\n<p>CD30+ Anaplastic large cell lymphoma</p>\n</td>\n<td>t(2;5)</td>\n<td><em>ALK</em></td>\n</tr>\n<tr>\n<td>\n<p>Lymphoplasmacytoid lymphoma</p>\n</td>\n<td>t(9;14)</td>\n<td><em>PAX5, IGH</em></td>\n</tr>\n<tr>\n<td>\n<p>Synovial sarcoma</p>\n</td>\n<td>t(X;18)(p11;q11)&nbsp;</td>\n<td>&nbsp;\n<p><em>SS18-SSX2</em></p>\n<p><em>SS18-SSX4</em></p>\n</td>\n</tr>\n<tr>\n<td>&nbsp;Alveolar soft-part sarcoma</td>\n<td>&nbsp;t(X;17)(p11.2;q25)</td>\n<td>&nbsp;<em>TFE3-ASPL</em></td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF2198",
      "difficulty": "medium"
    },
    {
      "text": "A 42-year-old female patient presents with cough, low-grade fever, and hemoptysis. Investigations reveal a cavitary lesion on her right lung apex, which on biopsy reveals caseous necrosis. The underlying pathophysiology is :",
      "choices": [
        {
          "id": 1,
          "text": "Enzyme degradation"
        },
        {
          "id": 2,
          "text": "Type 4 hypersensitivity reaction"
        },
        {
          "id": 3,
          "text": "Fibrinoid deposition"
        },
        {
          "id": 4,
          "text": "Sudden cut-off of blood supply"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The clinical scenario with complaints of cough, low-grade fever, hemoptysis is suggestive of <strong>pulmonary tuberculosis</strong>. The diagnosis is further supported by a cavitary lesion in the apex of the lung and a biopsy showing caseous necrosis. The pathophysiology is a&nbsp;<strong>type 4 hypersensitivity reaction</strong> mediated by activated macrophages.</p>\n<div class=\"page\" title=\"Page 377\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Tuberculosis is a chronic pulmonary and systemic disease caused by <em>Mycobacterium tuberculosis</em>. Granulomatous inflammation and tissue damage&nbsp;are by Th-1 mediated macrophage activation and killing of bacteria. Interferon-gamma (IFN-&gamma;)&nbsp;released by Th-1 cells is the critical mediator that activates the macrophages. This activation differentiates the macrophages into epithelioid cells that aggregate to form granuloma. This is a T-cell mediated (Type 4) hypersensitivity reaction.</p>\n</div>\n</div>\n</div>\n</div>\n<p>Pulmonary TB due to&nbsp;exogenous (new infection) or&nbsp;endogenous (reactivation of a dormant primary lesion) infection&nbsp;in a sensitized individual is called <strong>post-primary or reactivation or secondary or adult-type</strong> TB.</p>\n<p>The apical and posterior segments of the upper lobe and superior segments of the lower lobe are most commonly involved in post-primary TB due to increased ventilation in these segments than the lower zones. Patients often present with fever, productive cough, blood-streaked sputum, night sweats, malaise, loss of appetite, and weight loss.</p>\n<p>Radiological findings include ill-defined opacification in the upper lobes, consolidation, collapse, and cavitation development.</p>\n<ul>\n<li>Typically, the disease is parenchymal without nodal enlargement.</li>\n<li><strong>Cavitation</strong> is a distinguishing feature of postprimary TB.\n<ul>\n<li>Typical cavities are thick-walled and irregular.</li>\n<li>Air-fluid levels are uncommon in TB. The presence of air-fluid levels indicates superadded infections.</li>\n</ul>\n</li>\n<li>Upper-lobe involvement with cavitation and the absence of lymphadenopathy distinguishes postprimary TB from primary TB.</li>\n</ul>\n<p>The image below shows chest X-ray findings of a post-primary TB with a cavity (black arrows) in the right upper lobe and bilateral pulmonary infiltrates (white triangles) in the apical regions.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/9a06ff8efb6249c4911fe53cc3a8f21dx590x542.JPEG\" alt=\"Explanation Image\"><p>Image shows a gross picture of <strong>caseous necrosis.</strong> Notice the characteristic <strong>\"cheesy appearance\"</strong> due to its white appearance of the area of necrosis.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/616e91a9283049569dcbbf09f307e0afx1280x848.JPEG\" alt=\"Explanation Image\"><p>Image below shows <strong>tuberculoid granuloma</strong> associated with caseous necrosis (upper right) and surrounding&nbsp;epithelioid cells, Langhans' multinucleated giant cells.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/b3093885bd9c4c76a011df879e315d7bx1165x829.PNG\" alt=\"Explanation Image\"><p>Other options:</p>\n<p>Option A:&nbsp;<strong>Enzyme degradation</strong> is seen in <strong>liquefactive necrosis</strong> which is characterized by digestion of the dead cells, resulting in transformation of the tissue into a viscous liquid. It is seen in focal bacterial or fungal infections. Eg: Brain abscess.</p>\n<p>Option C:&nbsp;<strong>Fibrinoid deposition</strong> is seen in <strong>fibrinoid necrosis.</strong> It is seen in immune reactions involving blood vessels with deposition of fibrinoid material which is combination of immune complexes and plasma proteins. Eg: Vasculitis syndromes</p>\n<p>Option D:&nbsp;<strong>Sudden cut-off of blood supply</strong> causes <strong>coagulative necrosis.</strong> It is a form of necrosis in which the original architecture of dead tissue is preserved with firm texture. Eg:&nbsp;Ischemic injury in all organs,&nbsp;except the brain.</p><hr><h3>Related Pearl: ATT Regimen for TB Patients</h3><p>As per the latest recommendations from <strong>National Tuberculosis Elimination Programme (NTEP)</strong>, treatment of TB is now based primarily on <strong>drug susceptibility testing</strong>. This is irrespective of new cases, previously treated cases or recurrent TB cases. <br />All cases of TB are treated with Drug Sensitive TB Regimen, as long as the patient is sensitive to isoniazid and rifampicin. (<strong>No classification into category I or II</strong>)</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Type of TB Case</strong></td>\n<td><strong>Intensive Phase</strong></td>\n<td><strong>Continuation Phase</strong></td>\n</tr>\n<tr>\n<td>New and previously treated cases (H and R sensitive)</td>\n<td>2 months H R Z E</td>\n<td>4 months H R E</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<h2><strong><span>Classification based on drug resistance. </span></strong></h2>\n<p><span>The<strong> </strong>cases are classified as:</span></p>\n<ul>\n<li><strong>Mono-resistant (MR):</strong> A TB patient, who is resistant to one 1st line anti-TB drug only.</li>\n<li><strong>Poly-Drug Resistant (PDR):</strong> A TB patient, who is resistant to more than one 1st line anti-TB drug, other than Rifampicin and isoniazid. </li>\n<li><strong>Rifampicin Resistant (RR):</strong> A TB patient, who is resistant to <strong>rifampicin</strong> with or without resistance to other drugs. Patients, who have rifampicin resistance, should be managed as if they are an MDR TB case.</li>\n<li><strong>Multi-Drug Resistant (MDR):</strong> A TB patient, who is resistant to <strong>both isoniazid and rifampicin.</strong></li>\n<li><strong>Extensively Drug-Resistant (XDR):</strong> A MDR TB patient who is additionally resistant to a <strong>fluoroquinolone</strong> (ofloxacin, levofloxacin, or moxifloxacin) and at least one additional group A drug (as of 2021, these are bedaquiline and linezolid)</li>\n</ul>\n<h2><strong><span>Standard DR TB regimen</span></strong></h2>\n<table>\n<tbody>\n<tr>\n<td><strong>Regimen class</strong></td>\n<td><strong>Drugs</strong></td>\n<td><strong>Comments</strong></td>\n</tr>\n<tr>\n<td><strong>H mono-resistant/ poly-drug resistant TB regimen</strong></td>\n<td>Lfx R E Z for 6 months</td>\n<td>\n<p>6 months long</p>\n<p>Oral drugs only</p>\n</td>\n</tr>\n<tr>\n<td><strong>BPaLM regime (New MDR regime by WHO)</strong></td>\n<td>Bdq Pa Lzd Mfx for 6 months</td>\n<td>\n<p>6 months long</p>\n</td>\n</tr>\n<tr>\n<td><strong>9- 11 months shorter oral bedaquiline regime (Shorter MDR)</strong></td>\n<td>\n<p><strong>Intensive Phase:</strong></p>\n<p>Lfx Bdq(6 months) Cfz Z Hh E Eto for 4-6 months</p>\n<p><strong>Continuation phase:</strong></p>\n<p>Lfx Cfz Z E for 5 months</p>\n</td>\n<td>\n<p>9-11 months long totally</p>\n<p>Injectables used in Intensive phase.</p>\n</td>\n</tr>\n<tr>\n<td><strong>Longer MDR TB regimen</strong></td>\n<td>Bdq(6 months or longer) Lfx Lzd Cfz Cs </td>\n<td>\n<p>18-20 months long</p>\n<p>Oral drugs only</p>\n<p>This regimen is used for XDR TB patients for 20 months.</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<h2> </h2>\n<h2><strong><span>Criteria for patients to receive standard Drug Resistant TB regimen:</span></strong></h2>\n<table>\n<tbody>\n<tr>\n<td><strong>Standard Drug Resistant TB regimen</strong></td>\n<td><strong>Inclusion criteria</strong></td>\n<td><strong>Exclusion criteria</strong></td>\n</tr>\n<tr>\n<td><strong>H mono-resistant/poly-drug resistant TB regimen</strong></td>\n<td><strong>Isoniazid resistant</strong> TB with <strong>rifampicin sensitive</strong></td>\n<td>No specific criteria</td>\n</tr>\n<tr>\n<td><strong>BPaLM regimen (New MDR TB regimen by WHO)</strong></td>\n<td>\n<ol>\n<li><strong>MDR/RR-TB</strong> or <strong>pre-XDR-TB</strong> ( MDR/RR-TB and resistance to fluoroquinolones). </li>\n<li>Those with <strong>confirmed</strong> pulmonary TB and all forms of extrapulmonary TB (except for TB involving CNS, osteoarticular, and miliary TB).</li>\n<li>Patients <strong>&gt;14 years of age.<br /></strong></li>\n</ol>\n</td>\n<td>Pregnant and lactating women</td>\n</tr>\n<tr>\n<td><strong>9- 11 months shorter MDR TB regimen</strong></td>\n<td>Patient with <strong>rifampicin resistant</strong> pulmonary or extra pulmonary TB</td>\n<td>Non drug sensitivity test based criteria:\n<ul>\n<li>Pregnancy</li>\n<li>Any extra pulmonary disease in PLHIV</li>\n<li>Disseminated meningeal or central nervous system TB</li>\n<li>Intolerance to any drug in the shorter MDR TB regimen</li>\n</ul>\nDrug sensitivity test based criteria:\n<ul>\n<li>If DST/DRT result for FQ or SLI is resistant (XDR TB)</li>\n<li>Presence of InhA mutation</li>\n<li>Resistant to Z </li>\n</ul>\n</td>\n</tr>\n<tr>\n<td><strong>Longer MDR TB regimen</strong></td>\n<td>Patients in whom <strong>shorter MDR TB regimen cannot be considered</strong> due to any reason</td>\n<td>None</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>Legend</p>\n<p>FQ: Fluoroquinolone</p>\n<p>SLI: Second Line Injectable</p>\n<p>PLHIV: People Living with HIV</p>\n<p>Lfx: Levofloxacin</p>\n<p>Pa: Pretomanid</p>\n<p>H: Isoniazid</p>\n<p>Hh: High Dose Isoniazid</p>\n<p>R: Rifampicin</p>\n<p>E: Ethambutol</p>\n<p>Z: Pyrazinamide</p>\n<p>Mfx: Moxifloxacin</p>\n<p>Km: Kanamycin</p>\n<p>Am: Amikacin</p>\n<p>Eto: Ethionamide</p>\n<p>Cfz: Clofazimine</p>\n<p>Bdq: Bedaquiline</p>\n<p>Lzd: Linezolid</p>\n<p>Cs: Cycloserine</p><hr><h3>Related Pearl: Diagnostic algorithm for Pulmonary TB – National Tuberculosis Elimination Programme (NTEP) 2020 Guidelines</h3><p>Any case of&nbsp;<strong>presumptive pulmonary TB</strong>&nbsp;should undergo <strong>sputum examination + chest X-ray + CB-NAAT</strong></p>\n<ul>\n<li>If sputum and chest X-ray normal:<strong> rule out TB and refer</strong></li>\n<li>If sputum is positive and CB NAAT is positive:<strong>&nbsp;microbiologically confirmed case of TB</strong></li>\n</ul>\n<p>The following protocol is used for <strong>CB-NAAT testing:</strong></p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/e8d17e5087654b588b4b519b350acb71x1280x2558.JPEG\" alt=\"Pearl Image\"><hr><h3>Related Pearl: Mechanisms of Hypersensitivity Reactions</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Type</strong></p>\n</td>\n<td>\n<p><strong>Immune Mechanisms</strong></p>\n</td>\n<td>\n<p><strong>Histopathological lesions</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Immediate </strong><br /><strong>&nbsp;hypersensitivity<br />(type I)<br /></strong></p>\n<ul>\n<li>Anaphylaxis</li>\n<li>Allergies</li>\n<li>Bronchial asthma</li>\n<li>Atopic dermatitis</li>\n</ul>\n</td>\n<td>\n<p>Production of IgE antibody &rarr;immediate release of vasoactive amines from mast cells</p>\n</td>\n<td>\n<p>Vascular dilatation, edema, smooth muscle contraction, mucus production, tissue injury, inflammation</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Antibody-mediated hypersensitivity<br />(type II)<br /></strong></p>\n<ul>\n<li>Autoimmune hemolytic anemia</li>\n<li>Goodpasture syndrome</li>\n</ul>\n</td>\n<td>\n<p>Production of IgG, IgM &rarr; binds to antigen on target cell or tissue &rarr; phagocytosis or lysis of target cell by activated complement or Fc receptors; recruitment of leukocytes</p>\n</td>\n<td>\n<p>Phagocytosis and lysis of cells; inflammation;</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Immune complex-mediated hypersensitivity<br /> (type III)<br /></strong></p>\n<ul>\n<li>SLE</li>\n<li>Serum sickness</li>\n<li>Arthus reaction</li>\n</ul>\n</td>\n<td>\n<p>Deposition of antigen-antibody complexes &rarr; complement activation &rarr;recruitment of leukocytes by complement products and Fc receptors &rarr; release of enzymes and other toxic molecules</p>\n</td>\n<td>\n<p>Inflammation, necrotizing vasculitis (fibrinoid necrosis)</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Cell-mediated hypersensitivity<br />(type IV)</strong></p>\n<ul>\n<li>Contact dermatitis</li>\n<li>Multiple sclerosis</li>\n<li>Type 1 diabetes</li>\n<li>Tuberculosis</li>\n</ul>\n</td>\n<td>\n<p>Activated T lymphocytes &rarr;</p>\n<p>1. Release of cytokines, inflammation, and macrophage activation</p>\n<p>2. T-cell-mediated cytotoxicity</p>\n</td>\n<td>\n<p>Perivascular cellular infiltrates; edema; granuloma formation; cell destruction</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/f55cab6c8fd44a7abfe8a663dde3980ex1280x2567.JPEG\" alt=\"Pearl Image\"><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/b2a98b94d6a9479b8e6e885ee59366cex1280x2089.JPEG\" alt=\"Pearl Image\"><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/d92e092ef5874477a6da091ca3b1234ax1280x1360.JPEG\" alt=\"Pearl Image\"><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/56fc1dfb49434818b5057534a97d6621x1280x4218.JPEG\" alt=\"Pearl Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF2235",
      "difficulty": "medium"
    },
    {
      "text": "A 45-year-old male patient was diagnosed with iron deficiency anemia. Which of the following is true about intracellular regulation of iron in the above condition?<div class='question-desc-html'><p>IRP- Iron regulatory protein</p>\n<p>IRE- Iron response elements</p></div>",
      "choices": [
        {
          "id": 1,
          "text": "Ferritin translation is increased by binding IRP to IRE"
        },
        {
          "id": 2,
          "text": "Ferritin translation is decreased by binding IRP to IRE"
        },
        {
          "id": 3,
          "text": "Transferrin receptor 1 translation is unaffected by binding IRP to IRE"
        },
        {
          "id": 4,
          "text": "Transferrin receptor 1 translation is decreased by binding IRP to IRE"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>In iron deficiency anemia, <strong>ferritin translation</strong> is <strong>decreased</strong> by binding iron regulatory protein to iron response elements.</p>\n<p>Dietary iron is <strong>carried</strong> in the blood by <strong>transferrin</strong> and <strong>enters</strong> cells via endocytosis, mediated by the <strong>transferrin receptor.</strong> Excess iron is <strong>stored</strong> by binding to&nbsp;<strong>ferritin</strong>. The levels of transferrin, transferrin receptor (TfR), and ferritin are therefore crucial to cellular iron homeostasis.</p>\n<p>The synthesis of these three proteins is regulated in response to<strong> iron availability</strong> and <strong>aconitase </strong>(enzyme in citric acid cycle).</p>\n<div class=\"page\" title=\"Page 2114\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>When a cell is <strong>depleted of iron</strong>, the aconitase enzyme is converted to <strong>apoaconitase</strong>. Apoaconitase is identical to <strong>iron regulatory protein 1 (IRP-1)</strong> and is closely related to <strong>IRP-2.&nbsp;</strong>It regulates iron metabolism.</p>\n<p>The iron regulatory proteins (IRPs) are two cytoplasmic RNA-binding proteins that control iron metabolism. They bind to regions in the mRNA containing the ferritin and transferrin receptor. These mRNA sequences are part of hairpin structures known as iron response elements (IREs).&nbsp;</p>\n<ul>\n<li>When the IRPs bind to the 5' untranslated IRE sequence in the ferritin mRNA, <strong>IRPs block ferritin translation</strong>, thus decreasing ferritin.</li>\n<li>When IRPs are bound to the 3' end of the untranslated IRE sequence, they stabilize the mRNA, prevent its degradation and increase the copies of transferrin receptor per mRNA molecule.</li>\n</ul>\n<p>Hence, in iron-deficient cells, <strong>iron storage</strong> (bound to ferritin) is <strong>reduced</strong> and&nbsp;<strong>iron uptake</strong> (via transferrin receptor) becomes more <strong>efficient.&nbsp;</strong></p>\n</div>\n</div>\n</div>\n</div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF2266",
      "difficulty": "medium"
    },
    {
      "text": "A 65-year-old male patient with chronic fatigue and lymphadenopathy presents to the outpatient department. His peripheral smear shows the presence of smudge cells. Which of the following additional investigations will you do to arrive at a diagnosis?",
      "choices": [
        {
          "id": 1,
          "text": "Polymerase chain reaction"
        },
        {
          "id": 2,
          "text": "Fluorescent in situ hybridization"
        },
        {
          "id": 3,
          "text": "Flow cytometry"
        },
        {
          "id": 4,
          "text": "Cytogenetics"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>An elderly patient with chronic fatigue and lymphadenopathy, and a peripheral smear showing the&nbsp;presence of smudge cells suggest a diagnosis of&nbsp;<strong>chronic</strong> <strong>lymphocytic</strong> <strong>leukemia</strong>. Immunophenotyping using<strong> flow cytometry</strong> is the investigation done to arrive at the diagnosis. The classical immunophenotypic feature of CLL is&nbsp;CD 19+, CD20+,&nbsp;<strong>CD 23+, CD5+.</strong></p>\n<p><strong>Chronic Lymphocytic Leukemia (CLL)</strong><strong>&nbsp;</strong>is a peripheral B-cell neoplasm usually affecting adults, more commonly men. Patients are often asymptomatic at diagnosis. When symptomatic, it presents non specifically with easy fatigability, weight loss, and anorexia. <strong>Generalized lymphadenopathy </strong>and<strong> hepatosplenomegaly</strong> are present in most symptomatic patients.&nbsp;</p>\n<p>The chromosomal defects in CLL include:</p>\n<ul>\n<li>Deletion of<strong>&nbsp;13q</strong>&nbsp;(<strong>commonest</strong>&nbsp;and has a good prognosis)</li>\n<li>Deletion of 11q</li>\n<li>Trisomy 12q</li>\n<li>Deletion of&nbsp;<strong>17p</strong>&nbsp;(poor prognosis)</li>\n</ul>\n<p>The peripheral blood smear in cases of chronic lymphocytic leukemia&nbsp;(CLL) contains&nbsp;<strong>small</strong> <strong>round</strong> <strong>lymphocytes</strong>&nbsp;having condensed chromatin and scant cytoplasm. Some of these cells may get disrupted while preparing the smears, producing <strong>smudge</strong> <strong>cells. </strong>An absolute lymphocyte count of &gt;5000/mm<sup>3 </sup>is required for diagnosis. Hypogammaglobulinemia is commonly seen, making the patient susceptible to infections. A few patients may develop&nbsp;<strong>hemolytic anemia or thrombocytopenia</strong>&nbsp;due to autoantibodies made by non-neoplastic B cells.</p>\n<p>On lymph node biopsy: Lymph nodes are composed of small lymphocytes admixed with larger activated lymphocytes. The large lymphocytes contain mitotically active cells and&nbsp;gather in loose aggregates referred to as <strong>proliferation centers.</strong> These proliferation centers are pathognomic to CLL when present.</p>\n<div class=\"page\" title=\"Page 601\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<div class=\"page\" title=\"Page 813\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Expectant management&nbsp;is the treatment of choice for asymptomatic patients with chronic lymphocytic leukemia. The gold standard for therapy is a&nbsp;combination of&nbsp;<strong>fludarabine</strong>,&nbsp;<strong>cyclophosphamide</strong>, and&nbsp;<strong>rituximab.</strong></p>\n<p><strong>Richter&rsquo;s syndrome </strong>is a complication of CLL in which there is a transformation to an aggressive lymphoma, most commonly<strong>&nbsp;diffuse large B-cell lymphoma (DLBCL).</strong></p>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n<div class=\"page\" title=\"Page 814\">The image shows small round lymphocytes and smudge cells seen in CLL.</div><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/3c3c8325438b41cfacc5a99f7184c311x355x512.JPEG\" alt=\"Explanation Image\"><hr><h3>Related Pearl: Origin of leukemia / lymphoma and their immunophenotypes</h3><table>\n<tbody>\n<tr>\n<td><strong>B cell precursors</strong></td>\n<td><strong>Derived lymphomas/leukemia</strong></td>\n<td><strong>Immunophenotype</strong></td>\n</tr>\n<tr>\n<td>Pro-B cell</td>\n<td>Pro-B cell ALL</td>\n<td>CD34,&nbsp;CD19, CD79a</td>\n</tr>\n<tr>\n<td>Pre-B cell</td>\n<td>Pre-B cell ALL</td>\n<td>CD19, CD79a,&nbsp;CD10, Tdt</td>\n</tr>\n<tr>\n<td>Mature B cell</td>\n<td>CLL/SLL</td>\n<td>\n<p>CD19, CD79a,CD 20, CD21, CD22, surface IgM, CD 23, CD5</p>\n</td>\n</tr>\n<tr>\n<td>Mantle zone</td>\n<td>Mantle zone lymphoma</td>\n<td>CD19, CD79a,CD 20, CD21, CD22, surface IgM, CD5</td>\n</tr>\n<tr>\n<td>Germinal center/Follicular center</td>\n<td>\n<p>Follicular lymphoma</p>\n<p>&nbsp;</p>\n<p>Diffuse large B-cell lymphoma</p>\n<p>Burkitt lymphoma</p>\n</td>\n<td>\n<p>CD 79a, CD 19, CD20, CD21,CD22, CD10, CD 23, Bcl-2</p>\n<p>CD10, Cd23, Bcl-6</p>\n<p>CD19, CD20, CD22, CD79a, CD10, Bcl-6</p>\n</td>\n</tr>\n<tr>\n<td>Memory B cells</td>\n<td>Extranodal marginal zone lymphoma</td>\n<td>CD19, CD79a,CD 20, surface Ig</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>CLL:&nbsp;Chronic lymphocytic leukemia&nbsp;</p>\n<p>SLL:&nbsp;Small lymphocytic lymphoma</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF2206",
      "difficulty": "medium"
    },
    {
      "text": "Oil red O stain is used in which of the following?",
      "choices": [
        {
          "id": 1,
          "text": "Formalin fixation"
        },
        {
          "id": 2,
          "text": "Frozen section"
        },
        {
          "id": 3,
          "text": "Alcohol fixation"
        },
        {
          "id": 4,
          "text": "Gluteraldehyde fixation"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>Oil red O (ORO) stain&nbsp;is used in frozen section.</p>\n<p>Oil red O <strong>stains lipid/ fats</strong> and gives a characteristic <strong>orange/red appearance</strong>. It is used in the unfixed frozen sections as the fixation of fats with other routine processes may lose the lipid content. <strong>10% Neutral buffer formaldehyde (NBF)</strong> is the preferred fixative in histopathological sections staining with Oil red O. Zenker's fixative and Helly's fixative are best avoided during staining with ORO.</p>\n<p>Oil red O&nbsp;stains the lipid in the vacuoles in the pulmonary vasculature.&nbsp;It can be useful in identifying fat emboli in lung tissue, diagnosing renal cell carcinoma, and sebaceous gland tumors of the skin.</p>\n<div class=\"ng-scope\">\n<div class=\"ng-scope\">\n<p class=\"ng-binding\">&nbsp;Other stains used for lipids or fats:</p>\n<div class=\"page\" title=\"Page 67\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<ul>\n<li>Nile blue sulfate. The preferred fixative is formal calcium.</li>\n<li>Osmic acid is used in the frozen section. 10% NBF is the preferred fixative</li>\n<li>Sudan black B is used in the frozen section. The preferred fixative is 10% NBF.</li>\n</ul>\n<p>Other Options:</p>\n<p>Option A:&nbsp;<strong>Formalin fixation- </strong>Formalin&nbsp;as <strong>10% neutral buffered formalin (NBF)</strong> is the most common fixative used in diagnostic pathology.</p>\n<p>Option C:&nbsp;<strong>Ethyl alcohol</strong>- Ideal fixative for <strong>cytological smears</strong> because they act quickly and give good nuclear detail.</p>\n<p>Option D:&nbsp;<strong>Glutaraldehyde</strong>- Preferred&nbsp;fixative in <strong>electron microscopy.</strong> The standard solution is a 2.5% buffered glutaraldehyde.</p>\n<p>Image below shows microscopy of a <strong>oil red O stained bronchoalveolar lavage</strong> sample from a patient with acute lung injury.</p>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/0c66878a03164f31a3515090753ca42bx257x208.JPEG\" alt=\"Explanation Image\"><p>The image shows the lipid vesicles in the adipocytes stained using oil-red-O staining.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/49b4ee358500448eaa8aaf9a00c0768bx1280x960.JPEG\" alt=\"Explanation Image\"><hr><h3>Related Pearl: Special stains used for staining Lipid</h3><ul>\n<li>Oil Red O</li>\n<li>Sudan Black or Sudan IV</li>\n<li>Osmium tetroxide.</li>\n</ul><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/e7e3d66d3d444282bb04bb7e655d53edx800x600.JPEG\" alt=\"Pearl Image\"><p>The image shows Oil Red O staining of lipid.&nbsp;</p><hr><h3>Related Pearl: Various stains and their applications in Pathology and Microbiology</h3><table>\n<tbody>\n<tr>\n<td><strong>Staining technique</strong></td>\n<td><strong>Cells/inclusions stained</strong></td>\n<td><strong>Disorders</strong></td>\n</tr>\n<tr>\n<td><strong>H&amp;E</strong></td>\n<td>Most common stain used in routine&nbsp;<strong>histopathology</strong></td>\n<td>Commonly used for all slides</td>\n</tr>\n<tr>\n<td><strong>Papanicolaou stain</strong></td>\n<td>Universal stain for <strong>cytological</strong> preparations</td>\n<td>Cytological studies</td>\n</tr>\n<tr>\n<td><strong>PAS</strong></td>\n<td>Demonstrate&nbsp;<strong>glycogen,&nbsp;mucin,&nbsp;fungi, </strong>macrophages&nbsp;</td>\n<td>Whipple's disease, adenocarcinomas,&nbsp;and glycogen-positive tumors (Ewings sarcoma, renal cell carcinoma)</td>\n</tr>\n<tr>\n<td><strong><strong>PTAH (</strong></strong><strong>Phosphotungstic acid hematoxylin)</strong></td>\n<td>Fibrin</td>\n<td>Gliosis, Ependymomas, Tumours of skeletal muscles, Fibrin deposits</td>\n</tr>\n<tr>\n<td><strong>Alcian blue</strong></td>\n<td>For <strong>acid mucins</strong>: Positive stain for mucins of the intestinal mucosa and negative stain for mucins of gastric mucosa and Brunner's gland</td>\n<td>Barrett's esophagus, Gastric disorders</td>\n</tr>\n<tr>\n<td><strong>Perl's Prussian blue</strong></td>\n<td>Demonstrate&nbsp;<strong>hemosiderin and iron</strong></td>\n<td>Hemochromatosis&nbsp;</td>\n</tr>\n<tr>\n<td><strong>Masson&ndash;Fontana stain</strong></td>\n<td>Demonstrate <strong>melanin</strong></td>\n<td>Nevus and malignant melanoma</td>\n</tr>\n<tr>\n<td><strong>von Kossa method</strong></td>\n<td>Demonstrate&nbsp;<strong>calcium</strong></td>\n<td>Calcification of tissues</td>\n</tr>\n<tr>\n<td><strong>Van Gieson stain</strong></td>\n<td>\n<p>Demonstrate <strong>collagen </strong>in; Differentiate amyloid from collagen</p>\n</td>\n<td>Spindle-cell neoplasm; Delineate extent of fibrosis&nbsp;</td>\n</tr>\n<tr>\n<td><strong>Masson trichrome stain</strong></td>\n<td>Demonstrate <strong>collagen and muscle</strong></td>\n<td>Connective tissue disorders, muscle and fibroblast tumors, liver cirrhosis, neuromuscular diseases&nbsp;</td>\n</tr>\n<tr>\n<td><strong>Reticulin stain</strong></td>\n<td>Demonstrate <strong>reticulin fibers</strong></td>\n<td>Distinguish epithelial from non-epithelial neoplasm, Hodgkin's lymphoma, early cirrhosis of the&nbsp;liver, myelofibrosis</td>\n</tr>\n<tr>\n<td><strong>Verhoeff's method</strong></td>\n<td>Demonstrate <strong>elastic fibers</strong></td>\n<td>Malignant hypertension, arteriovenous malformation aneurysms, Marfan's syndrome, emphysema lung</td>\n</tr>\n<tr>\n<td><strong>Oil red O</strong> <strong>Sudan Black</strong> <strong>Sudan III/IV</strong></td>\n<td>Demonstrate&nbsp;<strong>fat/lipids</strong></td>\n<td>Fatty liver-fat embolism-fibroma vs. thecoma of the&nbsp;ovary-liposarcoma&nbsp;</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p><strong>Microbiology stains:</strong></p>\n<table>\n<tbody>\n<tr>\n<td><strong>Stain</strong></td>\n<td><strong>&nbsp;Uses</strong></td>\n</tr>\n<tr>\n<td><strong>Ziehl&ndash;Neelsen Stain</strong></td>\n<td>Mycobacteria (all species, including <em>Mycobacterium leprae</em>), <em>Nocardia </em>spp. Cyst of&nbsp;<em>Cryptosporidium parvum</em>, <em>Isospora </em>spp., and&nbsp;<em>Cyclospora</em>&nbsp;spp., Head of sperms</td>\n</tr>\n<tr>\n<td><strong>Masson&rsquo;s Fontana</strong></td>\n<td>Melanin and argentaffin Cells</td>\n</tr>\n<tr>\n<td><strong>Gomori Methenamine Silver</strong></td>\n<td>Fungi</td>\n</tr>\n<tr>\n<td><strong>Luxol Fast Blue (LFB)</strong></td>\n<td>Myelin</td>\n</tr>\n<tr>\n<td><strong>Phosphotungstic Acid-hematoxylin</strong></td>\n<td>Cross striations of skeletal muscle, fibrin</td>\n</tr>\n<tr>\n<td><strong>Toluidine blue</strong></td>\n<td>Mast cells</td>\n</tr>\n<tr>\n<td><strong>Warthin&ndash;Starry</strong></td>\n<td>Helicobacter pylori, spirochetes</td>\n</tr>\n<tr>\n<td><strong>Van Gieson</strong></td>\n<td>Collagen fibres</td>\n</tr>\n<tr>\n<td><strong>Mucicarmine</strong></td>\n<td>Mucin, <em>Cryptococcus</em> capsule</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF2431",
      "difficulty": "easy"
    },
    {
      "text": "A boy presents with fever, night sweats, and neck swelling. The biopsy of swelling showed a starry sky appearance. What is the most likely genetic abnormality seen in this case?",
      "choices": [
        {
          "id": 1,
          "text": "MYC"
        },
        {
          "id": 2,
          "text": "RAS"
        },
        {
          "id": 3,
          "text": "BCR-ABL"
        },
        {
          "id": 4,
          "text": "p53"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<div class=\"page\" title=\"Page 610\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p><span data-preserver-spaces=\"true\">The given clinical scenario and the classical histopathological finding of starry sky appearance suggest the diagnosis of&nbsp;<strong>Burkitt's lymphoma</strong>&nbsp;and the most likely genetic abnormality is the translocation of the&nbsp;<strong>MYC gene </strong>on<strong> chromosome 8.</strong> </span></p>\n<p><span data-preserver-spaces=\"true\">Burkitt's lymphoma arises from&nbsp;</span>mature&nbsp;germinal center B-cells that express surface IgM, CD19, CD20, CD10, and BCL6.</p>\n<p>It is divided into endemic and sporadic types, both of which occur mainly in children or young adults.</p>\n<ul>\n<li><strong>African (endemic) Burkitt lymphoma</strong> often presents as a mass involving the mandible and may involve the abdominal viscera, particularly the kidneys, ovaries, and adrenal glands.&nbsp;</li>\n<li><strong>Sporadic (non-endemic) Burkitt lymphoma</strong> most often appears as a mass involving the ileocecum and peritoneum.&nbsp;</li>\n<li>A subset of aggressive lymphomas occurs in individuals infected with HIV.</li>\n</ul>\n<div class=\"page\" title=\"Page 606\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>All forms of Burkitt lymphoma are associated with translocations of the MYC gene on chromosome 8 that lead to increased MYC protein levels. Essentially all endemic Burkitt lymphomas are latently infected with <strong>Epstein-Barr virus</strong> (EBV).</p>\n<p>The tumor shows a <strong>high mitotic index</strong> with numerous <strong>apoptotic cells.</strong> The nuclear remnants of these apoptotic cells are phagocytosed by interspersed benign macrophages. The phagocytes have abundant clear cytoplasm, creating a characteristic <strong>starry sky pattern</strong>.</p>\n<p>Burkitt lymphoma is very aggressive but responds well to intensive chemotherapy.</p>\n<p>The image below shows the starry sky appearance seen in Burkitt's lymphoma.</p>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/2a7252784f1e4817b46fc86c42004172x1280x853.JPEG\" alt=\"Explanation Image\"><hr><h3>Related Pearl: Malignancies, Translocations and Affected Genes</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Malignancy </strong></p>\n</td>\n<td>\n<p><strong>Translocation</strong></p>\n</td>\n<td>\n<p><strong>Affected Genes</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>CLL/ Small lymphocytic lymphoma</p>\n</td>\n<td>\n<p>t(14;19)</p>\n</td>\n<td>\n<p><em>-</em></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Chronic myelogenous leukemia (CML)</p>\n</td>\n<td>\n<p>t(9;22)</p>\n</td>\n<td>\n<p><em>ABL </em>9q34</p>\n<p><em>BCR </em>22q11</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Acute myeloid leukemia (AML)</p>\n</td>\n<td>\n<p>t(8; 21), t(15; 17)</p>\n</td>\n<td>\n<p><em>AML1 21</em>q22</p>\n<p><em>ETO 8</em>q22</p>\n<p><em>PML </em>15q22</p>\n<p><em>RARA </em>17q21</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Precursor B cell ALL</p>\n</td>\n<td>\n<p>t(9;22), t(4;11)</p>\n</td>\n<td>&nbsp;\n<p>BCR/ABL</p>\n<p>AF4, ALLI</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Burkitt lymphoma</p>\n</td>\n<td>\n<p>t(8; 14), t(2;8) t(8;22)</p>\n</td>\n<td>\n<p><em>c-myc&nbsp;</em>8q24</p>\n<p><em>IGH </em>14q32</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Mantle cell lymphoma</p>\n</td>\n<td>\n<p>t(11; 14)</p>\n</td>\n<td>\n<p><em>CCND1 </em>11q13</p>\n<p><em>IGH </em>14q32</p>\n<p><em>BCL1</em></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Follicular lymphoma</p>\n</td>\n<td>\n<p>t(14; 18)</p>\n</td>\n<td>\n<p><em>IGH </em>14q32</p>\n<p><em>BCL2 </em>18q21</p>\n<p>&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Ewing sarcoma</p>\n</td>\n<td>\n<p>t(11; 22)</p>\n</td>\n<td>\n<p><em>FLI1 </em>11q24</p>\n<p><em>EWSR1 </em>22q12</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Prostatic adenocarcinoma</p>\n</td>\n<td>\n<p>t(7; 21), t(17; 21)</p>\n</td>\n<td>\n<p><em>TMPRSS2 </em>(21q22.3)</p>\n<p><em>ETV1</em> (7p21.2)</p>\n<p><em>ETV4 </em>(17q21)</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Diffuse large B-cell lymphoma</p>\n</td>\n<td>&nbsp;t(14;18)</td>\n<td>&nbsp;\n<p><em>BCL-6</em>,&nbsp;p53</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>MALT lymphoma</p>\n</td>\n<td>t(11;18)</td>\n<td><em>API2/MALT</em>, <em>BCL-10</em></td>\n</tr>\n<tr>\n<td>\n<p>CD30+ Anaplastic large cell lymphoma</p>\n</td>\n<td>t(2;5)</td>\n<td><em>ALK</em></td>\n</tr>\n<tr>\n<td>\n<p>Lymphoplasmacytoid lymphoma</p>\n</td>\n<td>t(9;14)</td>\n<td><em>PAX5, IGH</em></td>\n</tr>\n<tr>\n<td>\n<p>Synovial sarcoma</p>\n</td>\n<td>t(X;18)(p11;q11)&nbsp;</td>\n<td>&nbsp;\n<p><em>SS18-SSX2</em></p>\n<p><em>SS18-SSX4</em></p>\n</td>\n</tr>\n<tr>\n<td>&nbsp;Alveolar soft-part sarcoma</td>\n<td>&nbsp;t(X;17)(p11.2;q25)</td>\n<td>&nbsp;<em>TFE3-ASPL</em></td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p><hr><h3>Related Pearl: Cell Cycle Regulators and Associated Cancers</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Cell cycle regulator</strong></p>\n</td>\n<td>\n<p><strong>Proto-oncogene</strong></p>\n</td>\n<td>\n<p><strong>Mode of activation in tumor</strong></p>\n</td>\n<td>\n<p><strong>Associated tumor</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Cyclins</p>\n</td>\n<td>\n<p>CCND1 (Cyclin D1)</p>\n</td>\n<td>\n<p>Translocation</p>\n<p>Amplification</p>\n</td>\n<td>\n<p>Mantle cell lymphoma, multiple myeloma</p>\n<p>Breast and esophageal cancers</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Cyclin-dependent kinase</p>\n</td>\n<td>\n<p>CDK4</p>\n</td>\n<td>\n<p>Amplification or point mutation</p>\n</td>\n<td>\n<p>Glioblastoma, melanoma, sarcoma</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF2158",
      "difficulty": "easy"
    },
    {
      "text": "An electron microscopic picture of a cut section of a nerve fiber is given.  Identify the area which will be affected in the most common variant of Guillain-Barré syndrome.",
      "choices": [
        {
          "id": 1,
          "text": "1"
        },
        {
          "id": 2,
          "text": "2"
        },
        {
          "id": 3,
          "text": "3"
        },
        {
          "id": 4,
          "text": "4"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The most common variant of <strong>Guillain-Barré</strong> syndrome is<strong> acute inflammatory demyelinating</strong> <strong>polyneuropathy </strong>(AIDP). The area affected in this condition is the <strong>myelin sheath</strong> (marked as <strong>2 </strong>in the image). </p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/a435899dd47645c58091ca5f4390f44dx1280x1500.JPEG\" alt=\"Explanation Image\"><div class=\"page\" title=\"Page 3271\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Guillain-Barré syndrome (GBS) is an acute autoimmune disease that causes fulminant <strong>polyradiculoneuropathy</strong>. It is a <strong>T-cell mediated</strong> immune response. </p>\n<p>GBS is usually associated with a history of upper respiratory infection (<strong>URI</strong>) or acute gastroenteritis (<strong>AGE</strong>) 1-3 weeks prior. The causative organisms may be <em>Campylobacter jejuni</em>, cytomegalovirus, Epstein-Barr virus, and <em>Mycoplasma pneumoniae.</em></p>\n<div class=\"page\" title=\"Page 3271\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>It presents with the following features:</p>\n<ul>\n<li><strong>Ascending motor paralysis</strong> (lower limbs &gt; upper limbs)</li>\n<li>Sensory deficits may or may not be seen</li>\n<li>Deep tendon reflexes - absent </li>\n<li>Transient bladder dysfunction - severe cases</li>\n<li>Autonomic manifestations - loss of vasomotor control, postural hypotension, cardiac dysrhythmias </li>\n</ul>\n<div class=\"page\" title=\"Page 1220\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<div class=\"page\" title=\"Page 1220\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<div class=\"page\" title=\"Page 1221\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<div class=\"page\" title=\"Page 1221\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Histological examination shows inflammation of peripheral nerves, manifested as <strong>perivenular</strong> and <strong>endoneurial infiltration</strong> by lymphocytes, macrophages, and a few plasma cells. On electron microscopy, an early effect on myelin sheaths is seen. There is <strong>segmental demyelination</strong> induced by the actions of activated macrophages.</p>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n<p>There are several <strong>types</strong> of Guillain–Barre syndrome:</p>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n<ul>\n<li>Demyelinating\n<ul>\n<li>Acute inflammatory demyelinating polyneuropathy (<strong>AIDP</strong>) - <strong>most common</strong></li>\n</ul>\n</li>\n<li>Axonal\n<ul>\n<li>Acute motor axonal neuropathy (AMAN)</li>\n<li>Acute motor-sensory axonal neuropathy (AMSAN)</li>\n</ul>\n</li>\n<li>Regional GBS syndromes: Miller–Fisher syndrome (MFS)</li>\n</ul><hr><h3>Related Pearl: Antibodies seen in Guillian Barre syndrome</h3><table>\n<tbody>\n<tr>\n<td><strong>Type</strong></td>\n<td><strong>Antibody</strong></td>\n</tr>\n<tr>\n<td>AIDP</td>\n<td>Anti GM1</td>\n</tr>\n<tr>\n<td>AMAN</td>\n<td>Anti GD1a</td>\n</tr>\n<tr>\n<td>AMSAN</td>\n<td>Anti GD1a</td>\n</tr>\n<tr>\n<td>Miller Fisher syndrome</td>\n<td>Anti GQ1b</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<ul>\n<li>AIDP-Acute inflammatory demyelinating polyneuropathy&nbsp;</li>\n<li>AMAN-Acute motor axonal neuropathy&nbsp;</li>\n<li>AMSAN-Acute motor sensory axonal neuropathy&nbsp;</li>\n</ul><hr><h3>Related Pearl: Mechanism of Immunopathogenesis of Guillain-Barre Syndrome</h3><p>The following sequence of events, takes into consideration, the development of Guillain-Barre syndrome (GBS) associated with <em>Campylobacter jejuni</em><strong> infection</strong>.</p>\n<ol>\n<li><strong>B cells</strong> recognize glycoconjugates on <strong> jejuni (Cj)</strong> that cross-react with <strong>ganglioside</strong> present on <strong>Schwann cell surface</strong> and <strong>subjacent peripheral nerve myelin</strong>.</li>\n<li>Most of the B cells are activated via a partially T cell&ndash;dependent route and secrete primarily <strong>IgG autoantibodies</strong>. Some B cells, activated via a T cell&ndash;independent mechanism, secrete primarily IgM</li>\n<li><strong>The</strong> <strong>activated B cells</strong> escape from Peyer&rsquo;s patches into regional lymph nodes.</li>\n<li><strong>Activated T cells</strong> also function to assist in the opening of the blood-nerve barrier, facilitating penetration of pathogenic autoantibodies.</li>\n<li>The earliest changes in myelin consist of <strong>edema between myelin lamellae</strong> and <strong>vesicular disruption</strong> of the outermost myelin layers.</li>\n<li>These effects are associated with activation of the <strong>C5b-C9 membrane attack complex</strong> and mediated by <strong>calcium entry</strong>; it is possible that the macrophage cytokine tumor necrosis factor (TNF) also participates in <strong>myelin damage</strong>.</li>\n</ol><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/b40cb513616a452c90a928eb9e4fc6d7x1280x1987.JPEG\" alt=\"Pearl Image\"><hr><h3>Related Pearl: Adverse Events following Immunization</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Vaccine</strong></p>\n</td>\n<td>\n<p><strong>Common, Minor Reactions</strong></p>\n</td>\n<td>\n<p><strong>Rare, Serious Reactions</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>BCG</p>\n</td>\n<td>\n<p>Local pain and swelling</p>\n</td>\n<td>\n<p>Suppurative lymphadenitis</p>\n<p>BCG osteitis</p>\n<p>Disseminated BCG infection</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Hepatitis B</p>\n</td>\n<td>\n<p>Local reaction, fever</p>\n</td>\n<td>\n<p>Anaphylaxis</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Inactivated influenza</p>\n</td>\n<td>\n<p>Local reaction</p>\n</td>\n<td>\n<p>Guillain-Barre syndrome (GBS)</p>\n<p>Oculo-respiratory syndrome</p>\n<p>Anaphylaxis</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>JE vaccine</p>\n</td>\n<td>\n<p>Local reaction, low-grade fever, myalgia</p>\n</td>\n<td>\n<p>Neurologic events like encephalitis</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Measles/MMR</p>\n</td>\n<td>\n<p>Local reactions, fever, malaise, irritability</p>\n</td>\n<td>\n<p>Febrile seizures, arthralgia, thrombocytopenia</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Yellow fever</p>\n</td>\n<td>\n<p>Headache, flu like symptoms, local reactions</p>\n</td>\n<td>\n<p>Vaccine-associated viscerotropic disease</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Oral Polio</p>\n</td>\n<td>\n<p>None</p>\n</td>\n<td>\n<p>Vaccine associated paralytic poliomyelitis</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>DPT</p>\n</td>\n<td>\n<p>Local reaction, fever</p>\n</td>\n<td>\n<p>Neurologic events like encephalitis, seizures, HHE (hypotonic hyporesponsive episode), anaphylaxis, persistent inconsolable screaming</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/9ce700194b27458f8367ffba297d57f9.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF2486",
      "difficulty": "medium"
    }
  ]
}